Case number 1:18-cv-00192
Pharmacyclics LLC et al v. Sandoz Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 11, 2021 | 560 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal Between Plaintiffs and Sandoz Inc. and Lek Pharmaceuticals d.d. by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| May 11, 2021 | 561 | SO ORDERED (2) Docket Text: SO ORDERED, re [560] Stipulation of Dismissal filed by Janssen Biotech Inc., Pharmacyclics LLC, ***Civil Case Terminated. Signed by Judge Colm F. Connolly on 5/11/2021. (fms) |
| May 11, 2021 | 562 | Patent/Trademark Report to Commissioner (18) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): See reports for patent numbers. (Attachments: # (1) Stipulation of Dismissal)(fms) |
| May 11, 2021 | 562 | Stipulation of Dismissal (2) |
| May 3, 2021 | 558 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal [Joint] by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| May 3, 2021 | 559 | SO ORDERED (2) Docket Text: SO ORDERED, re [558] Stipulation of Dismissal filed by Janssen Biotech Inc., Pharmacyclics LLC. Party Cipla Limited, Cipla USA Inc. terminated. Signed by Judge Colm F. Connolly on 5/3/2021. (fms) |
| Mar 11, 2021 | 557 | Notice (Other) (5) Docket Text: NOTICE of Withdrawal of Counsel (Jennifer A. Ward) by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc. (Ward, Jennifer) |
| Feb 15, 2021 | 556 | Notice Requesting Removal of Co-Counsel (5) Docket Text: NOTICE requesting Clerk to remove Anna Q. Han as co-counsel. Reason for request: No longer with firm. (Ward, Jennifer) |
| Feb 2, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The transcript entry previously found at D.I. 552 has been deleted as it was docketed in error. (nmf) |
| Feb 2, 2021 | 554 | Transcript (319) Docket Text: Official Transcript of bench trial held on October 20, 2020 before Judge Connolly. Court Reporter/Transcriber Valerie Gunning,Email: Valerie_Gunning@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/23/2021. Redacted Transcript Deadline set for 3/5/2021. Release of Transcript Restriction set for 5/3/2021. (vjg) |
| Feb 2, 2021 | 555 | Transcript (333) Docket Text: Official Transcript of bench trial held on October 21, 2020 before Judge Connolly. Court Reporter/Transcriber Valerie Gunning,Email: Valerie_Gunning@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/23/2021. Redacted Transcript Deadline set for 3/5/2021. Release of Transcript Restriction set for 5/3/2021. (vjg) |
| Feb 1, 2021 | 548 | Transcript (296) Docket Text: Official Transcript of bench trial held on October 13, 2020 before Judge Connolly. Court Reporter/Transcriber Valerie Gunning,Email: Valerie_Gunning@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/22/2021. Redacted Transcript Deadline set for 3/4/2021. Release of Transcript Restriction set for 5/3/2021. (vjg) |
| Feb 1, 2021 | 549 | Transcript (285) Docket Text: Official Transcript of bench trial held on October 14, 2020 before Judge Connolly. Court Reporter/Transcriber Valerie Gunning,Email: Valerie_Gunning@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/22/2021. Redacted Transcript Deadline set for 3/4/2021. Release of Transcript Restriction set for 5/3/2021. (vjg) |
| Feb 1, 2021 | 550 | Transcript (317) Docket Text: Official Transcript of bench trial held on October 15, 2020 before Judge Connolly. Court Reporter/Transcriber Valerie Gunning,Email: Valerie_Gunning@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/22/2021. Redacted Transcript Deadline set for 3/4/2021. Release of Transcript Restriction set for 5/3/2021. (vjg) |
| Feb 1, 2021 | 551 | Transcript (291) Docket Text: Official Transcript of bench trial held on October 16, 2020 before Judge Connolly. Court Reporter/Transcriber Valerie Gunning,Email: Valerie_Gunning@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/22/2021. Redacted Transcript Deadline set for 3/4/2021. Release of Transcript Restriction set for 5/3/2021. (vjg) |
| Feb 1, 2021 | 553 | Transcript (334) Docket Text: Official Transcript of bench trial held on October 19, 2020 before Judge Connolly. Court Reporter/Transcriber Valerie Gunning,Email: Valerie_Gunning@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/22/2021. Redacted Transcript Deadline set for 3/4/2021. Release of Transcript Restriction set for 5/3/2021. (vjg) |
| Jan 11, 2021 | 547 | Exhibit List (12) Docket Text: Exhibit List by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Jan 8, 2021 | 546 | Redacted Document (30) Docket Text: REDACTED VERSION of (334 in 1:19-cv-00434-CFC-CJB, 542 in 1:18-cv-00192-CFC-CJB) POST Trial Brief by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Jan 7, 2021 | 543 | Proposed Findings of Fact (30) Docket Text: Proposed Findings of Fact by Lek Pharmaceuticals D.D., Sandoz Inc.. (Gattuso, Dominick) |
| Jan 7, 2021 | 544 | POST Trial Brief (30) Docket Text: POST TRIAL BRIEF Sandoz's Opening Post-Trial Invalidity Brief by Lek Pharmaceuticals D.D., Sandoz Inc.. (Gattuso, Dominick) |
| Jan 7, 2021 | 545 | POST Trial Brief (28) Docket Text: POST TRIAL BRIEF Sandoz's Post-Trial Invalidity Reply Brief by Lek Pharmaceuticals D.D., Sandoz Inc.. (Gattuso, Dominick) |
| Jan 5, 2021 | 540 | Proposed Findings of Fact (30) Docket Text: Proposed Findings of Fact by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Jan 5, 2021 | 541 | POST Trial Brief (30) Docket Text: POST TRIAL BRIEF [Plaintiffs' Post-Trial Brief with Respect to Defendants Sandoz Inc. and Lek Pharmaceuticals d.d.] by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Tigan, Jeremy) |
| Jan 4, 2021 | 539 | Proposed Findings of Fact (30) Docket Text: Proposed Findings of Fact by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Dec 29, 2020 | 538 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Post-Trial Brief with Respect to Defendants Alvogen Pine Brook LLC and Natco Pharma Ltd., and (2) Plaintiffs' Post-Trial Brief with Respect to Defendants Sandoz Inc. and Lek Pharmaceuticals d.d. filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Ward, Jennifer) |
| Dec 23, 2020 | 537 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of Plaintiffs' Post-Trial Brief with Respect to Defendants Sandoz Inc. and Lek Pharmaceuticals d.d. filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Tigan, Jeremy) |
| Nov 25, 2020 | 535 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Sandoz Inc.'s Opening Post-Trial Invalidity Brief; and, (ii) Sandoz Inc.'s Proposed Findings of Fact filed by Lek Pharmaceuticals D.D., Sandoz Inc..(Gattuso, Dominick) |
| Nov 25, 2020 | 536 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of Plaintiffs' Post-Trial Proposed Findings of Fact with Respect to Defendants Alvogen Pine Brook LLC and Natco Pharma Ltd. filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Ward, Jennifer) |
| Nov 24, 2020 | 520 | Redacted Document (30) Docket Text: REDACTED VERSION of (276 in 1:19-cv-00434-CFC-CJB, 482 in 1:18-cv-00192-CFC-CJB) Proposed Pretrial Order (Volume 1 of 14) by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Nov 24, 2020 | 521 | Redacted Document (30) Docket Text: REDACTED VERSION of (277 in 1:19-cv-00434-CFC-CJB, 483 in 1:18-cv-00192-CFC-CJB) Proposed Pretrial Order (Volume 2 of 14) by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Nov 24, 2020 | 522 | Redacted Document (30) Docket Text: REDACTED VERSION of (278 in 1:19-cv-00434-CFC-CJB, 484 in 1:18-cv-00192-CFC-CJB) Proposed Pretrial Order (Volume 3 of 14) by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Nov 24, 2020 | 523 | Redacted Document (30) Docket Text: REDACTED VERSION of (485 in 1:18-cv-00192-CFC-CJB, 279 in 1:19-cv-00434-CFC-CJB) Proposed Pretrial Order (Volume 4 of 14) by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Nov 24, 2020 | 524 | Redacted Document (30) Docket Text: REDACTED VERSION of (486 in 1:18-cv-00192-CFC-CJB, 280 in 1:19-cv-00434-CFC-CJB) Proposed Pretrial Order (Volume 5 of 14) by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Nov 24, 2020 | 525 | Redacted Document (30) Docket Text: REDACTED VERSION of (487 in 1:18-cv-00192-CFC-CJB, 281 in 1:19-cv-00434-CFC-CJB) Proposed Pretrial Order (Volume 6 of 14) by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Nov 24, 2020 | 526 | Redacted Document (30) Docket Text: REDACTED VERSION of (282 in 1:19-cv-00434-CFC-CJB, 488 in 1:18-cv-00192-CFC-CJB) Proposed Pretrial Order (Volume 7 of 14) by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Nov 24, 2020 | 527 | Redacted Document (30) Docket Text: REDACTED VERSION of (283 in 1:19-cv-00434-CFC-CJB, 489 in 1:18-cv-00192-CFC-CJB) Proposed Pretrial Order (Volume 8 of 14) by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Nov 24, 2020 | 528 | Redacted Document (30) Docket Text: REDACTED VERSION of (284 in 1:19-cv-00434-CFC-CJB, 490 in 1:18-cv-00192-CFC-CJB) Proposed Pretrial Order (Volume 9 of 14) by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Nov 24, 2020 | 529 | Redacted Document (30) Docket Text: REDACTED VERSION of (491 in 1:18-cv-00192-CFC-CJB, 285 in 1:19-cv-00434-CFC-CJB) Proposed Pretrial Order (Volume 10 of 14) by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Nov 24, 2020 | 530 | Redacted Document (30) Docket Text: REDACTED VERSION of (492 in 1:18-cv-00192-CFC-CJB, 286 in 1:19-cv-00434-CFC-CJB) Proposed Pretrial Order (Volume 11 of 14) by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Nov 24, 2020 | 531 | Redacted Document (30) Docket Text: REDACTED VERSION of (287 in 1:19-cv-00434-CFC-CJB, 493 in 1:18-cv-00192-CFC-CJB) Proposed Pretrial Order (Volume 12 of 14) by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Nov 24, 2020 | 532 | Redacted Document (30) Docket Text: REDACTED VERSION of (494 in 1:18-cv-00192-CFC-CJB, 288 in 1:19-cv-00434-CFC-CJB) Proposed Pretrial Order (Volume 13 of 14) by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Nov 24, 2020 | 533 | Redacted Document (30) Docket Text: REDACTED VERSION of (289 in 1:19-cv-00434-CFC-CJB, 495 in 1:18-cv-00192-CFC-CJB) Proposed Pretrial Order (Volume 14 of 14) by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Nov 24, 2020 | 534 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of Plaintiffs' Post-Trial Proposed Findings of Fact with Respect to Defendants Sandoz Inc. and Lek Pharmaceuticals d.d. filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Ward, Jennifer) |
| Nov 23, 2020 | 519 | SO ORDERED (3) Docket Text: SO ORDERED, re (306 in 1:19-cv-00434-CFC-CJB, 518 in 1:18-cv-00192-CFC-CJB) STIPULATION TO EXTEND TIME to Submit Redacted Versions of the Proposed Pretrial Order (Volumes 1-14) to November 24, 2020 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 11/23/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| Nov 20, 2020 | 518 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit Redacted Versions of the Proposed Pretrial Order (Volumes 1-14) to November 24, 2020 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Nov 16, 2020 | 517 | SO ORDERED (3) Docket Text: SO ORDERED, re (304 in 1:19-cv-00434-CFC-CJB) STIPULATION TO EXTEND TIME to Submit Redacted Versions of the Proposed Pretrial Order (Volumes 1-14) to November 20, 2020 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 11/16/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| Nov 13, 2020 | 516 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit Redacted Versions of the Proposed Pretrial Order (Volumes 1-14) to November 20, 2020 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Nov 12, 2020 | 514 | Redacted Document (9) Docket Text: REDACTED VERSION of [507] Letter, to The Honorable Colm F. Connolly from Dominick T. Gattuso, Esquire regarding Inventorship Objection by Lek Pharmaceuticals D.D., Sandoz Inc.. (Attachments: # (1) Certificate of Compliance Compliance Certificate, # (2) Exhibit Certificate of Service)(Gattuso, Dominick) |
| Nov 12, 2020 | 514 | Certificate of Compliance Compliance Certificate (2) |
| Nov 12, 2020 | 514 | Exhibit Certificate of Service (1) |
| Nov 12, 2020 | 515 | Redacted Document (7) Docket Text: REDACTED VERSION of [508] Declaration, Declaration of Natalie Clayton In Support of Sandoz and Lek's Letter to the Honorable Colm F. Connolly regarding Inventorship by Lek Pharmaceuticals D.D., Sandoz Inc.. (Attachments: # (1) Exhibit 1-3 Shall Remain Under Seal, # (2) Exhibit 4 Redacted, # (3) Exhibit 5 Shall Remain Under Seal, # (4) Exhibit 6 Redacted, # (5) Exhibit 7 Redacted, # (6) Exhibit 8-13 Public, # (7) Exhibit 14 Shall Remain Under Seal, # (8) Exhibit 15 Redacted, # (9) Exhibit 16 Shall Remain Under Seal, # (10) Exhibit 17-23 Public, # (11) Exhibit Certificate of Service)(Gattuso, Dominick) |
| Nov 12, 2020 | 515 | Exhibit 1-3 Shall Remain Under Seal (1) |
| Nov 12, 2020 | 515 | Exhibit 4 Redacted (6) |
| Nov 12, 2020 | 515 | Exhibit 5 Shall Remain Under Seal (1) |
| Nov 12, 2020 | 515 | Exhibit 6 Redacted (2) |
| Nov 12, 2020 | 515 | Exhibit 7 Redacted (4) |
| Nov 12, 2020 | 515 | Exhibit 8-13 Public (36) |
| Nov 12, 2020 | 515 | Exhibit 14 Shall Remain Under Seal (1) |
| Nov 12, 2020 | 515 | Exhibit 15 Redacted (16) |
| Nov 12, 2020 | 515 | Exhibit 16 Shall Remain Under Seal (1) |
| Nov 12, 2020 | 515 | Exhibit 17-23 Public (169) |
| Nov 12, 2020 | 515 | Exhibit Certificate of Service (1) |
| Nov 11, 2020 | 513 | Redacted Document (9) Docket Text: REDACTED VERSION of [509] Letter by Janssen Biotech Inc., Pharmacyclics LLC. (Attachments: # (1) Exhibit A-O)(Ward, Jennifer) |
| Nov 11, 2020 | 513 | Exhibit A-O (86) |
| Nov 10, 2020 | 512 | Memorandum and Order (6) Docket Text: MEMORANDUM ORDER granting Plaintiffs' request to preclude Sandoz from pursuing its Pharmorphix inventorship theory. Signed by Judge Colm F. Connolly on 11/10/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(nmf) |
| Nov 5, 2020 | 511 | SO ORDERED (3) Docket Text: SO ORDERED, re (510 in 1:18-cv-00192-CFC-CJB, 301 in 1:19-cv-00434-CFC-CJB) Stipulation and Order regarding Post-Trial Briefing filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 11/5/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| Nov 4, 2020 | 510 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding Post-Trial Briefing by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Oct 30, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: On or before November 4, 2020, the parties shall submit a joint proposed order reflecting the briefing deadlines and word count for the post-trial briefing discussed during the October 29, 2020 teleconference. Ordered by Judge Colm F. Connolly on 10/30/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(nmf) |
| Oct 29, 2020 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 10/29/2020. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(nmf) |
| Oct 29, 2020 | 505 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit Redacted Versions of the Proposed Pretrial Order (Volumes 1-14) to November 13, 2020 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Oct 29, 2020 | 506 | SO ORDERED (3) Docket Text: SO ORDERED, re (299 in 1:19-cv-00434-CFC-CJB, 505 in 1:18-cv-00192-CFC-CJB) STIPULATION TO EXTEND TIME to Submit Redacted Versions of the Proposed Pretrial Order (Volumes 1-14) to November 13, 2020 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 10/29/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| Oct 22, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER Setting Teleconference: Counsel for Plaintiffs to coordinate the call and email the dial-in information to chambers. A Telephone Conference is set for 10/29/2020 at 02:00 PM before Judge Colm F. Connolly.. Ordered by Judge Colm F. Connolly on 10/22/2020. (nmf) |
| Oct 21, 2020 | N/A | Bench Trial - Completed (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Bench Trial completed on 10/21/2020 (DAY 7). (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| Oct 20, 2020 | N/A | Bench Trial - Held (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Bench Trial held on 10/20/2020 (DAY 6). (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| Oct 20, 2020 | 504 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Dominick T. Gattuso, Esquire regarding decision tree and case law references. (Attachments: # (1) Exhibit decision tree and case law)(Gattuso, Dominick) |
| Oct 20, 2020 | 504 | Exhibit decision tree and case law (57) |
| Oct 19, 2020 | N/A | Bench Trial - Held (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Bench Trial held on 10/19/2020 (DAY 5). (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| Oct 16, 2020 | N/A | Bench Trial - Held (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Bench Trial held on 10/16/2020 (DAY 4). (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| Oct 15, 2020 | N/A | Bench Trial - Held (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Bench Trial held on 10/15/2020 (DAY 3). (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| Oct 14, 2020 | N/A | Bench Trial - Held (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Bench Trial held on 10/14/2020 (DAY 2). (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| Oct 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [502] STIPULATION of Dismissal between Plaintiffs and Zydus Worldwide DMCC and Cadila Healthcare Limited. Party Cadila Healthcare Limited and Zydus Worldwide DMCC terminated. Signed by Judge Colm F. Connolly on 10/13/2020. (nmf) |
| Oct 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [503] STIPULATION and Order Regarding U.S. Patent Nos. 9,296,753; 9,713,617; 9,725,455; 10,125,140; 10,294,231; and 10,294,232. Signed by Judge Colm F. Connolly on 10/13/2020. (nmf) |
| Oct 13, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael B. Cottler for Cipla Limited and for Cipla USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Oct 13, 2020 | N/A | Bench Trial - Held (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Bench Trial held on 10/13/2020 (DAY 1). (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| Oct 12, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The bench trial set to begin on 10/13/2020 is available to the public by telephone, using Dial In: 1-800-201-9352, Conference Code: 487710. Audio or video reproduction of the proceeding is strictly prohibited. ORDERED by Judge Colm F. Connolly on 10/12/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| Oct 12, 2020 | 502 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal between Plaintiffs and Zydus Worldwide DMCC and Cadila Healthcare Limited by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| Oct 12, 2020 | 503 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order Regarding U.S. Patent Nos. 9,296,753; 9,713,617; 9,725,455; 10,125,140; 10,294,231; and 10,294,232 by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| Oct 11, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [501] MOTION for Pro Hac Vice Appearance of Attorney Michael B. Cottler filed by Cipla Limited, Cipla USA Inc. Signed by Judge Colm F. Connolly on 10/11/2020. (fms) |
| Oct 9, 2020 | 501 | Motion for Leave to Appear Pro Hac Vice (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael B. Cottler - filed by Cipla Limited, Cipla USA Inc.. (Attachments: # (1) Cottler Pro Hac Certification)(Bilson, David) |
| Oct 9, 2020 | 501 | Cottler Pro Hac Certification (1) |
| Oct 1, 2020 | 500 | SO ORDERED (3) Docket Text: SO ORDERED, re (293 in 1:19-cv-00434-CFC-CJB, 499 in 1:18-cv-00192-CFC-CJB) STIPULATION TO EXTEND TIME for the parties to Submit Redacted Versions of the Proposed Pretrial Order (Volumes 1-14) to October 30, 2020 filed by Zydus Worldwide DMCC, Cadila Healthcare Limited. Signed by Judge Colm F. Connolly on 10/1/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(nmf) |
| Sep 30, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER Setting Teleconference: Counsel for Plaintiffs to coordinate the call and email the dial-in information to chambers. A Telephone Conference is set for 9/30/2020 at 01:00 PM before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 9/30/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(nmf) |
| Sep 30, 2020 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 9/30/2020. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(nmf) |
| Sep 30, 2020 | 499 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the parties to Submit Redacted Versions of the Proposed Pretrial Order (Volumes 1-14) to October 30, 2020 - filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Palapura, Bindu) |
| Sep 25, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (498 in 1:18-cv-00192-CFC-CJB, 292 in 1:19-cv-00434-CFC-CJB) STIPULATION TO EXTEND TIME to Submit Redacted Versions of the Proposed Pretrial Order (Volumes 1-14) to October 2, 2020 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 9/25/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| Sep 24, 2020 | 498 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit Redacted Versions of the Proposed Pretrial Order (Volumes 1-14) to October 2, 2020 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Sep 23, 2020 | N/A | Remark (0) Docket Text: Remark: The Pretrial Conference at 1:00 p.m. today is a public hearing. The information for the hearing is: Dial-in: (877) 434-2295 Passcode: 3023519106 Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(nmf) |
| Sep 23, 2020 | N/A | Pretrial Conference - Final (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Final Pretrial Conference held on 9/23/2020. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(nmf) |
| Sep 22, 2020 | 497 | Order (2) Docket Text: ORDER RE: TRIAL SCHEDULE Signed by Judge Colm F. Connolly on 9/22/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(nmf) |
| Sep 21, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER Re-Setting Scheduling Order Deadlines: The Final Pretrial Conference is rescheduled for 9/23/2020 at 01:00 PM before Judge Colm F. Connolly. Counsel for Plaintiffs shall coordinate the call and email the dial-in information to chambers. Ordered by Judge Colm F. Connolly on 9/21/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(nmf) |
| Sep 21, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed the parties' supplemental letter briefs, (D.I. 471; D.I. 474), with respect to Defendants Alvogen Pine Brook LLC, Natco Pharma Ltd.'s (together "Alvogen"), Zydus Worldwide DMCC ("Zydus") and Cadila Healthcare Ltd.'s ("Cadila") (collectively, "Moving Defendants") request to strike the rebuttal reports of certain of Plaintiffs' experts regarding indefiniteness, enablement, written description and double patenting of seven patents-in-suit, (D.I. 437 in 18-192-CFC-CJB; D.I. 231 in 19-434-CFC-CJB), submitted in connection with the Court's September 1, 2020 oral order, (D.I. 466 in 18-192-CFC-CJB; D.I. 260 in 19-434-CFC-CJB), hereby DENIES this portion of Moving Defendants' Motion for the following reasons: (1) With regard to Alvogen's request to strike Dr. Reider's opinions relating to indefiniteness of the '711 patent, (D.I. 438 at 4; D.I. 471 at 1), Alvogen had first put the theory forward in its Initial Contentions ("Alvogen's Initial Contentions"), and Plaintiffs provided a substantive response to the theory in its claim construction briefing, (D.I. 474 at 1 (citing id., ex. A at 76; id., ex. B at 16, 36-37)). Thus, Dr. Reider's opinion on this issue was not untimely. Further, the Court agrees with Plaintiffs that Alvogen's expert Dr. Lepore's opening report appears to raise new indefiniteness theories, (D.I. 474, ex. C at para. 456-66), and therefore Plaintiffs' expert's responses to these new theories cannot be said to be untimely. (2) With regard to Moving Defendants' request to strike Dr. Reider's opinions relating to indefiniteness of the '309 patent, (D.I. 438 at 4; D.I. 471 at 1-2), Defendants' experts appear to advance new theories as compared to those presented in Alvogen's January 2019 pre-suit Paragraph IV Notice and Alvogen's Initial Contentions, (D.I. 474 at 1-2). For example, Alvogen therein did not contend that the term "pharmaceutically acceptable excipient" is indefinite, (D.I. 471, ex. 6 at 69-70; id., ex. 1 at 53-56), yet Dr. Fassihi's opening report opined that the term is indefinite, (id., ex. 7 at 441-471). Plaintiffs' expert's response to this theory is not untimely. The Court also agrees with Plaintiffs that Dr. Lepore's indefiniteness theory with regard to the term "pharmaceutically acceptable salt" is different than that advanced in Alvogen's Initial Contentions. (D.I. 474 at 1-2 (citing id., ex. A at 55-56; id., ex. C at para. 362-64)) With regard to Dr. Reider's response regarding the term "compound," Plaintiffs had provided a substantive response in its claim construction briefing, (D.I. 474 at 2; id., ex. B at 36-37), and any additional substantive opinions by Dr. Reider regarding the term constitute a proper response to Dr. Lepore's opinion, (id., ex. M at 431-36). To the extent that Plaintiffs did not earlier disclose their responsive theory with respect to the indefiniteness of the term "therapeutically effective amount," (D.I. 474 at 2; id., ex. M at para. 438-41), the Pennypack factors do not weigh in favor of striking Dr. Reider's opinion. The content of his report with regard to this issue is not "voluminous[,]" (D.I. 438 at 5), and Defendants' experts served replies with respect to the issue, (see, e.g., D.I. 474, ex. Q at 355-57). (3) With regard to Moving Defendants' request to strike Dr. Myerson's opinions relating to lack of enablement and written description of the '753, '455, '548 and '140 patents ("Crystalline Form Patents"), (D.I. 438 at 4; D.I. 471 at 2), the bulk of the paragraphs at issue respond to Dr. Swift's opinions regarding these Section 112 theories, (D.I. 471, ex. 13 at para. 643-61). However, Dr. Swift provided her opinion on behalf of Alvogen, (D.I. 474, ex. E at para. 1), and Alvogen has not demonstrated that it disclosed these Section 112 theories prior to service of Dr. Swift's opening report, (D.I. 471 at 2; D.I. 474 at 2). And to the extent that the paragraphs at issue in Dr. Myerson's report respond to Section 112 theories put forward by the Capsule Defendants, it does not appear that they earlier requested Plaintiffs' responses to any Section 112 theories articulated in their contentions. (D.I. 474 at 2) (4) With regard to Alvogen's request to strike Dr. Myerson's opinions regarding non-statutory obviousness-type double patenting ("OTDP") of the Crystalline Form Patents, (D.I. 438 at 4; D.I. 471 at 2-3), the paragraphs at issue respond to Alvogen's experts' OTDP theories, (D.I. 471, ex. 13 at para. 483-512; D.I. 474 at 3). While Alvogen may have disclosed (in a few sentences) OTDP theories with respect to certain patents in view of certain other patents in its Initial Disclosures, (D.I. 474, ex. A at 105-06, 119, 131, 133), Alvogen's experts' opinions expanded far beyond these assertions, (see, e.g., D.I. 474, ex. E at para. 219-90, 343-95, 436-82, 511-67; id., ex. D at para. 485-99). Plaintiffs' expert's response is therefore not improper. To the extent Dr. Myerson's opinions address the brief assertions that were first set out in Alvogen's Initial Disclosures (to which Plaintiffs may not have earlier clearly disclosed their responsive theories), the Pennypack factors do not weigh in favor of striking this material. (5) With regard to Alvogen's request to strike Dr. Rule's opinions regarding non-statutory OTDP of the '090 patent, (D.I. 438 at 4; D.I. 471 at 3), here again while it is true that Alvogen's Initial Contentions did assert that claims 1 and 2 of the '090 patent are patentably indistinct from claims 2 and 8 of the '277 patent and claim 3 of the '563 patent with a one sentence explanation as to why, (D.I. 471, ex. 1 at 83), Alvogen's expert Dr. Grossbard's OTDP opinion regarding the '090 patent extensively expanded upon that one sentence explanation, (id., ex. 8 at para. 339-49, 361-72; D.I. 474 at 3). Under these circumstances, the Court does not find Dr. Rule's rebuttal opinions to Alvogen's expanded theories to be untimely. Ordered by Judge Christopher J. Burke on 9/21/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(mlc) |
| Sep 17, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER Setting Scheduling Order Deadlines: The Final Pretrial Conference on 9/23/2020 at 04:30 PM before Judge Colm F. Connolly shall be held by telephone. Counsel for Plaintiffs shall coordinate the call and email the dial-in information to chambers. Ordered by Judge Colm F. Connolly on 9/17/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(nmf) |
| Sep 15, 2020 | 481 | Redacted Document (30) Docket Text: REDACTED VERSION of (474 in 1:18-cv-00192-CFC-CJB, 267 in 1:19-cv-00434-CFC-CJB) Letter, by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Sep 14, 2020 | 480 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Charlotte A. Pontillo as co-counsel. Reason for request: no longer with the firm of Kasowitz Benson Torres LLP. (Palapura, Bindu) |
| Sep 11, 2020 | 478 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sandoz Inc. and Lek Pharmaceuticals d.d.s Notice Pursuant to 35 U.S.C. ยง 282 [CONFIDENTIAL] filed by Lek Pharmaceuticals D.D., Sandoz Inc..(Gattuso, Dominick) |
| Sep 11, 2020 | 479 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice Pursuant to 35 U.S.C. Section 282 of Defendants Zydus Worldwide DMCC and Cadila Healthcare Limited filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Palapura, Bindu) |
| Sep 10, 2020 | 476 | Redacted Document (13) Docket Text: REDACTED VERSION of (263 in 1:19-cv-00434-CFC-CJB, 470 in 1:18-cv-00192-CFC-CJB) Letter by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Sep 10, 2020 | 477 | Redacted Document (8) Docket Text: REDACTED VERSION of (471 in 1:18-cv-00192-CFC-CJB, 264 in 1:19-cv-00434-CFC-CJB) Letter, to The Honorable Christopher J. Burke from James L. Higgins regarding Defendants' Supplemental Letter in Support of Their Motion to Strike Plaintiffs' Untimely Opinions. by Alvogen Pine Brook LLC, Natco Pharma Ltd., Cadila Healthcare Limited, Zydus Worldwide DMCC. (Lee, Steven) |
| Sep 9, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (473 in 1:18-cv-00192-CFC-CJB, 266 in 1:19-cv-00434-CFC-CJB) MOTION for Pro Hac Vice Appearance of Attorney Eric R. Sonnenschein filed by Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 9/9/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| Sep 9, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed Defendants Alvogen Pine Brook LLC and Natco Pharma Ltd. (together "Alvogen"), Zydus Worldwide DMCC and Cadila Healthcare Ltd. (together "Zydus") and Sandoz Inc. and Lek Pharms.'s d.d.'s (together, "Sandoz" and collectively with the other Defendants, "Moving Defendants") motion to strike ("Motion"), (Civil Action No. 18-192-CFC-CJB, D.I. 461 and Civil Action No. 19-434-CFC-CJB, D.I. 255), and the briefing related thereto, (Civil Action No. 18-192-CFC-CJB, D.I. 463, D.I. 470) and having heard oral argument on September 8, 2020, hereby ORDERS as follows: (1) With regard to Moving Defendants motion to strike Plaintiffs' experts' opinions to the extent that those opinions were "supported by confidential documents and information produced by one Defendant[ and used] against another Defendant[,]" (D.I. 463 at 1 (emphasis omitted); id. at 1-2; D.I. 470 at 1-3), it is DENIED. During oral argument, Plaintiffs' counsel represented that any such document that their experts rely on in this way was provided to the Defendant at issue at least as of August 11, and in most cases, well before then (i.e., as of the date the relevant expert reports were served). (D.I. 470 at 1 & n.1, 2 ("Plaintiffs have also produced the disputed documents to each Defendant.")) If that is so, then even if it could be said that certain of these documents had been untimely produced pursuant to Rule 26(a)(2)(B), (D.I. 463 at 1), the record does not show that the Pennypack factors militate in favor of striking the material at issue. Indeed, Moving Defendants have not made the case as to why any particular confidential document, if produced by August 11 or before, was provided too late for Moving Defendants to be able to appropriately respond to Plaintiffs' expert's related position. If a Moving Defendant can show the District Court that another Defendants confidential document, which Plaintiffs intend to use against it, was not produced to it as of August 11 (or was never produced to it), then nothing in this order prevents that Defendant from seeking further relief from the District Court in connection with the trial process.; and (2) With regard to Alvogens request that Dr. Bodmeier's report be stricken and that he be precluded from testifying, (D.I. 463 at 3; D.I. 470 at 3), it is DENIED. The request is premised on the fact that after the Courts August 6 order that Dr. Bodmeier be deposed, (D.I. 433), Dr. Bodmeier was not available for deposition until at least today, September 9 (in fact, Dr. Bodmeier is to be deposed today by Alvogen). (D.I. 463 at 3) But the Court does not have the record to support a conclusion that this amounted to improper sandbagging by Plaintiffs. And, as it turned out, with the Court recently permitting Dr. Bodmeier to submit a sur-reply report, (D.I. 465), which was served on September 2, (D.I. 470 at 3), it probably made most sense for the deposition to occur when it did. Lastly, to the extent that Alvogen complained during oral argument about the parties' discussions regarding other discovery relating to infringement of the '857 patent, such argument was not in Alvogen's letter brief, which only addressed Dr. Bodmeier's deposition. (D.I. 463 at 3) So the Court will not address it here. Plus, as the Court set out in its August 28 order, there really should not be the need for much, if any, further discovery on this non-infringement argument, which was made in four paragraphs in the relevant report of Alvogen's expert. (D.I. 465). Ordered by Judge Christopher J. Burke on 9/9/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(dlb) |
| Sep 8, 2020 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Discovery dispute teleconference held on 9/8/2020 regarding Defendants' discovery dispute motion, (C.A. No. 18-192-CFC-CJB, D.I. 461; C.A. No. 19-434-CFC-CJB, D.I. 255). The Court took the matter under advisement and will issue an order. (Court Reporter Valerie Gunning. Clerk: M. Crawford) Appearances: J. Blumenfeld, J. Tigan, E. Andersen, B. Bharkhda, A. Hansen for Plaintiff Pharmacyclics LLC; J. Blumenfeld, J. Tigan, I. Royzman, H. Lee for Plaintiff Janssen Biotech, Inc.; J. Higgins, S. Gutman for Defendants Alvogen Pine Brook LLC and Natco Pharma Ltd.; D. Gattuso, N. Clayton and S. Abhyankar for Defendant Sandoz Inc.; B. Palapura, H. Stern, D. Danca for Defendant Zydus Worldwide. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(mlc) |
| Sep 7, 2020 | 473 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Eric R. Sonnenschein - filed by Pharmacyclics LLC. (Blumenfeld, Jack) |
| Sep 4, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed Plaintiffs' motion seeking to strike certain disclosures of Defendant Alvogen Pine Brook LLC and Natco Pharma Ltd.'s (together "Alvogen") expert Dr. Jennifer Swift and of Zydus Worldwide DMCC ("Zydus"), Cadila Healthcare Ltd. ("Cadila"), Sandoz, Inc. and Lek Pharms. d.d.'s (together, "Sandoz" and with the other Defendants, "Moving Defendants") expert Dr. Gregory A. Stephenson, (Civil Action No. 18-192-CFC-CJB, D.I. 435; Civil Action No. 19-434-CFC-CJB, D.I. 229), and the briefing relating thereto, (Civil Action No. 18-192-CFC-CJB, D.I. 436; D.I. 448; D.I. 453), hereby ORDERS as follows: (1) With regard to Plaintiffs' request to strike Dr. Swift's opinions that two terms from the Crystalline Form Patents ("non-hygroscopic" and "unsolvated") are indefinite, it is GRANTED. Contrary to Alvogen's argument, (D.I. 448 at 4), the Court does not see how Dr. Swift disclosed these indefiniteness opinions in her opening expert report, (compare D.I. 448, ex. 2 at paras. 156-62, 330 with D.I. 436, ex. 1 at paras. 220-25, 230-42; id., ex. 2 at paras. 213, 227-35; id., ex. 3 at paras. 315-16). Moreover, Alvogen did not sufficiently explain how such late-rising opinions were driven by "new context" provided in the reports of Plaintiffs' infringement expert, Dr. Myerson, (D.I. 448 at 4 & n.7); indeed, Dr. Swift's indefiniteness opinions seem primarily driven by what was or was not disclosed in the patents-in-suit, material available to her when submitting her opening report. And because this late disclosure would have been surprising and prejudicial to Plaintiffs, and because with just weeks left until trial it is too late to be investigating new opinions/theories, this material should be stricken.; (2) With regard to Plaintiffs request to strike the anticipation arguments in Dr. Swift's reply based on the Advani 2010 and Fowler 2010 references regarding the '753 patent, and their request to strike the anticipation arguments in Dr. Swifts reply directed to the '455, '548 and '140 patents, these are DENIED. In her opening report, Dr. Swift performed a detailed analysis as to why Pollyea 2009 anticipated the '753 patent's claims, and then stated cursorily that this same analysis explained why Advani 2010 and Fowler 2010 anticipated that same patent's claims. And Dr. Swift performed a detailed analysis as to why certain references anticipated the claims of the '753 patent, and then stated cursorily that this same analysis largely explained why these references anticipated the claims of three other patents. Alvogen states that the reason why Dr. Swift took this route is that the rationale for anticipation was substantively similar across the various references/patents. (D.I. 448 at 2-3 & n.2-3) Although every reference has different content and every claim is a little bit different, the Court can see how in some cases, Alvogen's explanation for Dr. Swift's approach would make sense; in some other cases, it might not. They key here, however, is that Plaintiffs did not do enough to explain to the Court why this "cross-referencing" approach was insufficient in this particular case, on these particular facts. And as Alvogen notes, it seems that, at least in part, Plaintiffs' expert Dr. Myerson took the same cross-referencing approach in responding to Dr. Swift's arguments. (Id. at 3); (3) With regard to Plaintiffs' request to strike Dr. Swift's reply opinions that rely on certain documents not cited in her opening report or in Alvogen's final contentions, it is DENIED. It is not wrong per se for an expert to cite to a document in her reply report that was not cited in her opening report, so long as the material cited is offered to directly contradict or rebut the opposing party's expert's rebuttal report, see Helios Software, LLC v. SpectorSoft Corp., C.A. No. 12-081-LPS, 2014 WL 4796111, at *3 (D. Del. Sept. 18, 2014). Here, as Alvogen notes, (D.I. 448 at 3 & n.4), Dr. Swift tended to cite these documents as part of an explanation as to how she was attempting to rebut criticism in Dr. Myerson's rebuttal report. And the Court otherwise simply does not have enough to go on to conclude that these documents really should have fairly been cited in Dr. Swift's opening report.; (4) With regard to Plaintiffs' request to strike Dr. Swift's opinions in her reply report that claims 1 and 17 of the '753 patent are obvious over the claims of the '455 patent due to obviousness-type double-patenting, it is DENIED. The heart of Plaintiffs' argument seems to be that in paragraphs 260-61 of her reply report, Dr. Swift included material that should have been in her opening report on the subject. (D.I. 453 at 2) But so far as the Court can see, there is not a great difference between the content of those two paragraphs and the relevant paragraphs of Dr. Swift's opening report. (D.I. 448, ex. 2 at paras. 282-290); (5) With regard to Plaintiffs' request to strike portions of Dr. Stephenson's reply report in which he uses four new references (Fowler 2010, Honigberg 2010, Buggy and Honigberg '742) in making an obviousness argument, it is DENIED. This was a close call. But in his opening report, Dr. Stephenson did at least note that "various prior art references" indicated that ibrutinib was in clinical trials before June 4, 2012. (D.I. 448, ex. 10 at para. 135) Though he only disclosed the names of four references he was referring to in his reply brief (in response to criticism from Dr. Myerson), (see D.I. 436, ex. 5 at para. 42), and though it would have been more advisable for him to have named those references in the opening report, the references were not unfamiliar ones to Plaintiffs, (D.I. 448 at 5), and under the circumstances, the Court cannot say that this amounts to an untimely disclosure warranting the striking of such material. Moreover, the Court sees no evidence, contrary to Plaintiffs' statement, (D.I. 436 at 3), that these Defendants intend to use these references as part of a previously undisclosed obviousness combination. (Id., ex. 6 at 1). Ordered by Judge Christopher J. Burke on 9/4/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(dlb) |
| Sep 3, 2020 | 468 | Redacted Document (30) Docket Text: REDACTED VERSION of (257 in 1:19-cv-00434-CFC-CJB, 463 in 1:18-cv-00192-CFC-CJB) Letter, to The Honorable Christopher J. Burke from James L. Higgins, Esq., Bindu A. Palapura, Esq. and Dominick T. Gattuso regarding Defendants' Opening Discovery Dispute Letter Brief by Alvogen Pine Brook LLC, Natco Pharma Ltd., Cadila Healthcare Limited, Lek Pharmaceuticals D.D., Sandoz Inc., Zydus Worldwide DMCC. (Lee, Steven) |
| Sep 3, 2020 | 469 | Redacted Document (9) Docket Text: REDACTED VERSION of (464 in 1:18-cv-00192-CFC-CJB, 258 in 1:19-cv-00434-CFC-CJB) Appendix, 1 to Defendants' Opening Discovery Dispute Letter Brief by Alvogen Pine Brook LLC, Natco Pharma Ltd., Cadila Healthcare Limited, Lek Pharmaceuticals D.D., Sandoz Inc., Zydus Worldwide DMCC. (Lee, Steven) |
| Sep 2, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [467] MOTION for Pro Hac Vice Appearance of Attorney Joshua A. Whitehill of Kasowitz Benson Torres LLP filed by Zydus Worldwide DMCC, Cadila Healthcare Limited. Signed by Judge Colm F. Connolly on 9/2/2020. (fms) |
| Sep 1, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed Defendants Alvogen Pine Brook LLC, Natco Pharma Ltd.'s (together "Alvogen"), Zydus Worldwide DMCC ("Zydus") and Cadila Healthcare Ltd.s ("Cadila") (collectively, "Moving Defendants") motion to strike certain opinions of Plaintiffs' experts, ("Moving Defendants' Motion"), (D.I. [437] in 18-192-CFC-CJB, D.I. [231] in 19-434-CFC-CJB), the briefing relating thereto, (Civil Action No. 18-192-CFC-CJB, D.I. 438; D.I. 449; D.I. 452), and having heard oral argument on August 24, 2020, ("Tr."), hereby ORDERS as follows with regard to the portions of Moving Defendants' Motion that the Court has not yet decided: (1) With regard to the request to strike opinions of various of Plaintiffs' experts regarding objective indicia of non-obviousness, it is DENIED. By the time of oral argument, it became clear to the Court that Moving Defendants' challenge here was really based on the fact that Plaintiffs, in their February 2020 supplemental interrogatory response regarding objective indicia (which was fairly robust, covering nearly 25 pages), (Civil Action No. 18-192-CFC-CJB, D.I. 450, ex. A at 49-72), did not sufficiently explain why Imbruvica was embodied by each of the claims (i.e., by including a chart comparing Imbruvica and its use to the respective claim requirements), so as to better explain why any objective indicia related to Imbruvica was also relevant to those claims, (Tr. at 91-94, 101-03). However, although Moving Defendants had previously asserted to Plaintiffs that Plaintiffs' interrogatory responses regarding objective indicia were deficient due to a failure of specificity as to the "purported nexus between any purported secondary consideration to the claimed subject matter of the asserted claims[,]" (D.I. 452, ex. 2 at 1; see also id. at 6; D.I. 438, ex. 5 at 1), or because "Plaintiffs' identification of 'Imbruvica' in its discussion of secondary considerations without identifying the particular product is also improper[,]" (D.I. 452, ex. 2 at 2), or due to the lack of specified "nexus between the purported inventions and any alleged indicia of non-obviousness" and the failure to "adequately identify the product(s) they contend establish non-obviousness, and the specific claims and patents that are implicated[,]" (D.I. 438, ex. 7 at 6), it is not clear to the Court that Moving Defendants ever previously articulated to Plaintiffs what they are now claiming is the specific alleged failing of Plaintiffs' prior responses (i.e., "The reason why your responses are insufficient is that you do not chart how Imbruvica reads on each claim limitation."). Indeed, even as late as oral argument, Plaintiffs' counsel still was unsure as to what specific alleged failing Moving Defendants were putting at issue. (Tr. at 97 (Plaintiffs' counsel noting "you can... see why we're struggling to understand what they wanted"); see also id. at 94-101, 104-05) In light of what seems like a moving target put forward by Moving Defendants, and in light of the otherwise robust substance of Plaintiffs' February 2020 responses regarding objective indicia, the Court does not find Plaintiffs' experts' opinions on this subject to be untimely.; (2) With regard to the request to strike certain arguments of Plaintiffs' expert Dr. Paul Reider regarding the alleged non-obviousness of the '309, '711 and '091 patents in light of Hirst Compound A and six other prior art references, (D.I. 438 at 4), it is DENIED. So far as the Court can tell from the record, Moving Defendants never disclosed any of the particular obviousness combinations at issue (save one) prior to the submission of their final invalidity contentions in January 2020. (D.I. 449 at 6-7 & n.10 (citing D.I. 450, exs. C & Y)) And those January 2020 contentions included these combinations within incredibly broad and vague disclosures that made reference to 20+-reference combinations; those kind of disclosures are hardly notice of anything. (Id. at 7 & n.10 (citing D.I. 450, ex. DD)) Thus, as a practical matter, Moving Defendants "failed to inform Plaintiffs of their obviousness theories until expert discovery[,]" (id. at 7 n.10), and so Dr. Reider's rebuttal report did not amount to a late disclosure, (see also D.I. 465).; and (3) With regard to the request to strike the rebuttal reports of certain of Plaintiffs' experts regarding indefiniteness, enablement, written description and double patenting of seven patents-in-suit, (D.I. 438 at 4), the Court does not have enough information to make a decision. This request to strike a particular Section 112 or double-patenting theory might be well-taken, but only (at a minimum) if Moving Defendants could show the Court: (a) how they clearly disclosed that theory well before final invalidity contentions were due in January 2020; (b) how the same theory was thereafter found in their opening expert reports on invalidity; and (c) how Plaintiffs never provided any substantive response to that theory until the submission of Plaintiffs' rebuttal expert reports regarding invalidity. (If a theory does not at least meet the above criteria, the Court will not be striking Plaintiffs' response to that theory from Plaintiffs' rebuttal expert reports.). Yet the current record is too jumbled and unclear--it does not allow the Court to easily determine which of Moving Defendants' theories might meet these three criteria and which might not. Therefore, by no later than September 3, 2020, Moving Defendants may submit a supplemental letter of no more than three single-spaced pages that attempts to make this showing (with specific pin cites to relevant pages of the respective discovery/reports). Plaintiffs may file a responsive letter by no later than September 8, 2020, of no more than three single-spaced pages, which disputes that such criteria has been met as to a theory, or argues that even if it has, Plaintiffs' response should not be stricken.Ordered by Judge Christopher J. Burke on 9/1/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(mlc) |
| Sep 1, 2020 | 467 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Joshua A. Whitehill of Kasowitz Benson Torres LLP - filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Palapura, Bindu) |
| Aug 28, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed Plaintiffs' motion to strike certain opinions of Defendants Alvogen Pine Brook LLC and Natco Pharma Ltd.s (together "Alvogen") experts Dr. Reza Fassihi and Dr. Michael L. Grossbard and Defendants Zydus Worldwide DMCC ("Zydus") and Cadila Healthcare Ltd.'s ("Cadila") expert Dr. Leslie Oleksowicz ("Plaintiffs' Motion"), (Civil Action No. 18-192-CFC-CJB, D.I. 418; Civil Action No. 19-434-CFC-CJB, D.I. 212), as well as the related portions of the four above-listed Defendants' (collectively, "Moving Defendants") motion to strike certain opinions of Plaintiffs' experts Dr. Robert Williams and Dr. Simon Rule (along with an accompanying declaration of Dr. Joseph Buggy (the "Buggy Declaration")) ("Moving Defendants' Motion"), (Civil Action No. 18-192-CFC-CJB, D.I. 437; Civil Action No. 19-434-CFC-CJB, D.I. 231), the briefing relating thereto, (Civil Action No. 18-192-CFC-CJB, D.I. 419; D.I. 434; D.I. 440; D.I. 438 at 1-2, 3-4; D.I. 449 at 2-4, 6; D.I. 452 at 2-3), and having heard oral argument on both motions on August 24, 2020, ("Tr."), hereby ORDERS as follows: (1) As to the issues regarding Dr. Rule/Dr. Buggy and Dr. Grossbard/Dr. Oleksowicz, they all stem from the fact that in Dr. Rule's rebuttal report, he introduced for the first time an argument that three of Moving Defendants' invalidity references (Advani 2010, the December 2009 Press Release and Roth 2010) do not constitute prior art. (D.I. 438 at 1 & n.2) Dr. Rule came to this conclusion based in significant part on the content of the Buggy Declaration, which was first served in May 2020 and which asserted that the three references were not prior art because they constituted an '090 patent inventor's (i.e. Dr. Buggy's) own work. (Id. (citing D.I. 439, App. A-2 & A-4)) The Court agrees with Moving Defendants that Dr. Rule's opinions and the Buggy Declaration were untimely submitted under Rule 26. In their initial invalidity contentions served back in November 2018, certain Defendants in the now-consolidated action (including Zydus/Cadila) clearly asserted that these three references at issue constituted relevant prior art. (D.I. 438, ex. 1 at 117-18, 130, 131-32) (Alvogen did not enter the litigation as a Defendant until much later, in mid-2019; it first identified the December 2009 Press Release in its initial invalidity contentions (or "IICs") on Aug. 28, 2019 and first identified Advani 2010 and Roth 2010 in its final invalidity contentions (or "FICs") on Jan. 30, 2020.). (D.I. 450, ex. U at 90-97 & ex. Y at 81-83) Yet in response to certain Defendants' interrogatories, which long ago sought Plaintiffs' position as to why the claims at issue are not invalid and why any asserted prior art did not qualify as prior art, Plaintiffs never explained that the three references at issue did not qualify as prior art because they were Dr. Buggy's own work. (D.I. 434 at 3; D.I. 438 at 2 & n.4) Instead, Plaintiffs did not put that theory forward until the submission of Dr. Rule's May 2020 rebuttal report. (Tr. at 56) Though this is a big case with lots of issues, that amount of delay in asserting this theory--one that would have been relevant since November 2018 and one that would have been well familiar to Dr. Buggy in November 2018 and at all times thereafter--is beyond the pale. (Id. at 66-67) And as to this issue, the Pennypack factors support exclusion, because: (a) given the length of time between when the references were first identified and when Dr. Rule's report was filed, Plaintiffs' late disclosure would have surprised and prejudiced Moving Defendants and (b) since trial begins on October 13, and since the question of who did or did not invent what portion of the claimed inventions is a very fact-specific endeavor, the parties could not complete the significant additional work needed to fairly investigate this theory prior to trial. (D.I. 438 at 5); see also TQ Delta, LLC v. ADTRAN, Inc., Civil Action No. 14-954-RGA, Civil Action No. 15-121-RGA, 2019 WL 4346530, at *2 (D. Del. Sept. 12, 2019). Thus, the Court GRANTS Moving Defendants' Motion to strike the challenged material. It also GRANTS Plaintiffs' Motion regarding Dr. Grossbard's/Dr. Oleksowicz's reports, since Moving Defendants have indicated they will not pursue those challenged theories if their own motion regarding Dr. Rule and Dr. Buggy is granted. (D.I. 434 at 1 & n.1, 3-4); and (2) With regard to the issues regarding Dr. Williams and Dr. Fassihi, these stem from the fact that Dr. Williams, in the portion of his rebuttal report regarding validity of the '857 patent, opined for the first time that a POSITA would not have been motivated to combine the teachings of the Goldstein reference with other references because Goldstein does not teach immediate release dosage forms. (D.I. 439, App. A-14) It is a close call, but under the unique circumstances here, the Court does not find Dr. Williams' disclosure to be untimely. That is because Alvogen did not itself disclose its reliance on the Goldstein reference until its Jan. 30, 2020 FICs--FICs that included approximately 500 more pages of contentions than were in Alvogen's IICs. (D.I. 450, ex. U at 166-206; Tr. at 12, 44) And this put Plaintiffs in a bind, because: (a) the fact discovery period (the period when Plaintiffs might normally be expected to update their contention-related interrogatory responses) had already closed, and (b) opening expert reports (wherein Alvogen might well be expected to further narrow or refine its invalidity theories) were due just a month later (on Feb. 28, 2020, later moved to early March 2020). (D.I. 449 at 1, 6; see also D.I. 438, ex. 8 at 1; Tr. at 13, 15) Under those circumstances, the Court does not find that Plaintiffs' decision to respond to Goldstein in Dr. Williams' May 2020 rebuttal report (and not before) amounts to an untimely disclosure. Therefore, the Court DENIES Moving Defendants' Motion on this ground. Additionally, with regard to Plaintiffs' Motion, which seeks to strike Dr. Fassihi's opinion that Alvogen does not infringe the patent to the extent the patent's claims are directed to immediate release solid tablet formulations of ibrutinib, (D.I. 419 at 1), it appears that the parties (including Alvogen) were not aware that they had a dispute over whether the patents claims cover such formulations until Dr. Williams' report was submitted in May 2020, (D.I. 434 at 1-2 & n.3; Tr. at 25, 30-32, 48). Thus, the Court does not understand Plaintiffs' view that Alvogen "could have presented [this] opinion[] in their contentions and earlier reports[.]" (D.I. 419 at 2) And as for Plaintiffs' assertion that Alvogen's non-infringement argument is not "credible[,]" (D.I. 440 at 1; see also Tr. at 20, 31), the Court is in no position to adjudicate that issue here. Thus, the Court DENIES Plaintiffs Motion in this regard. It also GRANTS Plaintiffs' request to file a sur-reply report regarding Alvogen's infringement of the '857 patent, (D.I. 419 at 3), and ORDERS that the parties meet and confer regarding the appropriate due date of that filing and the scope of any additional required discovery on this issue. The Court concludes that this path makes sense, as it is unconvinced that any further work needed on this non-infringement theory, which is set out in only four paragraphs of Dr. Fassihi's report, could not be fully addressed prior to trial. (D.I. 434 at 5). Ordered by Judge Christopher J. Burke on 8/28/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(mlc) |
| Aug 27, 2020 | 461 | Motion for Discovery (2) Docket Text: Joint MOTION for Discovery Teleconference to Resolve Discovery Disputes - filed by Alvogen Pine Brook LLC, Natco Pharma Ltd.. Motions referred to Christopher J. Burke.(Higgins, James) |
| Aug 27, 2020 | 462 | Redacted Document (8) Docket Text: REDACTED VERSION of (452 in 1:18-cv-00192-CFC-CJB, 247 in 1:19-cv-00434-CFC-CJB) Letter, regarding Reply in Support of Defendants' Motion to Strike Plaintiffs' Untimely Opinions by Alvogen Pine Brook LLC, Natco Pharma Ltd., Cadila Healthcare Limited, Zydus Worldwide DMCC. (Higgins, James) |
| Aug 25, 2020 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 8/25/2020. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| Aug 25, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. [460] replaced per counsel's request to correct case number. (kmd) |
| Aug 25, 2020 | 460 | Letter (1) Docket Text: Letter to The Honorable Christopher J. Burke from Dominick T. Gattuso, Esq. regarding Status Teleconference. (Gattuso, Dominick) (Main Document 460 replaced on 8/25/2020) (kmd). |
| Aug 24, 2020 | N/A | Motion Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Telephonic Motion Hearing held on 8/24/2020 regarding D.I. (437 in 1:18-cv-00192-CFC-CJB, 231 in 1:19-cv-00434-CFC-CJB) MOTION to Strike Plaintiffs' Untimely Opinions filed by Zydus Worldwide DMCC, Alvogen Pine Brook LLC, Natco Pharma Ltd., (212 in 1:19-cv-00434-CFC-CJB) MOTION to Strike Defendants' Untimely Expert Opinions filed by Janssen Biotech, Inc., Pharmacyclics LLC, (418 in 1:18-cv-00192-CFC-CJB) MOTION to Strike Defendants' Untimely Expert Opinions filed by Janssen Biotech Inc., Pharmacyclics LLC. The Court heard argument and will issue opinions resolving the motions. (Court Reporter Valerie Gunning. Clerk: M. Crawford) Appearances: J. Blumenfeld, J. Tigan, E. Andersen, B. Bharkhda, C. Sipes for Plaintiff Pharmacyclics LLC; J. Blumenfeld, J. Tigan, C. Willgoos, I. Royzman for Plaintiff Janssen Biotech, Inc.; J. Higgins, S. Lee, S. Gutman and D. Hanna for Defendants Alvogen Pine Brook LLC and Natco Pharma Ltd.; D. Gattuso, N. Clayton and S. Abhyankar for Defendant Sandoz Inc. and Lek Pharmaceuticals; B. Palapura, D. Moore, H. Stern, D. Danca for Defendant Zydus Worldwide. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(mlc) |
| Aug 24, 2020 | 455 | Notice (Other) (1) Docket Text: NOTICE of Change of State of Incorporation by Lek Pharmaceuticals D.D., Sandoz Inc. (Gattuso, Dominick) |
| Aug 24, 2020 | 456 | Redacted Document (9) Docket Text: REDACTED VERSION of (243 in 1:19-cv-00434-CFC-CJB, 448 in 1:18-cv-00192-CFC-CJB) Letter, regarding Response in Opposition to Plaintiffs' Second Motion to Strike by Alvogen Pine Brook LLC, Natco Pharma Ltd., Cadila Healthcare Limited, Lek Pharmaceuticals D.D., Sandoz Inc., Zydus Worldwide DMCC. (Higgins, James) |
| Aug 24, 2020 | N/A | Order Setting Teleconference (0) Docket Text: ORDER Setting Teleconference: The Court has reviewed the parties' August 21, 2020 letter requesting a discovery teleconference regarding two discovery disputes. (Civil Action No. 18-192-CFC-CJB, D.I. 454; Civil Action No. 19-434-CFC-CJB D.I. 249) It hereby ORDERS as follows with regard to these disputes: (1) A discovery dispute teleconference is set for 9/8/2020 at 04:00 PM before Judge Christopher J. Burke.; (2) By no later than August 27, 2020, all relevant Defendants jointly shall file a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining the issues in dispute and their position on those issues.; (3) By no later than September 3, 2020, Plaintiffs Pharmacyclics LLC and Janssen Biotech, Inc. may file a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining their reasons for their opposition.; (4) The parties shall file a joint "Motion for Teleconference to Resolve Discovery Dispute," the text of which can be found in the "Forms" tab of Judge Burke's page on the District Court's website.; (5) By no later than September 3, 2020, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via e-mail to use for the call.; and (6) It is possible that the Court may choose to resolve these disputes prior to the telephone conference and may, in that event, cancel the conference.Ordered by Judge Christopher J. Burke on 8/24/2020. Associated Cases: 1:19-cv-00434-CFC-CJB, 1:18-cv-00192-CFC-CJB(mlc) |
| Aug 24, 2020 | 458 | Redacted Document (10) Docket Text: REDACTED VERSION of (244 in 1:19-cv-00434-CFC-CJB, 449 in 1:18-cv-00192-CFC-CJB) Letter, by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Aug 24, 2020 | 459 | Redacted Document (30) Docket Text: REDACTED VERSION of (450 in 1:18-cv-00192-CFC-CJB, 245 in 1:19-cv-00434-CFC-CJB) Exhibit to a Document, by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Aug 21, 2020 | 454 | Letter (2) Docket Text: Letter to The Honorable Christopher J. Burke from Melanie K. Sharp, Esq. regarding Request for Scheduling of a Discovery Teleconference. (Sharp, Melanie) |
| Aug 20, 2020 | 453 | Letter (5) Docket Text: Letter to The Honorable Christopher J. Burke from Jeremy A. Tigan regarding Reply in Support of Plaintiffs' Motion to Strike Defendants' Untimely Crystalline Form Expert Disclosures - re (229 in 1:19-cv-00434-CFC-CJB, 435 in 1:18-cv-00192-CFC-CJB) MOTION to Strike Defendants' Untimely Expert Opinions . (Tigan, Jeremy) |
| Aug 19, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (442 in 1:18-cv-00192-CFC-CJB, 237 in 1:19-cv-00434-CFC-CJB) Joint STIPULATION and Order re deadline for the parties to complete expert discovery. Signed by Judge Colm F. Connolly on 8/19/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(nmf) |
| Aug 19, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER Setting Teleconference: Counsel for Plaintiffs to coordinate the call and email the dial-in information to chambers. A Telephonic Status Conference is set for 8/25/2020 at 11:00 AM before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 8/19/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(nmf) |
| Aug 18, 2020 | 451 | Redacted Document (5) Docket Text: REDACTED VERSION of (234 in 1:19-cv-00434-CFC-CJB, 440 in 1:18-cv-00192-CFC-CJB) Letter, by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Attachments: # (1) Exhibits A-L)(Ward, Jennifer) |
| Aug 18, 2020 | 451 | Exhibits A-L (30) |
| Aug 17, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER REFERRING MOTIONS TO Magistrate Judge Christopher J. Burke: (437 in 1:18-cv-00192-CFC-CJB, 231 in 1:19-cv-00434-CFC-CJB) MOTION to Strike Plaintiffs' Untimely Opinions, (229 in 1:19-cv-00434-CFC-CJB, 435 in 1:18-cv-00192-CFC-CJB) MOTION to Strike Defendants' Untimely Expert Opinions. Ordered by Judge Colm F. Connolly on 8/17/2020. Motions referred to Magistrate Judge Christopher J. Burke.Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(nmf) |
| Aug 17, 2020 | 443 | Redacted Document (7) Docket Text: REDACTED VERSION of (437 in 1:18-cv-00192-CFC-CJB, 231 in 1:19-cv-00434-CFC-CJB) MOTION to Strike Plaintiffs' Untimely Opinions by Alvogen Pine Brook LLC, Natco Pharma Ltd., Cadila Healthcare Limited, Zydus Worldwide DMCC. (Lee, Steven) |
| Aug 17, 2020 | 444 | Redacted Document (10) Docket Text: REDACTED VERSION of (232 in 1:19-cv-00434-CFC-CJB, 438 in 1:18-cv-00192-CFC-CJB) Letter, in Support of Defendants' Motion to Strike Plaintiffs' Untimely Opinions by Alvogen Pine Brook LLC, Natco Pharma Ltd., Cadila Healthcare Limited, Zydus Worldwide DMCC. (Lee, Steven) |
| Aug 17, 2020 | 445 | Redacted Document (12) Docket Text: REDACTED VERSION of (439 in 1:18-cv-00192-CFC-CJB, 233 in 1:19-cv-00434-CFC-CJB) Appendix, to Defendants' Motion to Strike Plaintiffs' Untimely Opinions by Alvogen Pine Brook LLC, Natco Pharma Ltd., Cadila Healthcare Limited, Zydus Worldwide DMCC. (Lee, Steven) |
| Aug 17, 2020 | 446 | Redacted Document (9) Docket Text: REDACTED VERSION of (229 in 1:19-cv-00434-CFC-CJB, 435 in 1:18-cv-00192-CFC-CJB) MOTION to Strike Defendants' Untimely Expert Opinions by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Ward, Jennifer) |
| Aug 17, 2020 | 447 | Redacted Document (5) Docket Text: REDACTED VERSION of (230 in 1:19-cv-00434-CFC-CJB, 436 in 1:18-cv-00192-CFC-CJB) Letter, by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Attachments: # (1) Exhibits 1-7)(Ward, Jennifer) |
| Aug 17, 2020 | 447 | Exhibits 1-7 (1) |
| Aug 14, 2020 | 441 | Redacted Document (17) Docket Text: REDACTED VERSION of (228 in 1:19-cv-00434-CFC-CJB, 434 in 1:18-cv-00192-CFC-CJB) Letter Defendants' Responsive Letter Brief in Opposition to Plaintiffs' Motion to Strike by Alvogen Pine Brook LLC, Natco Pharma Ltd., Cadila Healthcare Limited, Zydus Worldwide DMCC. (Higgins, James) |
| Aug 14, 2020 | 442 | Stipulation (3) Docket Text: Joint STIPULATION and [Proposed] Order re deadline for the parties to complete expert discovery by Zydus Worldwide DMCC. (Palapura, Bindu) |
| Aug 6, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having considered the remaining portions of the Alvogen Defendants' discovery dispute motion (joined by the Sandoz and Zydus Defendants with respect to various portions), ("Motion"), (D.I. (431 in 1:18-cv-00192-CFC-CJB); D.I. (219 in 1:19-cv-00434-CFC-CJB), the parties' letter briefs relating thereto, (Civil Action No. 18-192-CFC-CJB, D.I. 424; D.I. 427), and having heard argument on August 3, 2020, hereby ORDERS as follows: (1) With respect to Alvogen, Sandoz and Zydus's request that the Court order each of Drs. Myerson and Williams to appear for one or more depositions lasting no more than ten hours of record time, (Civil Action No. 18-192-CFC-CJB, D.I. 424 at 5), the Motion is GRANTED. The Court agrees with Defendants that their suggested compromise of ten hours for each deposition is a reasonable one under the rules, and that ten hours is an appropriate length of time for the reasons Defendants express in their letter. (Id.) As for Plaintiffs' request that the Court order that Drs. Fassihi and Swift each appear for eight hours on the record, (Civil Action No. 18-192-CFC-CJB, D.I. 427 at 6), the request is also GRANTED. While Drs. Myerson and Williams provided opinions on infringement and invalidity in two separate actions (technically entitling Defendants to 14 hours of deposition time as to these witnesses, and making 10 hours a reasonable compromise), Drs. Fassihi and Swift provided opinions in only one action with respect to the Alvogen Defendants. That said, it does seem like the two experts have a lot of material to cover, so a total of eight hours for their depositions (i.e. more than the typical seven-hour limit) makes sense here. (Id.); (2) With respect to Alvogen, Sandoz and Zydus's request that the Court: (a) strike each argument Plaintiffs make against Alvogen, Sandoz and Zydus that is supported only by documents produced by other Defendants; and (b) order that Plaintiffs cannot use one Defendant's documents as evidence against another Defendant, (Civil Action No.18-192-CFC-CJB, D.I. 424 at 5), the Motion is DENIED. In their letter, Defendants premised this request on the assertion that "[u]nder the Protective Orders, defendants do not have access to other defendants' confidential information, whereas Plaintiffs have access to confidential information from all defendants. (Id. at 5 n.3) However, the Protective Orders do appear to allow for cross-disclosure of one Defendant's confidential information to another Defendant. (Civil Action No. 18-192-CFC-CJB, D.I. 427 at 6 (citing Civil Action No. 18-192-CFC-CJB, D.I. 50 at paras. 8, 6(c), 6(i); Civil Action 19-434-CFC-CJB, D.I 62, at para. 18)) To the extent that Defendants' counsel raised a separate issue during the teleconference (i.e., that Plaintiffs have not actually produced to it certain of these documents that Plaintiffs intend to rely on), that issue is not presently ripe before the Court. The parties shall continue to further meet and confer with respect to that issue, and to the extent they cannot resolve the issue, they may utilize the Court's discovery dispute procedures.; (3) With respect to Alvogen's request that the Court compel the deposition of Plaintiffs' expert Dr. Roland Bodmeier, (Civil Action No. 18-192-CFC-CJB, D.I. 424 at 6), the Motion is GRANTED. Although Plaintiffs contend that there are no genuine issues in dispute with respect to Dr. Bodmeier's opinion of infringement of the asserted claims of the '857 patent, (Civil Action No. 18-192-CFC-CJB, D.I. 427 at 4-5), there is currently no stipulation to infringement regarding this patent; thus, this remains a live issue in the case. Pursuant to Federal Rule of Civil Procedure 26(b)(4)(A), "[a] party may depose any person who has been identified as an expert whose opinions may be presented at trial." In light of this Rule and the fact that infringement of the '857 patent remains a live issue, the Court has no basis to prohibit Alvogen from deposing Dr. Bodmeier at this time. That said, Alvogen should recognize that: (a) it may be a waste of resources for Alvogen to proceed with taking a deposition in this large, complex case with respect to an issue that it may well know will not ultimately be contested; and (b) if Alvogen takes the deposition, and it turns out later to have been wasteful, Plaintiffs will likely seek relief from the Court. (See Civil Action No. 19-434-CFC-CJB, D.I. 176 at 60-61); and (4) With respect to Alvogen and Zydus's request that Plaintiffs serve updated expert reports deleting all opinions that relied upon Plaintiffs' expert Dr. Steven Coutre, (Civil Action No. 18-192-CFC-CJB, D.I. 424 at 6), the Motion is DENIED. There is no dispute that: (a) Plaintiffs have withdrawn the report of Dr. Coutre; and (b) all opinions that relied upon Dr. Coutre's report have been withdrawn by both parties. (Id.) Defendants nevertheless assert that it is "often unclear which of the other experts' opinions rely upon Dr. Coutre's report," (id.), but they do not sufficiently explain how that is so, (Civil Action No. 18-192-CFC-CJB, D.I. 427 at 5). The Court will not require Plaintiffs to do unnecessary work in these complex cases that are fast approaching trial.Ordered by Judge Christopher J. Burke on 8/6/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(mlc) |
| Aug 5, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having considered the portion of the Alvogen and Zydus Defendants' ("Defendants") discovery dispute motion, ("Motion"), (D.I. (431 in 1:18-cv-00192-CFC-CJB); D.I. (219 in 1:19-cv-00434-CFC-CJB), requesting to proceed with taking various discovery pending resolution of Alvogen's motions to strike Plaintiffs' allegedly untimely expert reports ("motions to strike"), (Civil Action No. 18-192-CFC-CJB, D.I. 424 at 1-4), the parties' letter briefs relating thereto, (Civil Action No. 18-192-CFC-CJB, D.I. 424; D.I. 427), and having heard argument on August 3, 2020, hereby ORDERS that this portion of the Motion is DENIED. Instead of ordering that such discovery should proceed forward now, the Court will follow its typical path in this scenario, which is to first adjudicate the motions to strike (which Defendants have not even filed yet) and, only after deciding whether the portions of the expert reports at issue should be stricken, to then assess whether any additional discovery is even needed or warranted (and if so, how to accomplish it). Indeed, even some portions of Defendants' briefing implicitly suggest that this is the right course. (Civil Action No. 18-192-CFC-CJB, D.I. 424 at 3 ("If the Court is not inclined to strike Plaintiffs untimely expert reports, Alvogen asks the Court to order the following discovery to proceed without delay."); see also id. at 4) As for Defendants' argument that if they "are to have an opportunity to meaningfully address Plaintiffs' new theories, they cannot wait to begin taking discovery pending a ruling on the motions to strike, particularly in view of the fast approaching October 13 trial[,]" (id.), it appears that Defendants could have moved sooner with respect to at least certain of the requested discoverysuch as the fact witnesses relevant to the Buggy Declaration that they now seek to depose. While Defendants received Plaintiffs' rebuttal reports relying on the Buggy Declaration on May 18, 2020, it appears that they waited five weeks to ask for Plaintiffs' consent to proceed with subpoenas of these fact witnesses. (Civil Action No. 18-192-CFC-CJB, D.I. 410; D.I. 427 at 2 & n.6) In any event, in a case where the parties have much still to do before trial, it does not make sense from a cost or efficiency perspective to order that certain discovery occur, before deciding whether that discovery is even necessary. Ordered by Judge Christopher J. Burke on 8/5/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(mlc) |
| Aug 4, 2020 | 431 | Motion for Discovery (2) Docket Text: Joint MOTION for Discovery Dispute Teleconference - filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. Motions referred to Christopher J. Burke.(Palapura, Bindu) |
| Aug 3, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Madeline E. Byrd for Lek Pharmaceuticals D.D.,for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Aug 3, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [426] MOTION for Pro Hac Vice Appearance of Attorney Charlotte A. Pontillo of Kasowitz Benson Torres LLP filed by Zydus Worldwide DMCC, Cadila Healthcare Limited. Signed by Judge Colm F. Connolly on 8/3/2020. (fms) |
| Aug 3, 2020 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Discovery Conference held on 8/3/2020. The Court heard argument regarding the parties' discovery disputes, (D.I. 431 in Civil Action No. 18-192; D.I. 219 in Civil Action No. 19-434), and took the matters under advisement. (Court Reporter Valerie Gunning. Clerk: M. Crawford) Appearances: J. Blumenfeld, J. Tigan, E. Andersen, B. Bharkhda, C. Willgoos for Plaintiffs; M. Sharp, J. Higgins, S. Lee, S. Gutman, D. Hanna for Defendants Alvogen Pine Brook LLC and Natco Pharma Ltd.; D. Gattuso, Natalie. Clayton and S. Abhyankar for Defendant Sandoz Inc.; B. Palapura, H. Stern and J. Guhaniyogi for Defendants Zydus Worldwise DMCC and Cadilla Healthcare Ltd. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(mlc) |
| Aug 3, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: By no later than August 4, 2020, the parties shall file the "Joint Motion for Teleconference to Resolve Discovery Dispute" required by the Court's July 21, 2020 Order. (D.I. 421) While the docket of related case Civil Action No. 19-434-CFC-CJB reflects such a motion, (D.I. 219), there was no such motion filed in this case. Ordered by Judge Christopher J. Burke on 8/3/2020. (mlc) |
| Aug 3, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having considered the portion of the Alvogen and Zydus Defendants' discovery dispute motion ("Motion"), (D.I. (219 in 1:19-cv-00434-CFC-CJB)), in which they request the Court's guidance on a procedure for moving to strike expert testimony, (Civil Action No. 18-192-CFC-CJB, D.I. 424 at 1), the parties' letter briefs relating thereto, (Civil Action No. 18-192-CFC-CJB, D.I. 424 at 1; Civil Action No. 18-192-CFC-CJB, D.I. 427 at 4), and having heard argument on August 3, 2020, hereby ORDERS as follows: (1) With respect to Plaintiffs' Motion to Strike Defendants' Untimely Expert Opinions (Civil Action No. 18-192, D.I. 418; Civil Action No. 19-434, D.I. 212), any Defendant(s) opposing the motion shall file a responsive letter, not to exceed five (5) single-spaced pages, by August 7, 2020. Plaintiffs shall file a reply letter, not to exceed two (2) single-spaced pages, by August 11, 2020. (2) With respect to the motion to strike that Defendants intend to file discussed during the teleconference, they shall file such motion and an accompanying letter, not to exceed five (5) single-spaced pages, describing the basis for the requested relief and attaching the document(s) contain the materials to be stricken, by no later than August 10, 2020. Plaintiffs shall file a responsive letter, not to exceed eight (8) single-spaced pages, by August 17, 2020. Defendants shall file a reply letter, not to exceed three (3) single-spaced pages, by August 20, 2020. (3) If the parties intend to file any other motions to strike, they shall do so by August 10, 2020, and the briefing shall follow the standard process set out in Judge Burke's "Rule 16 Scheduling Order - Patent" absent further order of the Court. (4) A teleconference regarding all then-pending motions to strike is set for August 24, 2020 at 1:00 p.m. before Judge Christopher J. Burke. By no later than August 21, 2020, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via e-mail to use for the call.Ordered by Judge Christopher J. Burke on 8/3/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(mlc) |
| Jul 31, 2020 | 428 | Redacted Document (30) Docket Text: REDACTED VERSION of (222 in 1:19-cv-00434-CFC-CJB, 424 in 1:18-cv-00192-CFC-CJB) Letter, to The Honorable Christopher J. Burke from James L. Higgins, Esq. regarding Discovery Disputes by Alvogen Pine Brook LLC, Natco Pharma Ltd., Cadila Healthcare Limited, Lek Pharmaceuticals D.D., Sandoz Inc., Zydus Worldwide DMCC. (Higgins, James) |
| Jul 30, 2020 | 426 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charlotte A. Pontillo of Kasowitz Benson Torres LLP - filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Palapura, Bindu) |
| Jul 28, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [425] MOTION for Pro Hac Vice Appearance of Attorney Madeline E. Byrd filed by Lek Pharmaceuticals D.D., Sandoz Inc. Signed by Judge Colm F. Connolly on 7/28/2020. (fms) |
| Jul 28, 2020 | 425 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Madeline E. Byrd - filed by Lek Pharmaceuticals D.D., Sandoz Inc.. (Gattuso, Dominick) |
| Jul 22, 2020 | 423 | Notice of Change of Address (5) Docket Text: NOTICE of Change of Address by Jeremy A. Tigan (Tigan, Jeremy) |
| Jul 21, 2020 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the parties' July 20, 2020 letters requesting a discovery teleconference regarding six discovery disputes. (D.I. 215; D.I. 216) It hereby ORDERS as follows with regard to these disputes: (1) A discovery dispute teleconference is set for August 3, 2020 at 11:30 a.m. before Judge Christopher J. Burke.; (2) By no later than July 24, 2020, all relevant Defendants jointly shall file a letter, not to exceed six (6) single-spaced pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues.; (3) By no later than July 30, 2020, Plaintiffs Pharmacyclics LLC and Janssen Biotech, Inc. may file a letter, not to exceed six (6) single-spaced pages, in no less than 12-point font, outlining that party(s) reasons for its opposition.; (4) The parties shall file a joint "Motion for Teleconference to Resolve Discovery Dispute," the text of which can be found in the "Forms" tab of Judge Burke's page on the District Court's website.; (5) United States District Court for the District of Delaware Local Rule 30.2 shall apply pending resolution of the parties' dispute regarding the depositions of five fact witnesses (Drs. Advani, Hamdy, Pollyea, Loury, and Fyfe).; (6) By no later than July 30, 2020, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via e-mail to use for the call.; and (7) It is possible that the Court may choose to resolve these disputes prior to the telephone conference and may, in that event, cancel the conference. Ordered by Judge Christopher J. Burke on 7/21/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(dlb)Modified on 7/21/2020 (dlb). |
| Jul 21, 2020 | 422 | Notice (Other) (9) Docket Text: NOTICE of Issuance of Amended Subpoena upon Ranjana Advani by Cadila Healthcare Limited, Zydus Worldwide DMCC (Moore, David) |
| Jul 20, 2020 | N/A | Motions Referred (0) Docket Text: MOTION REFERRED: [418] MOTION to Strike Defendants' Untimely Expert Opinions Motion referred to Magistrate Judge Christopher J. Burke.(nmf) |
| Jul 20, 2020 | 420 | Letter (2) Docket Text: Letter to The Honorable Christopher J. Burke from Jeremy A. Tigan regarding Request for a Discovery Dispute Teleconference. (Tigan, Jeremy) |
| Jul 17, 2020 | 418 | Motion to Strike (7) Docket Text: MOTION to Strike Defendants' Untimely Expert Opinions - filed by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| Jul 16, 2020 | 417 | Notice (Other) (30) Docket Text: NOTICE of Issuance of Subpoenas upon Ranjana Advani, Gwen Fyfe, Ahmed Hamdy, David James Loury, and Daniel A. Pollyea by Cadila Healthcare Limited, Zydus Worldwide DMCC (Moore, David) |
| Jul 13, 2020 | 414 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Paul J. Reider on July 17, 2020 filed by Alvogen Pine Brook LLC, Natco Pharma Ltd., Cadila Healthcare Limited, Zydus Worldwide DMCC.(Higgins, James) |
| Jul 13, 2020 | 415 | Notice (Other) (9) Docket Text: NOTICE of Issuance of Amended Subpoena upon Daniel A. Pollyea by Cadila Healthcare Limited, Zydus Worldwide DMCC (Moore, David) |
| Jul 13, 2020 | 416 | Notice (Other) (9) Docket Text: NOTICE of Issuance of Second Amended Subpoena upon David James Loury by Cadila Healthcare Limited, Zydus Worldwide DMCC (Moore, David) |
| Jul 10, 2020 | 412 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Joseph Buggy on July 14, 2020 filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Moore, David) |
| Jul 10, 2020 | 413 | Notice (Other) (9) Docket Text: NOTICE of Issuance of Amended Subpoena upon David James Loury by Cadila Healthcare Limited, Zydus Worldwide DMCC (Moore, David) |
| Jul 9, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (202 in 1:19-cv-00434-CFC-CJB, 411 in 1:18-cv-00192-CFC-CJB) MOTION for Pro Hac Vice Appearance of Attorney Christine Willgoos of Kramer, Levin, Naftalis, & Frankel LLP filed by Janssen Biotech, Inc. Signed by Judge Colm F. Connolly on 7/9/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| Jul 9, 2020 | 411 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christine Willgoos of Kramer, Levin, Naftalis, & Frankel LLP - filed by Janssen Biotech, Inc.. (Tigan, Jeremy) |
| Jul 7, 2020 | 408 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Leslie Oleksowicz, M.D., Including Exhibits A-C, Marked Confidential filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Palapura, Bindu) |
| Jul 7, 2020 | 409 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Jonathan W. Steed, Ph.D. Regarding the Invalidity of U.S. Patent No. 10,106,548 Including Exhibit 1-5, Marked Highly Confidential-Outside Counsel Eyes Only Under the Protective Order; and Reply Expert Report of Gregory A. Stephenson, Ph.D. Regarding the Invalidity of U.S. Patent No. 10,106,548, Including Exhibits A-D, Marked Highly Confidential-Outside Counsel Eyes Only Under the Protective Order filed by Cadila Healthcare Limited, Lek Pharmaceuticals D.D., Sandoz Inc., Zydus Worldwide DMCC.(Palapura, Bindu) |
| Jul 7, 2020 | 410 | Notice (Other) (1) Docket Text: NOTICE of Issuance of Subpoenas upon Ranjana Advani, Gwen Fyfe, Ahmed Hamdy, David Loury, and Daniel A. Pollyea by Cadila Healthcare Limited, Zydus Worldwide DMCC (Attachments: # (1) Exhibit 1-5)(Moore, David) |
| Jul 7, 2020 | 410 | Exhibit 1-5 (40) |
| Jul 6, 2020 | 402 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Reports of James Ferrara M.D., Maureen Donovan, Ph.D., and Mansoor M. Amiji, R.Ph., Ph.D. filed by Lek Pharmaceuticals D.D., Sandoz Inc..(Gattuso, Dominick) |
| Jul 6, 2020 | 403 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Salvatore Lepore, Ph.D. filed by Alvogen Pine Brook LLC, Natco Pharma Ltd., Zydus Worldwide DMCC.(Lee, Steven) |
| Jul 6, 2020 | 404 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Steven J. Bernstein as co-counsel. Reason for request: No Longer Affiliated with the case. (Bilson, David) |
| Jul 6, 2020 | 405 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Reply Expert Report of Dr. Kenneth Cooke, M.D. Concerning Infringement and Objective Evidence of U.S. Patent No. 9,795,604, (2) Reply Expert Report of Pierre Cremieux, (3) Reply Expert Report of Allan S. Myerson, Ph.D. Regarding Infringement of, And Objective Indicia of Non-Obviousness of U.S. Patent Nos. 9,725,455, 9,296,753, 10,106,548 and 10,125,140, (4) Reply Report of Paul J. Reider, Ph.D., (5) Reply Expert Report of Professor Simon A.J. Rule, B.M.B.S., (6) Reply Expert Report of Robert O. Williams III, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 9,655,857, (7) Opening Expert Report of Robert O. Williams III, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 10,294,231, and (8) Reply Expert Report of David Drover, M.D., M.Sc., FRCP(C) filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Tigan, Jeremy) |
| Jul 6, 2020 | 406 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Reply Expert Report of Dr. Kenneth Cooke, M.D. Concerning Infringement and Objective Evidence of U.S. Patent No. 9,795,604, (2) Reply Expert Report of Pierre Cremieux, (3) Reply Expert Report of Allan S. Myerson, Ph.D. Regarding Infringement of, And Objective Indicia of Non-Obviousness of U.S. Patent Nos. 9,725,455, 9,296,753, 10,106,548 and 10,125,140, (4) Reply Report of Paul J. Reider, Ph.D., (5) Reply Expert Report of Professor Simon A.J. Rule, B.M.B.S., (6) Reply Expert Report of Robert O. Williams III, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 9,655,857 and (7) Opening Expert Report of Robert O. Williams III, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 10,294,231 filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Tigan, Jeremy) |
| Jul 6, 2020 | 407 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Reply Expert Report of Dr. Kenneth Cooke, M.D. Concerning Infringement and Objective Evidence of U.S. Patent No. 9,795,604, (2) Reply Expert Report of Pierre Cremieux, (3) Reply Expert Report of Allan S. Myerson, Ph.D. Regarding Infringement of, And Objective Indicia of Non-Obviousness of U.S. Patent Nos. 9,725,455, 9,296,753, 10,106,548 and 10,125,140, (4) Reply Report of Paul J. Reider, Ph.D., (5) Reply Expert Report of Professor Simon A.J. Rule, B.M.B.S., (6) Reply Expert Report of Robert O. Williams III, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 9,655,857 and (7) Opening Expert Report of Robert O. Williams III, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 10,294,231 filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Tigan, Jeremy) |
| Jun 29, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (195 in 1:19-cv-00434-CFC-CJB, 401 in 1:18-cv-00192-CFC-CJB) STIPULATION TO EXTEND TIME for the parties to serve their reply expert reports to July 3, 2020 filed by Zydus Worldwide DMCC, Cadila Healthcare Limited. Signed by Judge Colm F. Connolly on 6/29/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| Jun 29, 2020 | 401 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to serve their reply expert reports to July 3, 2020 - filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Palapura, Bindu) |
| Jun 16, 2020 | 400 | Transcript (62) Docket Text: Official Transcript of hearing held on October 17, 2018 before Judge Connolly. Court Reporter/Transcriber Valerie Gunning,Email: Valerie_Gunning@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 7/7/2020. Redacted Transcript Deadline set for 7/17/2020. Release of Transcript Restriction set for 9/14/2020. (vjg) |
| Jun 12, 2020 | N/A | Document Unsealed (0) Docket Text: Document Unsealed. [389] Order unsealed. (dlb) |
| May 27, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [397] STIPULATION TO EXTEND TIME to propose redactions to Magistrate Judge Burke's May 19, 2020 Sealed Memorandum Order to June 3, 2020 filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited Ordered by Judge Christopher J. Burke on 5/27/2020. (mlc) |
| May 27, 2020 | 397 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to propose redactions to Magistrate Judge Burke's May 19, 2020 Sealed Memorandum Order to June 3, 2020 - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited. (Farnan, Kelly) |
| May 27, 2020 | 398 | Redacted Document (6) Docket Text: REDACTED VERSION of [382] Letter to Honorable Christopher J. Burke from Kelly E. Farnan regarding Plaintiffs' Motion to Compel by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited. (Attachments: # (1) Exhibit 1-13)(Farnan, Kelly) |
| May 27, 2020 | 398 | Exhibit 1-13 (26) |
| May 27, 2020 | 399 | Redacted Document (5) Docket Text: REDACTED VERSION of [378] Letter by Janssen Biotech Inc., Pharmacyclics LLC. (Attachments: # (1) Exhibits 1-12)(Ward, Jennifer) |
| May 27, 2020 | 399 | Exhibits 1-12 (29) |
| May 26, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [395] STIPULATION TO EXTEND TIME to File Public Versions of Plaintiffs' Opening Discovery Dispute Letter (D.I. 378), Sun's Responsive Discovery Dispute Letter (D.I. 382), and to Propose Redactions to Magistrate Judge Burke's May 19, 2020 Seal filed by Janssen Biotech Inc., Pharmacyclics LLC Ordered by Judge Christopher J. Burke on 5/26/2020. (mlc) |
| May 26, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [396] Stipulation of Dismissal filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Party Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited terminated.. Ordered by Judge Colm F. Connolly on 5/26/2020. (fms) |
| May 22, 2020 | 395 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to File Public Versions of Plaintiffs' Opening Discovery Dispute Letter (D.I. 378), Sun's Responsive Discovery Dispute Letter (D.I. 382), and to Propose Redactions to Magistrate Judge Burke's May 19, 2020 Sealed Memorandum Order (D.I. 389) to May 27, 2020 - filed by Janssen Biotech Inc., Pharmacyclics LLC. (Ward, Jennifer) |
| May 22, 2020 | 396 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal [Joint] by Janssen Biotech Inc., Pharmacyclics LLC, Janssen Biotech, Inc.. (Tigan, Jeremy) |
| May 21, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [394] STIPULATION TO EXTEND TIME to serve rebuttal expert reports and disclose expert availability for depositions to various dates filed by Janssen Biotech Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 5/21/2020. (fms) |
| May 21, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [393] STIPULATION TO EXTEND TIME to File Public Versions of Plaintiffs' Opening Discovery Dispute Letter (D.I. 378) and Sun's Responsive Discovery Dispute Letter (D.I. 382) to May 22, 2020 filed by Janssen Biotech Inc., Pharmacyclics LLC. Ordered by Judge Christopher J. Burke on 5/21/2020. (dlb) |
| May 20, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [383] STIPULATION TO EXTEND TIME re: deadline to file a public version of Plaintiffs' opening discovery dispute letter D.I. 378 to May 20, 2020 filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited. Ordered by Judge Christopher J. Burke on 5/20/2020. (dlb) |
| May 20, 2020 | 390 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Rebuttal Expert Report of Professor Simon A.J. Rule, B.M.B.S., (2) Rebuttal Expert Report of Robert O. Williams III, Ph.D., Regarding the Validity of U.S. Patent Nos. 9,655,857 and 10,213,386, (3) Rebuttal Expert Report of David R. Taft, Ph.D., (4) Responsive Expert Report of Allan S. Myerson, Ph.D. Regarding the Validity of U.S. Patent Nos. 9,725,455, 9,296,753, 10,106,548, and 10,125,140, and (5) Rebuttal Expert Report of Paul J. Reider, Ph.D. filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Ward, Jennifer) |
| May 20, 2020 | 391 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of (1) Rebuttal Expert Report of David R. Taft, Ph.D., (2) Responsive Expert Report of Allan S. Myerson, Ph.D. Regarding the Validity of U.S. Patent Nos. 9,725,455, 9,296,753, 10,106,548, and 10,125,140, (3) Rebuttal Expert Report of Robert O. Williams III, Ph.D., Regarding the Validity of U.S. Patent No. 10,294,231, and (4) Rebuttal Report of Dr. Kenneth Cooke, M.D. Regarding Validity of U.S. Patent No. 9,795,604 filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Ward, Jennifer) |
| May 20, 2020 | 392 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Rebuttal Expert Report of Professor Simon A.J. Rule, B.M.B.S., (2) Responsive Expert Report of Allan S. Myerson, Ph.D. Regarding the Validity of U.S. Patent Nos. 9,725,455, 9,296,753, 10,106,548, and 10,125,140, and (3) Rebuttal Expert Report of Paul J. Reider, Ph.D. filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Ward, Jennifer) |
| May 20, 2020 | 393 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to File Public Versions of Plaintiffs' Opening Discovery Dispute Letter (D.I. 378) and Sun's Responsive Discovery Dispute Letter (D.I. 382) to May 22, 2020 - filed by Janssen Biotech Inc., Pharmacyclics LLC. (Ward, Jennifer) |
| May 20, 2020 | 394 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to serve rebuttal expert reports and disclose expert availability for depositions to various dates - filed by Janssen Biotech Inc., Pharmacyclics LLC. (Ward, Jennifer) |
| May 19, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [385] STIPULATION TO EXTEND TIME to serve rebuttal expert reports to May 20, 2020 filed by Janssen Biotech Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 5/19/2020. (fms) |
| May 19, 2020 | 386 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Rebuttal Report of Salvatore D. Lepore, Ph.D. Regarding Non-Infringement of U.S. Patent No. 8,697,711 and (2) Rebuttal Report of Salvatore D. Lepore, Ph.D. Regarding Secondary Considerations of Non-Obviousness filed by Alvogen Pine Brook LLC, Natco Pharma Ltd., Zydus Worldwide DMCC.(Lee, Steven) |
| May 19, 2020 | 387 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Expert Report of DeForest McDuff, Ph.D. (Highly Confidential - Outside Counsel Eyes Only); Rebuttal Expert Report of Leslie Oleksowicz, M.D. Regarding Objective Indicia of Non-Obviousness (Confidential) and Expert Report of Jonathan W. Steed, Ph.D. Regarding Non-Infringement of U.S. Patent No. 10,106,548 (Highly Confidential - Outside Counsel Eyes Only) filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Palapura, Bindu) |
| May 19, 2020 | 388 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sandoz Inc. and Lek Pharmaceuticals d.d.s Rebuttal Expert Reports of Ivan T. Hoffman, James Ferrara M.D., and Nelson Chao, M.D. filed by Lek Pharmaceuticals D.D., Sandoz Inc..(Gattuso, Dominick) |
| May 19, 2020 | 389 | Order (2) Docket Text: [UNSEALED] ORDER re [380] MOTION for Teleconference to Resolve Discovery Dispute filed by Janssen Biotech Inc., Pharmacyclics LLC. Signed by Judge Christopher J. Burke on 5/19/2020.This order has been emailed to local counsel. (dlb) Modified on 6/12/2020 (dlb). (Main Document 389 replaced on 6/13/2020) (dlb). |
| May 18, 2020 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Discovery dispute teleconference held on 5/18/2020. The Court heard argument from the parties' regarding Plaintiffs' discovery dispute motion, D.I. [380]. The Court took the matter under advisement and will issue an order. (Court Reporter Stacy Ingram (Hawkins). Clerk: M. Crawford) Appearances: J. Blumenfeld, B. Bharkhda, E. Andersen, D. Denuyl, M. Colucci for Plaintiffs; K. Farnan, S. Lockner for Defendants. (mlc) |
| May 18, 2020 | 384 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Rebuttal Expert Report of Gregory Stephenson, Ph.D. and 2) Rebuttal Expert Report of Mansoor M. Amiji, R.Ph.Ph.D. filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Delcollo, Renee) |
| May 18, 2020 | 385 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to serve rebuttal expert reports to May 20, 2020 - filed by Janssen Biotech Inc., Pharmacyclics LLC. (Ward, Jennifer) |
| May 15, 2020 | 383 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME re: deadline to file a public version of Plaintiffs' opening discovery dispute letter D.I. 378 to May 20, 2020 - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited. (Farnan, Kelly) |
| May 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [381] STIPULATION TO EXTEND TIME to serve expert reports to various dates filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited. Signed by Judge Colm F. Connolly on 5/13/2020. (fms) |
| May 12, 2020 | 381 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to serve expert reports to various dates - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited. (Farnan, Kelly) |
| May 11, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (188 in 1:19-cv-00434-CFC-CJB, 379 in 1:18-cv-00192-CFC-CJB) STIPULATION TO EXTEND TIME to Serve Opposition and Reply Expert Reports and for Disclosure of Expert Availability for Depositions to Various Dates (see stipulation) filed by Janssen Biotech Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 5/11/2020. Associated Cases: 1:18-cv-00192-CFC-CJB, 1:19-cv-00434-CFC-CJB(fms) |
| May 11, 2020 | 379 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Serve Opposition and Reply Expert Reports and for Disclosure of Expert Availability for Depositions to Various Dates (see stipulation) - filed by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| May 11, 2020 | 380 | Motion for Miscellaneous Relief (2) Docket Text: MOTION for Teleconference to Resolve Discovery Dispute - filed by Janssen Biotech Inc., Pharmacyclics LLC. Motions referred to Christopher J. Burke.(Tigan, Jeremy) |
| May 5, 2020 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the parties' May 4, 2020 requesting a discovery dispute teleconference regarding 1 discovery dispute. (D.I. 376) It hereby ORDERS as follows with regard to this dispute: (1) A discovery dispute teleconference is set for May 18, 2020 at 2:00 PM before Judge Christopher J. Burke. (2) On May 8, 2020, any party seeking relief shall file with the Court a letter, not to exceed three (3) pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. On May 13, 2020, any party opposing the application for relief may file a letter, not to exceed three (3) pages, in no less than 12-point font, outlining that party(s) reasons for its opposition.; (3) The Court may choose to resolve the disputes prior to the telephone conference and will, in that event, cancel the conference.; and (4) The moving party shall file the motion referenced at D.I. 375. Ordered by Judge Christopher J. Burke on 5/5/2020. (dlb) |
| May 4, 2020 | 376 | Letter (1) Docket Text: Letter to The Honorable Christopher J. Burke from Jeremy A. Tigan regarding Request for Discovery Teleconference. (Tigan, Jeremy) |
| May 1, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed the case history in light of the April 30, 2020 referral, hereby ORDERS that the procedures for resolving a dispute relating to discovery or the protective order set out in the Scheduling Order, (D.I. 85 at 4), will be modified as follows: Should counsel find, after good faith efforts including verbal communication among Delaware and Lead Counsel for all parties to the dispute, that they are unable to resolve a discovery or protective order matter, the parties involved in the dispute shall submit a joint letter with the text set out in the Court's standard Rule 16 Scheduling Order for Patent cases, which can be found in the "Forms" tab of Magistrate Judge Burke's page on the District Court's website. For disputes relating to discovery, the moving party (i.e., the party seeking relief from the Court) should also file a Motion For Teleconference To Resolve Discovery Dispute, and for disputes relating to protective orders, the parties shall file a Joint Motion for Teleconference to Resolve Protective Order Dispute. The suggested text for these motions can be found in the same Forms tab. The Court will thereafter set a discovery or protective order dispute telephone conference. Ordered by Judge Christopher J. Burke on 5/1/2020. (dlb) |
| Apr 30, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [374] MOTION for Pro Hac Vice Appearance of Attorney Jennell C. Bilek filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited. Signed by Judge Colm F. Connolly on 4/30/2020. (fms) |
| Apr 30, 2020 | 373 | Order Referring Case to Magistrate Judge (1) Docket Text: ORDER REFERRING CASE to Magistrate Judge Christopher J. Burke for all disputes relating to discovery and the protective order. Signed by Judge Colm F. Connolly on 4/30/2020. (nmf) |
| Apr 30, 2020 | 374 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jennell C. Bilek - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited. (Farnan, Kelly) |
| Apr 28, 2020 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 4/28/2020. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00434-CFC-CJB(nmf) |
| Apr 27, 2020 | 372 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Jack B. Blumenfeld regarding Trial Length and Structure. (Blumenfeld, Jack) |
| Apr 24, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [371] MOTION for Pro Hac Vice Appearance of Attorney Trevor J. Welch of Kasowitz Benson Torres LLP filed by Zydus Worldwide DMCC, Cadila Healthcare Limited. Signed by Judge Colm F. Connolly on 4/24/2020. (fms) |
| Apr 24, 2020 | 371 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Trevor J. Welch of Kasowitz Benson Torres LLP - filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Palapura, Bindu) |
| Apr 20, 2020 | 370 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Supplemental Responses and Objections to Interrogatory No. 10 and 2) Second Supplemental Responses and Objections to First Set of Requests for Admission (No. 23) filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| Mar 27, 2020 | 369 | Notice (Other) (6) Docket Text: NOTICE of Withdrawal of Counsel (Jeffrey J. Lyons) by Janssen Biotech Inc., Pharmacyclics LLC (Lyons, Jeffrey) |
| Mar 13, 2020 | 368 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Opening Expert Report of Dr. Steven E. Coutre, M.D. Regarding Infringement and Use of Imbruvica to Treat Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) and Other Conditions, (2) Expert Report of Pierre Cremieux, (3) Opening Expert Report of Paul J. Reider, Ph.D., (4) Opening Expert Report of Professor Simon A.J. Rule, B.M.B.S. Regarding Infringement of U.S. Patent No. 8,754,090 and Objective Indicia of Non-Obviousness filed by Janssen Biotech, Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Mar 12, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [361] Stipulation filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited. Signed by Judge Colm F. Connolly on 3/12/2020. (fms) |
| Mar 12, 2020 | 360 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sandoz Inc. and Lek Pharmaceuticals d.d.'s Opening Expert Reports of Dr. Maureen Donovan and Dr. James L. Ferrara filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Mar 12, 2020 | 361 | Stipulation (2) Docket Text: STIPULATION To Extend Time re: Opening and Rebuttal Expert Reports by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited. (Farnan, Kelly) |
| Mar 12, 2020 | 362 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Opening Expert Report of Jonathan W. Steed, Ph.D. Regarding Invalidity of U.S. Patent Nos. 10,106,548 and 10,125,140 (Confidential - Subject to Stipulation Regarding Confidentiality and Protective Order) filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Moore, David) |
| Mar 12, 2020 | 363 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Opening Expert Report of Dr.Kenneth Cooke, M.D., (2) Opening Expert Report of Dr. Steven E. Coutr, M.D. Regarding Infringement and Use of Imbruvica to Treat Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) and Other Conditions, (3) Expert Report of Pierre Cremieux, (4) Opening Expert Report of David Drover, M.D., M.Sc., FRCP(C), (5) Expert Report of Fabia Gozzo, Ph.D. Regarding S-XRPD Testing, (6) Opening Expert Report of Allan S. Myerson, Ph.D. Regarding the Infringement of, And Objective Indicia of Non-Obviousness Relating to, U.S. Patent Nos. 9,725,455, 9,296,753, 10,106,548 and 10,125,140, (7) Opening Expert Report of Paul J. Reider, Ph.D., (8) Opening Expert Report of Professor Simon A.J. Rule, B.M.B.S. Regarding Infringement of U.S. Patent No. 8,754,090 and Objective Indicia of Non-Obviousness, (9) Opening Expert Report of Robert O. Williams III, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos.9,655,857, (10) Opening Expert Report of Robert O. Williams III, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 10,294,231 and 10,294,232 and (11) Opening Expert Report of Ronald Bodmeier Regarding Alvogen's Infringement of U.S. Patent No. 9,655,857 filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Tigan, Jeremy) |
| Mar 12, 2020 | 364 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Opening Expert Report of Christopher K. Daugherty, M.D., Regarding Invalidity of U.S. Patent Nos. 8,999,999, 9,801,881, 9,801,883, and 10,004,746 filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Delcollo, Renee) |
| Mar 12, 2020 | 365 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Opening Expert Report of Dr.Kenneth Cooke, M.D., (2) Opening Expert Report of Dr. Steven E. Coutr, M.D. Regarding Infringement and Use of Imbruvica to Treat Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) and Other Conditions, (3) Expert Report of Pierre Cremieux, (4) Opening Expert Report of David Drover, M.D., M.Sc., FRCP(C), (5) Expert Report of Fabia Gozzo, Ph.D. Regarding S-XRPD Testing, (6) Opening Expert Report of Allan S. Myerson, Ph.D. Regarding the Infringement of, And Objective Indicia of Non-Obviousness Relating to, U.S. Patent Nos. 9,725,455, 9,296,753, 10,106,548 and 10,125,140, (7) Opening Expert Report of Paul J. Reider, Ph.D., (8) Opening Expert Report of Professor Simon A.J. Rule, B.M.B.S. Regarding Infringement of U.S. Patent No. 8,754,090 and Objective Indicia of Non-Obviousness, (9) Opening Expert Report of Robert O. Williams III, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos.9,655,857, (10) Opening Expert Report of Robert O. Williams III, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 10,294,231 and 10,294,232 and (11) Opening Expert Report of Ronald Bodmeier Regarding Sandoz's Infringement of U.S. Patent No. 10,294,231 filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Tigan, Jeremy) |
| Mar 12, 2020 | 366 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Opening Expert Report of Dr. Kenneth Cooke, M.D., (2) Opening Expert Report of Dr. Steven E. Coutre, M.D. Regarding Infringement and Use of Imbruvica to Treat Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) and Other Conditions, (3) Expert Report of Pierre Cremieux, (4) Opening Expert Report of David Drover, M.D., M.Sc., FRCP(C), (5) Expert Report of Fabia Gozzo, Ph.D. Regarding S-XRPD Testing, (6) Opening Expert Report of Allan S. Myerson, Ph.D. Regarding the Infringement of, And Objective Indicia of Non-Obviousness Relating to, U.S. Patent Nos. 9,725,455, 9,296,753, 10,106,548 and 10,125,140, (7) Opening Expert Report of Paul J. Reider, Ph.D., (8) Opening Expert Report of Professor Simon A.J. Rule, B.M.B.S. Regarding Infringement of U.S. Patent No. 8,754,090 and Objective Indicia of Non-Obviousness, (9) Opening Expert Report of Robert O. Williams III, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 9,655,867 and (10) Opening Expert Report of Robert O. Williams III, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 10,294,231 and 10,294,232 filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Tigan, Jeremy) |
| Mar 12, 2020 | 367 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Opening Expert Report of Ronald Bodmeier Regarding Sun's Infringement of U.S. Patent No. 10,294,232 (2) Opening Expert Report of Dr. Kenneth Cooke, M.D., (3) Opening Expert Report of David Drover, M.D., M.Sc., FRCP(C), (4) Expert Report of Fabia Gozzo, Ph.D. Regarding S-XRPD Testing, (5) Opening Expert Report of Allan S. Myerson, Ph.D. Regarding the Infringement of, And Objective Indicia of Non-Obviousness Relating to, U.S. Patent Nos. 9,725,455, 9,296,753, 10,106,548 and 10,125,140, (6) Opening Expert Report of Robert O. Williams III, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 9,655,867 and (7) Opening Expert Report of Robert O. Williams III, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 10,294,231 and 10,294,232 filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Tigan, Jeremy) |
| Mar 11, 2020 | 359 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Expert Report of Gregory Stephenson, Ph.D. and 2) Expert Report of Mansoor M. Amiji, R.Ph., Ph.D. filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| Mar 10, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (358 in 1:18-cv-00192-CFC, 179 in 1:19-cv-00434-CFC-CJB) STIPULATION TO EXTEND TIME to Serve Opening Expert Reports to March 11, 2020 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 3/10/2020. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00434-CFC-CJB(nmf) |
| Mar 10, 2020 | 358 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Serve Opening Expert Reports to March 11, 2020 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Tigan, Jeremy) |
| Mar 4, 2020 | 357 | SO ORDERED (5) Docket Text: SO ORDERED, re (177 in 1:19-cv-00434-CFC-CJB) Joint STIPULATION TO EXTEND TIME Deadlines Relating to Expert Discovery to (see Stipulation for details) filed by Alvogen Pine Brook LLC, Natco Pharma Ltd., ORDER, Setting Scheduling Order Deadlines: Expert Discovery due by 8/13/2020., The Telephone Conference is rescheduled for 4/28/2020 at 12:00 PM before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 3/4/2020. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00434-CFC-CJB(nmf) |
| Mar 3, 2020 | 356 | Stipulation to EXTEND Time (5) Docket Text: Joint STIPULATION TO EXTEND TIME Deadlines Relating to Expert Discovery to (see Stipulation for details) - filed by Alvogen Pine Brook LLC, Natco Pharma Ltd.. (Higgins, James) |
| Feb 28, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (175 in 1:19-cv-00434-CFC-CJB, 355 in 1:18-cv-00192-CFC) STIPULATION TO EXTEND TIME for the parties to serve opening expert reports to March 3, 2020 filed by Janssen Biotech, Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 2/28/2020. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00434-CFC-CJB(fms) |
| Feb 28, 2020 | 355 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME for the parties to serve opening expert reports to March 3, 2020 - filed by Janssen Biotech, Inc., Pharmacyclics LLC. (Blumenfeld, Jack) |
| Feb 24, 2020 | 354 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sandoz Inc. and Lek Pharmaceuticals d.d.s Fourth Supplemental Objections and Responses to Plaintiffs Interrogatories (Nos. 1-9) [Confidential] filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Feb 18, 2020 | 353 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Renata Degady on February 19, 2020 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Feb 14, 2020 | 352 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Zydus and Cadila's Second Supplemental Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-8) (Highly Confidential - Designated Outside Counsel's Eyes Only) filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Moore, David) |
| Feb 11, 2020 | 350 | SO ORDERED (3) Docket Text: SO ORDERED, re [349] Stipulation of Dismissal filed by Janssen Biotech Inc., Pharmacyclics LLC. Party Fresenius Kabi Oncology Limited and Party Fresenius Kabi USA, LLC terminated. Signed by Judge Colm F. Connolly on 2/11/2020. (nmf) |
| Feb 11, 2020 | 351 | Notice of Service (10) Docket Text: NOTICE OF SERVICE of Plaintiffs' Fifth Supplemental Responses to Defendants' First Set of Joint Interrogatories (Nos. 1-4) filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Lyons, Jeffrey) |
| Feb 10, 2020 | 348 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Jacob Bass as co-counsel. Reason for request: Leaving Firm. (Gattuso, Dominick) |
| Feb 10, 2020 | 349 | Stipulation of Dismissal (3) Docket Text: STIPULATION of Dismissal Between Pharmacyclics LLC and Janssen Biotech, Inc. and Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Limited by Janssen Biotech Inc., Pharmacyclics LLC. (Blumenfeld, Jack) |
| Feb 4, 2020 | 347 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Gregory Seitz on February 7, 2020 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Feb 3, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney M. Diana Danca for Cadila Healthcare Limited and Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Feb 3, 2020 | 346 | Order (5) Docket Text: CLAIM CONSTRUCTION ORDER re [343] Letter Signed by Judge Colm F. Connolly on 2/3/2020. (nmf) |
| Jan 31, 2020 | 344 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Plaintiffs' Final Infringement Contentions filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Jan 31, 2020 | 345 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendants' Alvogen Pine Brook LLC's, Natco Pharma Ltd.'s, Fresenius Kabi USA, LLC's, Fresenius Kabi Oncology Limited's, Zydus Worldwide DMCC's, and Cadila Healthcare Limited's Final Honigberg Invalidity Contentions with Respect to the Honigberg Patents and (2) Defendants Alvogen Pine Brook LLC's and Natco Pharma Ltd.'s Final Invalidity Contentions Related to Non-Honigberg Patents filed by Alvogen Pine Brook LLC, Natco Pharma Ltd..(Lee, Steven) |
| Jan 30, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [341] MOTION for Pro Hac Vice Appearance of Attorney M. Diana Danca of Kasowitz Benson Torres LLP filed by Zydus Worldwide DMCC, Cadila Healthcare Limited. Signed by Judge Colm F. Connolly on 1/30/2020. (nmf) |
| Jan 30, 2020 | 341 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney M. Diana Danca of Kasowitz Benson Torres LLP - filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Moore, David) |
| Jan 30, 2020 | 342 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Final Invalidity Contentions [with Exhibits 1-2] [Confidential] filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Jan 30, 2020 | 343 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Jeremy A. Tigan regarding Claim Construction Orders. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Tigan, Jeremy) |
| Jan 30, 2020 | 343 | Exhibit A (6) |
| Jan 30, 2020 | 343 | Exhibit B (9) |
| Jan 29, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (163 in 1:19-cv-00434-CFC-CJB, 340 in 1:18-cv-00192-CFC) STIPULATION TO EXTEND TIME for the Parties to Serve Final Contentions to January 30, 2020 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 1/29/2020. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00434-CFC-CJB(nmf) |
| Jan 29, 2020 | 340 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME for the Parties to Serve Final Contentions to January 30, 2020 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Lyons, Jeffrey) |
| Jan 27, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (339 in 1:18-cv-00192-CFC, 162 in 1:19-cv-00434-CFC-CJB) STIPULATION TO EXTEND TIME for the parties to serve final contentions to January 29, 2020 filed by Zydus Worldwide DMCC, Cadila Healthcare Limited. Signed by Judge Colm F. Connolly on 1/27/2020. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00434-CFC-CJB(nmf) |
| Jan 27, 2020 | 339 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME for the parties to serve final contentions to January 29, 2020 - filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Moore, David) |
| Jan 24, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (161 in 1:19-cv-00434-CFC-CJB, 334 in 1:18-cv-00192-CFC) STIPULATION TO EXTEND TIME Time to Prepare a Proposed Claim Construction Order to January 30, 2020 filed by Lek Pharmaceuticals d.d., Sandoz Inc. Signed by Judge Colm F. Connolly on 1/24/2020. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00434-CFC-CJB(nmf) |
| Jan 24, 2020 | 336 | Redacted Document (6) Docket Text: REDACTED VERSION of [331] Letter in Opposition to Motion to Enforce Scheduling Order by Lek Pharmaceuticals d.d., Sandoz Inc.. (Attachments: # (1) Exhibit A-F)(Farnan, Kelly) |
| Jan 24, 2020 | 336 | Exhibit A-F (1) |
| Jan 24, 2020 | 337 | Notice (Other) (3) Docket Text: NOTICE of Subpoena to AMRI f/k/a SSCI INC. to Testify and Produce Documents by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited (Attachments: # (1) Exhibit - Subpoena)(Farnan, Kelly) |
| Jan 24, 2020 | 337 | Exhibit - Subpoena (9) |
| Jan 24, 2020 | 338 | Notice (Other) (3) Docket Text: NOTICE of Subpoena to Catalent Pharma Solutions f/k/a Pharmatek to Testify and Produce Documents by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited (Attachments: # (1) Exhibit - Subpoena)(Farnan, Kelly) |
| Jan 24, 2020 | 338 | Exhibit - Subpoena (9) |
| Jan 23, 2020 | 334 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME Time to Prepare a Proposed Claim Construction Order to January 30, 2020 - filed by Lek Pharmaceuticals d.d., Sandoz Inc.. (Gattuso, Dominick) |
| Jan 23, 2020 | 335 | Redacted Document (6) Docket Text: REDACTED VERSION of [330] Letter, by Janssen Biotech Inc., Pharmacyclics LLC. (Attachments: # (1) Exhibit A-D, # (2) Exhibit E-I)(Tigan, Jeremy) |
| Jan 23, 2020 | 335 | Exhibit A-D (8) |
| Jan 23, 2020 | 335 | Exhibit E-I (11) |
| Jan 22, 2020 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Discovery Conference held on 1/22/2020. (Court Reporter V. Gunning.) (nmf) |
| Jan 22, 2020 | 333 | SO ORDERED (4) Docket Text: SO ORDERED, re (159 in 1:19-cv-00434-CFC-CJB, 332 in 1:18-cv-00192-CFC) STIPULATION TO EXTEND TIME to Serve Final Contentions to January 27, 2020 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 1/22/2020. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00434-CFC-CJB(nmf) |
| Jan 21, 2020 | 332 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME to Serve Final Contentions to January 27, 2020 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Lyons, Jeffrey) |
| Jan 16, 2020 | 329 | Motion for Miscellaneous Relief (11) Docket Text: MOTION to Enforce Scheduling Order - filed by Janssen Biotech Inc., Pharmacyclics LLC. (Blumenfeld, Jack) |
| Jan 13, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: On or before January 23, 2020, Counsel shall submit a proposed claim construction order to the Court incorporating the Court's rulings during the Markman hearing. Ordered by Judge Colm F. Connolly on 1/13/2020. (nmf) |
| Jan 7, 2020 | N/A | Set/Reset Hearings (0) Docket Text: Set Hearings: A Discovery Conference is set per request of counsel for 1/22/2020 at 02:00 PM in Courtroom 4B before Judge Colm F. Connolly. (nmf) |
| Dec 23, 2019 | 328 | Notice of Service (10) Docket Text: NOTICE OF SERVICE of Plaintiffs' Fourth Supplemental Responses to Defendants' First Set of Joint Interrogatories (Nos. 1-4) filed by Janssen Biotech, Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Dec 20, 2019 | 325 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of copies of (i) Defendant Sandoz Inc. and Lek Pharmaceuticals d.d.s Third Supplemental Objections and Responses to Plaintiffs Interrogatories (Nos. 1-9) [CONFIDENTIAL]; and, (ii) Defendant Sandoz Inc and Lek Pharmaceuticals d.d.s Rule 26(A)(1) Supplemental Initial Disclosures filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Dec 20, 2019 | 326 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Sun Pharma Global FZE's and Sun Pharmaceutical Industries, Ltd.'s Supplemental Responses and Objections to Plaintiffs' Interrogatory Nos. 7 and 18, and (2) Defendants Sun Pharma Global FZE's and Sun Pharmaceutical Industries, Ltd.'s Supplemental Responses and Objections to Plaintiffs' First Set of Requests for Admission (Nos. 11, 12, 24, and 25) filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| Dec 20, 2019 | 327 | Notice of Service (9) Docket Text: NOTICE OF SERVICE of Plaintiffs Pharmacyclics LLC and Janssen Biotech, Inc.'s Amended Initial Disclosures Pursuant to Rule 26(a)(1) filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Dec 13, 2019 | 324 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Leslie Amendola on December 18, 2019 filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Moore, David) |
| Dec 11, 2019 | N/A | Remark (0) Docket Text: The 12/19/2019 Discovery Conference is cancelled per request of counsel as it is no longer needed. (nmf) |
| Dec 11, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [322] STIPULATION TO EXTEND TIME of Certain Scheduling Order Deadlines to various dates (see Stipulation) filed by Janssen Biotech Inc., Pharmacyclics LLC, Set/Reset Scheduling Order Deadlines: Expert Discovery due by 7/24/2020. Signed by Judge Colm F. Connolly on 12/11/2019. (nmf) |
| Dec 11, 2019 | 322 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME of Certain Scheduling Order Deadlines to various dates (see Stipulation) - filed by Janssen Biotech Inc., Pharmacyclics LLC. (Lyons, Jeffrey) |
| Dec 11, 2019 | 323 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Elizabeth Purcell on December 16, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Dec 10, 2019 | 321 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Srinivas Gurram on December 12, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Dec 9, 2019 | 320 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses to Zydus Defendants' First Set of Joint Interrogatories (Nos. 1-9) filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Dec 6, 2019 | 315 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Responses and Objections to Second Set of Interrogatories (Nos. 8-25) and 2) Responses and Objections to First Set of Requests for Admission (Nos. 1-25) filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| Dec 6, 2019 | 316 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants Sandoz Inc. and Lek Pharmaceuticals d.d.'s Second Set of Requests for Admission (Nos. 6-9) and (2) Plaintiffs' Objections and Responses to Defendants Sandoz Inc. and Lek Pharmaceuticals d.d.'s Second Set of Interrogatories (Nos. 2-5) filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Dec 6, 2019 | 317 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Defendant Sandoz Inc. and Lek Pharmaceuticals d.d.s Objections and Responses to Plaintiffs First Request for Admissions Nos. 1-20 [CONFIDENTIAL]; and, (ii) Defendant Sandoz Inc and Lek Pharmaceuticals d.d.s Objections and Responses to Plaintiffs Second Set of Interrogatories (Nos. 10-25) [CONFIDENTIAL] filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Dec 6, 2019 | 318 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC and Cadila Healthcare Limited's Responses and Objections to Plaintiffs' Second Set of Requests for Interrogatories (Nos. 9-25) (Confidential - Subject to Protective Order) and Defendants Zydus Worldwide DMCC and Cadila Healthcare Limited's Responses and Objections to Plaintiffs' Requests for Admission (Nos. 1-22) (Confidential - Subject to Protective Order) filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(O'Byrne, Stephanie) |
| Dec 6, 2019 | 319 | Notice of Service (9) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Responses to Defendants' Second Set of Requests for Admission (Nos. 3-8), (2) Plaintiffs' Objections and Responses to Defendants' Amended Second Set of Joint Interrogatories to Plaintiffs (Nos. 5-8), and (3) Plaintiffs' Responses to Defendants' Third Set of Joint Interrogatories (Nos. 9-14) filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Dec 5, 2019 | 314 | Notice to Take Deposition (6) Docket Text: NOTICE to Take Deposition of Gargi Nadkarni on December 6, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Dec 3, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Ahmed M.T. Riaz for Fresenius Kabi Oncology Limited and Fresenius Kabi USA, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Dec 2, 2019 | N/A | Set/Reset Hearings (0) Docket Text: Set Hearings: A Discovery Conference is set per request of counsel for 12/19/2019 at 03:30 PM in Courtroom 4B before Judge Colm F. Connolly. (nmf) |
| Dec 2, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (313 in 1:18-cv-00192-CFC, 117 in 1:19-cv-00434-CFC) MOTION for Pro Hac Vice Appearance of Attorney Anna Q. Han and Laura Dolbow filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 12/2/2019. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00434-CFC(fms) |
| Dec 2, 2019 | 313 | Motion for Leave to Appear Pro Hac Vice (9) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Anna Q. Han and Laura Dolbow - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Tigan, Jeremy) |
| Nov 25, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [312] STIPULATION TO EXTEND TIME to EXTEND the deadline for the Completion of Fact Discovery to 12/20/2019 filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC. Setting Deadlines: ( Fact Discovery completed by 12/20/2019.) Signed by Judge Colm F. Connolly on 11/25/2019. (fms) |
| Nov 25, 2019 | 312 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to EXTEND the deadline for the Completion of Fact Discovery to 12/20/2019 - filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Nov 22, 2019 | 311 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Defendants Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Limited's Objections and Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-21) and (ii) Defendants Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Limited's Objections and Responses to Plaintiffs' Second Set of Interrogatories (Nos. 10-25) filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Nov 21, 2019 | 309 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contentions filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Nov 21, 2019 | 310 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sun Pharma Global FZE's and Sun Pharmaceutical Industries, Ltd's Initial Invalidity Contentions U.S. Patent Nos. 10,106,548; 10,125,140; 10,294,232 filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| Nov 18, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (308 in 1:18-cv-00192-CFC, 111 in 1:19-cv-00434-CFC) STIPULATION TO EXTEND TIME - Deadline for the Completion of Fact Discovery to November 20, 2019 filed by Alvogen Pine Brook LLC, Natco Pharma Ltd., Set/Reset Scheduling Order Deadlines: ( Fact Discovery completed by 11/20/2019.) Signed by Judge Colm F. Connolly on 11/18/2019. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00434-CFC(nmf) |
| Nov 15, 2019 | 308 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME - Deadline for the Completion of Fact Discovery to November 20, 2019 - filed by Alvogen Pine Brook LLC, Natco Pharma Ltd.. (Higgins, James) |
| Nov 13, 2019 | 304 | Notice (Other) (5) Docket Text: NOTICE of Defendants' Notice of Subpoenas to Evotect Company F/K/A Aptuit to Tesitfy and Produce Documents by Lek Pharmaceuticals d.d., Sandoz Inc. (Attachments: # (1) Exhibit Subpoena to Testify)(Gattuso, Dominick) |
| Nov 13, 2019 | 304 | Exhibit Subpoena to Testify (12) |
| Nov 13, 2019 | 305 | Notice (Other) (5) Docket Text: NOTICE of Defendants' Notice of Subpoenas to PCAS-Nanosyn LLC F/K/A Seres Laboratories Inc. to Testify and Produce Documents by Lek Pharmaceuticals d.d., Sandoz Inc. (Attachments: # (1) Exhibit Notice of Subpoena)(Gattuso, Dominick) |
| Nov 13, 2019 | 305 | Exhibit Notice of Subpoena (12) |
| Nov 13, 2019 | 306 | Notice (Other) (5) Docket Text: NOTICE of Defendants' Notice of Subpoenas to AMRI f/k/a SSCI Inc. to Testify and Produce Documents by Lek Pharmaceuticals d.d., Sandoz Inc. (Attachments: # (1) Exhibit Subpoena to Testify)(Gattuso, Dominick) |
| Nov 13, 2019 | 306 | Exhibit Subpoena to Testify (12) |
| Nov 13, 2019 | 307 | Notice (Other) (5) Docket Text: NOTICE of Defendants' Notice of Subpoenas to Catalent Pharma Solutions f/k/a Pharmatek to Testify and Produce Documents by Lek Pharmaceuticals d.d., Sandoz Inc. (Attachments: # (1) Exhibit Subpoena to Testify)(Gattuso, Dominick) |
| Nov 13, 2019 | 307 | Exhibit Subpoena to Testify (12) |
| Nov 12, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (301 in 1:18-cv-00192-CFC, 97 in 1:19-cv-00434-CFC) MOTION for Pro Hac Vice Appearance of Attorney Justin Thomas Howell of Covington & Burling LLP filed by Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 11/12/2019. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00434-CFC(fms) |
| Nov 11, 2019 | 301 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Justin Thomas Howell of Covington & Burling LLP - filed by Pharmacyclics LLC. (Tigan, Jeremy) |
| Nov 11, 2019 | 302 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Dhruv Mangal on November 12, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Nov 11, 2019 | 303 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Zoraida Nuesca on November 19, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Nov 8, 2019 | 299 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC and Cadila Healthcare Limited's Responses and Objections to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) (Confidential - Subject to Protective Order) filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Palapura, Bindu) |
| Nov 8, 2019 | 300 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Sriram Balasubramanian on November 15, 2019 filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Mosley, Renee) |
| Nov 7, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Chanson Chang for Pharmacyclics LLC,Chanson Chang for Pharmacyclics LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d), Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00434-CFC(sam) |
| Nov 7, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (96 in 1:19-cv-00434-CFC) MOTION for Pro Hac Vice Appearance of Attorney Alexa Hansen and David A. Garr of Covington & Burling LLP filed by Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 11/7/2019. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00434-CFC(fms) |
| Nov 7, 2019 | 298 | Motion for Leave to Appear Pro Hac Vice (9) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alexa Hansen and David A. Garr of Covington & Burling LLP - filed by Pharmacyclics LLC. (Tigan, Jeremy) |
| Nov 5, 2019 | 296 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of James Palmer on November 15, 2019 filed by Alvogen Pine Brook LLC, Natco Pharma Ltd..(Higgins, James) |
| Nov 5, 2019 | 297 | Notice of Service (16) Docket Text: NOTICE OF SERVICE of Subpoena Directed to Michael Green filed by Alvogen Pine Brook LLC, Natco Pharma Ltd..(Higgins, James) |
| Oct 30, 2019 | 295 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sun Pharma Global FZEs and Sun Pharmaceutical Industries, Ltd.s Second Amended Initial Disclosures Under Rule 26(a)(1) filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| Oct 29, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (82 in 1:19-cv-00434-CFC, 292 in 1:18-cv-00192-CFC) MOTION for Pro Hac Vice Appearance of Attorney David Denuyl filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 10/29/2019. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00434-CFC(fms) |
| Oct 29, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney David S. Denuyl for Pharmacyclics LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00434-CFC(kmd) |
| Oct 29, 2019 | 292 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David Denuyl - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Tigan, Jeremy) |
| Oct 29, 2019 | 293 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Supplemental Invalidity Contentions filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Oct 29, 2019 | 294 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sandoz Inc. and Lek Pharmaceuticals d.d.'s Objections and Responses to Plaintiffs' Notice of 30(b)(6) Deposition filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Oct 28, 2019 | 290 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of of Subpoena directed to Quest Diagnostics Incorporated, Celera Genomics Group and Celera Corporation filed by Alvogen Pine Brook LLC, Natco Pharma Ltd.. (Attachments: # (1) Exhibit 1)(Higgins, James) |
| Oct 28, 2019 | 290 | Exhibit 1 (12) |
| Oct 28, 2019 | 291 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sun Pharmaceutical Industries and Sun Pharma Global FZE Objections and Responses to Plaintiffs Notice of Deposition Under Fed. R. Civ. P. 30(b)(6) filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| Oct 24, 2019 | 289 | Notice of Service (9) Docket Text: NOTICE OF SERVICE of Plaintiffs' Third Supplemental Responses to Defendants' First Set of Joint Interrogatories (Nos. 1-4) filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Tigan, Jeremy) |
| Oct 23, 2019 | 288 | Notice (Other) (2) Docket Text: NOTICE of Deposition of Amy Jo Johnson by Lek Pharmaceuticals d.d., Sandoz Inc. (Gattuso, Dominick) |
| Oct 18, 2019 | 287 | Notice of Service (9) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Notice of Deposition to Plaintiff Pharmacyclics LLC Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Tigan, Jeremy) |
| Oct 17, 2019 | 285 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Fresenius Kabi USA LLC and Fresenius Kabi Oncology Limited's Responses and Objections to Plaintiffs' Notice of Rule 30(b)(6) Deposition filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Oct 17, 2019 | 286 | Notice (Other) (16) Docket Text: NOTICE of Issuance of Subpoena upon the Department of Health and Human Services by Cadila Healthcare Limited, Zydus Worldwide DMCC (Palapura, Bindu) |
| Oct 16, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [281] MOTION for Pro Hac Vice Appearance of Attorney Kirk T. Bradley filed by Lek Pharmaceuticals d.d., Sandoz Inc. Signed by Judge Colm F. Connolly on 10/16/2019. (fms) |
| Oct 16, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kirk T. Bradley for Lek Pharmaceuticals d.d. and Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Oct 16, 2019 | 281 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kirk T. Bradley - filed by Lek Pharmaceuticals d.d., Sandoz Inc.. (Gattuso, Dominick) |
| Oct 16, 2019 | 282 | Notice (Other) (16) Docket Text: NOTICE of Issuance of Subpoena upon Patricia Flatley Brennan, RN, PhD by Cadila Healthcare Limited, Zydus Worldwide DMCC (Moore, David) |
| Oct 16, 2019 | 283 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Sets of Requests for Admissions and Second Sets of Interrogatories to Defendants (addressed to various defendants as outlined in notice) filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Oct 16, 2019 | 284 | Notice (Other) (3) Docket Text: NOTICE of Subpoenas by Alvogen Pine Brook LLC, Natco Pharma Ltd. Notices of Subpoenas to be served upon Jana Lewis, Foley Hoag LLP and Michael J. Hostetler,Wilson Sonsini Goodrich & Rosati (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Sharp, Melanie) |
| Oct 16, 2019 | 284 | Exhibit 1 (7) |
| Oct 16, 2019 | 284 | Exhibit 2 (8) |
| Oct 15, 2019 | 280 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Mark D. Schuman as co-counsel. Reason for request: No longer with firm. (Farnan, Kelly) |
| Oct 14, 2019 | 279 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC's and Cadila Healthcare Limited's First Set of Interrogatories to Plaintiffs (Nos. 1-9) and Defendants' Second Set of Requests for Admission to Plaintiffs (Nos. 3-8) filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Palapura, Bindu) |
| Oct 11, 2019 | 276 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Service of (i) Sandoz Inc. and Lek Pharmaceuticals dds Second Set of Requests for Admissions to Plaintiffs (Nos. 6-9); and, (ii) Sandoz Inc. and Lek Pharmaceuticals dds Second set of Interrogatories to Plaintiffs (Nos. 2-5), filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Oct 11, 2019 | 277 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Kesavan Govindarajan on November 15, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Oct 11, 2019 | 278 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Krishnakumar Patel on November 13, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Oct 7, 2019 | 275 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Second Set of Joint Interrogatories to Plaintiffs (Nos. 5-8) filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Palapura, Bindu) |
| Oct 2, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [273] MOTION for Pro Hac Vice Appearance of Attorney Sarita Mutha Matheson filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited. Signed by Judge Colm F. Connolly on 10/2/2019. (fms) |
| Oct 2, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Sarita M. Matheson for Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Oct 2, 2019 | 274 | Notice (Other) (1) Docket Text: NOTICE of Issuance of Subpoena Duces Tecum and Subpoena Ad Testificandum upon Zhengying Pan by Cadila Healthcare Limited, Zydus Worldwide DMCC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Palapura, Bindu) |
| Oct 2, 2019 | 274 | Exhibit 1 (49) |
| Oct 2, 2019 | 274 | Exhibit 2 (5) |
| Oct 1, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [272] MOTION for Pro Hac Vice Appearance of Attorney Jonathan Pepin, Daniel Williams and Phuong Nguyen filed by Janssen Biotech Inc. Signed by Judge Colm F. Connolly on 10/1/2019. (fms) |
| Oct 1, 2019 | 272 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jonathan Pepin, Daniel Williams and Phuong Nguyen - filed by Janssen Biotech Inc.. (Tigan, Jeremy) |
| Oct 1, 2019 | 273 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Sarita Mutha Matheson - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited. (Mosley, Renee) |
| Sep 30, 2019 | 271 | Notice (Other) (2) Docket Text: NOTICE of Subpoena Ad Testificandum to Laurence Elias by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited (Attachments: # (1) Exhibit A - Subpoena)(Mosley, Renee) |
| Sep 30, 2019 | 271 | Exhibit A - Subpoena (4) |
| Sep 27, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [260] MOTION for Pro Hac Vice Appearance of Attorney Jacob Michael Bass filed by Lek Pharmaceuticals d.d., Sandoz Inc. Signed by Judge Colm F. Connolly on 9/27/2019. (fms) |
| Sep 27, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jacob M. Bass for Lek Pharmaceuticals d.d., Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Sep 27, 2019 | 263 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Biljana Jankovic on November 13, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Sep 27, 2019 | 264 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Ritesh Kapoor on October 30, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Sep 27, 2019 | 265 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Tamara Dejak on November 7, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Sep 27, 2019 | 270 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Supplemental Responses to Defendants' First Set of Joint Interrogatories (Nos. 1-4) filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Sep 26, 2019 | 260 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jacob Michael Bass - filed by Lek Pharmaceuticals d.d., Sandoz Inc.. (Gattuso, Dominick) |
| Sep 26, 2019 | 261 | Notice (Other) (5) Docket Text: NOTICE of Subpoena Ad Testificandum to Eric Hedrick by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited (Farnan, Kelly) |
| Sep 26, 2019 | 262 | Notice (Other) (5) Docket Text: NOTICE of Subpoena Ad Testificandum to Tarak Mody by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited (Farnan, Kelly) |
| Sep 25, 2019 | 258 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Anish Kumar on November 12, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Sep 25, 2019 | 259 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Neeraj Kumar on November 14, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Sep 23, 2019 | 254 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sandoz Inc. and Lek Pharmaceuticals d.d.'s Second Supplemental Objections and Responses to Plaintiffs' Interrogatories Nos. 1-9 [Confidential] filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Sep 23, 2019 | 255 | Notice to Take Deposition (1) Docket Text: NOTICE to Take Deposition of Tarak D. Mody on date to be determined filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| Sep 23, 2019 | 256 | Notice to Take Deposition (1) Docket Text: NOTICE to Take Deposition of Laurence Elias on date to be determined filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| Sep 23, 2019 | 257 | Notice to Take Deposition (1) Docket Text: NOTICE to Take Deposition of Eric Hedrick on date to be determined filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| Sep 20, 2019 | 247 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Mark Smyth on November 14, 2019 filed by Cadila Healthcare Limited, Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC, Lek Pharmaceuticals d.d., Sandoz Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Zydus Worldwide DMCC.(Palapura, Bindu) |
| Sep 20, 2019 | 248 | Notice (Other) (5) Docket Text: NOTICE of Subpoena to Erick Verner by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC (Attachments: # (1) Exhibit A)(Farnan, Brian) |
| Sep 20, 2019 | 248 | Exhibit A (51) |
| Sep 20, 2019 | 249 | Answer to Counterclaim (30) Docket Text: ANSWER to [227] Answer to Amended Complaint,, Counterclaim, -- Answer to Sandoz Inc. and Lek Pharmaceuticals d.d.'s Counterclaims to Plaintiffs' Second Amended Complaint -- by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Sep 20, 2019 | 250 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Nitin Gupta on November 8, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Sep 20, 2019 | 251 | Notice (Other) (8) Docket Text: NOTICE of of Subpoena to David Wirth to Testify on October 18, 2019 @ 9 a.m. by Lek Pharmaceuticals d.d., Sandoz Inc. (Gattuso, Dominick) |
| Sep 20, 2019 | 252 | Notice (Other) (8) Docket Text: NOTICE of of Subpoena to Norbert M. Purro to Testify on October 16, 2019 @ 9 a.m. by Lek Pharmaceuticals d.d., Sandoz Inc. (Gattuso, Dominick) |
| Sep 20, 2019 | 253 | Notice (Other) (7) Docket Text: NOTICE of of Subpoena to Jason A. Dubovsky to Testify on October 21, 2019 @ 9 a.m. by Lek Pharmaceuticals d.d., Sandoz Inc. (Gattuso, Dominick) |
| Sep 19, 2019 | 240 | Notice (Other) (3) Docket Text: NOTICE of Subpoenas Ad Testificandum and Subpoena Duces Tecum to Lee Honigberg by Cadila Healthcare Limited, Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC, Zydus Worldwide DMCC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Palapura, Bindu) |
| Sep 19, 2019 | 240 | Exhibit 1 (51) |
| Sep 19, 2019 | 240 | Exhibit 2 (6) |
| Sep 19, 2019 | 241 | Notice (Other) (3) Docket Text: NOTICE of Subpoenas Ad Testificandum and Subpoena Duces Tecum to Gwen Fyfe by Cadila Healthcare Limited, Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC, Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Zydus Worldwide DMCC (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Palapura, Bindu) |
| Sep 19, 2019 | 241 | Exhibit 1 (51) |
| Sep 19, 2019 | 241 | Exhibit 2 (6) |
| Sep 19, 2019 | 242 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Aleksander Aleksovski on October 16, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Sep 19, 2019 | 243 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Simon Skubin on October 18, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Sep 19, 2019 | 244 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Ramkinkar Santra on October 25, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Sep 19, 2019 | 245 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Mohan Prasad on October 29, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Sep 19, 2019 | 246 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Chandra Has Khanduri on November 5, 2019 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Sep 18, 2019 | 238 | Notice (Other) (5) Docket Text: NOTICE of Subpoena to Joseph Buggy by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC (Attachments: # (1) Exhibit A)(Farnan, Brian) |
| Sep 18, 2019 | 238 | Exhibit A (51) |
| Sep 18, 2019 | 239 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Erick Goldman on 10/23/2019 filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 17, 2019 | 235 | Answer to Counterclaim (30) Docket Text: ANSWER to [222] Answer to Amended Complaint, Counterclaim -- Plaintiffs' Answer to Defendant Cipla Limited's Third Amended Counterclaims -- by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Sep 17, 2019 | 236 | Answer to Counterclaim (30) Docket Text: ANSWER to [223] Answer to Amended Complaint, Counterclaim -- Plaintiffs' Answer to Fresenius Kabi USA LLC's Amended Counterclaims -- by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Sep 17, 2019 | 237 | Answer to Counterclaim (30) Docket Text: ANSWER to [225] Answer to Amended Complaint, Counterclaim -- Plaintiffs' Answer to Zydus's Second Amended Counterclaims -- by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Sep 16, 2019 | 232 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sandoz Inc.'s and Lek Pharmaceuticals d.d.'s Privilege Log filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Sep 16, 2019 | 233 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Worldwide DMCC and Cadila Healthcare Limited's Privilege Log (Confidential Subject to Stipulated Protective Order) filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Palapura, Bindu) |
| Sep 16, 2019 | 234 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of (1) Pharmacyclics LLC's Privilege Log and (2) Plaintiff Janssen Biotech, Inc.'s Privilege Log filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Sep 13, 2019 | 230 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Fresenius Kabi USA, LLC's Privilege Log filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 13, 2019 | 231 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contentions (to Sandoz) filed by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Sep 12, 2019 | 228 | Notice to Take Deposition (17) Docket Text: NOTICE to Take Deposition of Pharmacyclics LLC on a date and time agreed upon by counsel filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 12, 2019 | 229 | Notice to Take Deposition (17) Docket Text: NOTICE to Take Deposition of Janssen Biotech, Inc. on a date and time agreed upon by counsel filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 6, 2019 | 227 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [220] Amended Complaint with Jury Demand Defendants' Sandoz Inc. and Lek Pharmaceuticals D.D.'s Answer, Affirmative Defenses, and Counterclaims to Plaintiffs Second Amended Complaint, COUNTERCLAIM against All Plaintiffs by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Sep 4, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [226] STIPULATION TO EXTEND TIME to Answer Second Amended Complaint to September 6, 2019 filed by Lek Pharmaceuticals d.d., Sandoz Inc., Set/Reset Answer Deadlines: Lek Pharmaceuticals d.d. answer due 9/6/2019; Sandoz Inc. answer due 9/6/2019. Signed by Judge Colm F. Connolly on 9/4/2019. (fms) |
| Sep 4, 2019 | N/A | Patent Report Notice (0) Docket Text: PATENT REPORT NOTICE: Please note that IF patents are being added to this case, the filing party should complete the Report to Commissioner of Patents & Trademarks, and enter it on the docket using the PATENT/TRADEMARK REPORT event in the OTHER DOCUMENT list. The patent report form can be found at www.ded.uscourts.gov under the Clerk's Office FORMS button. (fms) |
| Sep 3, 2019 | 222 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [216] Amended Complaint Affirmative Defenses and, COUNTERCLAIM against Janssen Biotech Inc., Pharmacyclics LLC by Cipla Limited, Cipla USA Inc..(Phillips, John) |
| Sep 3, 2019 | 223 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [218] Amended Complaint , COUNTERCLAIM against Janssen Biotech Inc., Pharmacyclics LLC by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 3, 2019 | 224 | Answer to Counterclaim (24) Docket Text: ANSWER to [214] Answer to Amended Complaint, Counterclaim by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Sep 3, 2019 | 225 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [220] Amended Complaint , COUNTERCLAIM against Janssen Biotech Inc., Pharmacyclics LLC by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Moore, David) |
| Sep 3, 2019 | 226 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer Second Amended Complaint to September 6, 2019 - filed by Lek Pharmaceuticals d.d., Sandoz Inc.. (Gattuso, Dominick) |
| Aug 30, 2019 | 221 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Limited's First Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-9) filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Aug 20, 2019 | 214 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [204] Amended Complaint , COUNTERCLAIM against All Plaintiffs by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| Aug 20, 2019 | 215 | Order on Motion for Leave to File (1) Docket Text: ORDER granting [206] MOTION for Leave to File Third Amended Complaint Against Cipla. Signed by Judge Colm F. Connolly on 8/20/2019. (nmf) |
| Aug 20, 2019 | 216 | Amended Complaint (32) Docket Text: THIRD AMENDED COMPLAINT against Cipla Limited, Cipla USA Inc.- filed by Pharmacyclics LLC, Janssen Biotech Inc. (Attachments: # (1) Exhibits A-K)(nmf) |
| Aug 20, 2019 | 216 | Exhibits A-K (932) |
| Aug 20, 2019 | 217 | Order on Motion for Leave to File (1) Docket Text: ORDER granting [207] MOTION for Leave to File Second Amended Complaint Against Fresenius. Signed by Judge Colm F. Connolly on 8/20/2019. (nmf) |
| Aug 20, 2019 | 218 | Amended Complaint (45) Docket Text: SECOND AMENDED COMPLAINT against Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC- filed by Pharmacyclics LLC, Janssen Biotech Inc. (Attachments: # (1) Exhibits A-S)(nmf) |
| Aug 20, 2019 | 218 | Exhibits A-S (1405) |
| Aug 20, 2019 | 219 | Order on Motion for Leave to File (1) Docket Text: ORDER granting [208] MOTION for Leave to File to File Second Amended Complaint Against Zydus and Sandoz. Signed by Judge Colm F. Connolly on 8/20/2019. (nmf) |
| Aug 20, 2019 | 220 | Amended Complaint (60) Docket Text: SECOND AMENDED COMPLAINT against Cadila Healthcare Limited, Lek Pharmaceuticals d.d., Sandoz Inc., Zydus Worldwide DMCC- filed by Pharmacyclics LLC, Janssen Biotech Inc. (Attachments: # (1) Exhibits A-L, # (2) Exhibits M-V, # (3) Exhibits W-X)(nmf) |
| Aug 20, 2019 | 220 | Exhibits A-L (991) |
| Aug 20, 2019 | 220 | Exhibits M-V (918) |
| Aug 20, 2019 | 220 | Exhibits W-X (139) |
| Aug 20, 2019 | 220 | Amended Complaint* (1) |
| Aug 20, 2019 | 218 | Amended Complaint* (1) |
| Aug 20, 2019 | 216 | Amended Complaint* (1) |
| Aug 15, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Cristina L. Martinez and Marcus A. Colucci for Janssen Biotech Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Aug 9, 2019 | 213 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC's and Cadila Healthcare Limited's First Supplemental Responses and Objections to Plaintiff's First Set of Interrogatories (Nos. 1-8) with Appendix A (Confidential) filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Palapura, Bindu) |
| Aug 8, 2019 | 210 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,294,231 B2 ;10,294,232 B2 . (Blumenfeld, Jack) |
| Aug 8, 2019 | 211 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,294,231 B2 ;10,294,232 B2 (Fresenius Second Amended Complaint). (Blumenfeld, Jack) |
| Aug 8, 2019 | 212 | Patent/Trademark Report to Commissioner (3) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,294,231 B2 ;10,294,232 B2 (Second Amended Complaint Against Zydus and Sandoz). (Blumenfeld, Jack) |
| Aug 7, 2019 | 209 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sun Pharma Global FZE's and Sun Pharmaceutical Industries, Ltd.'s Supplemental Responses and Objections to Plaintiffs' Interrogatories 1-4 and 6 filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| Aug 6, 2019 | 203 | Order on Motion for Leave to File (1) Docket Text: ORDER granting [198] Motion for Leave to File a Second Amended Complaint against defendants Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd. Signed by Judge Colm F. Connolly on 8/2/2019. (nmf) |
| Aug 6, 2019 | 204 | Amended Complaint (24) Docket Text: SECOND AMENDED COMPLAINT against Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited- filed by Pharmacyclics LLC, Janssen Biotech Inc. (Attachments: # (1) Exhibits A-H)(nmf) |
| Aug 6, 2019 | 204 | Exhibits A-H (723) |
| Aug 6, 2019 | 206 | Motion for Leave to File (5) Docket Text: MOTION for Leave to File Third Amended Complaint Against Cipla - filed by Janssen Biotech Inc., Pharmacyclics LLC. (Attachments: # (1) Third Amended Complaint, # (2) Exhibits A-K to Third Amended Complaint, # (3) Exhibit 2 - Redline)(Blumenfeld, Jack) |
| Aug 6, 2019 | 206 | Third Amended Complaint (32) |
| Aug 6, 2019 | 206 | Exhibits A-K to Third Amended Complaint (932) |
| Aug 6, 2019 | 206 | Exhibit 2 - Redline (35) |
| Aug 6, 2019 | 207 | Motion for Leave to File (6) Docket Text: MOTION for Leave to File Second Amended Complaint Against Fresenius - filed by Janssen Biotech Inc., Pharmacyclics LLC. (Attachments: # (1) Second Amended Complaint Against Fresenius, # (2) Exhibits A-S to Second Amended Complaint, # (3) Exhibit 2 - Redline)(Blumenfeld, Jack) |
| Aug 6, 2019 | 207 | Second Amended Complaint Against Fresenius (45) |
| Aug 6, 2019 | 207 | Exhibits A-S to Second Amended Complaint (1405) |
| Aug 6, 2019 | 207 | Exhibit 2 - Redline (49) |
| Aug 6, 2019 | 208 | Motion for Leave to File (6) Docket Text: MOTION for Leave to File to File Second Amended Complaint Against Zydus and Sandoz - filed by Janssen Biotech Inc., Pharmacyclics LLC. (Attachments: # (1) Second Amended Complaint Against Zydus and Sandoz, # (2) Exhibits A-L to Second Amended Complaint, # (3) Exhibits M-V to Second Amended Complaint, # (4) Exhibits W-X to Second Amended Complaint, # (5) Exhibit 2 - Redline)(Blumenfeld, Jack) |
| Aug 6, 2019 | 208 | Second Amended Complaint Against Zydus and Sandoz (60) |
| Aug 6, 2019 | 208 | Exhibits A-L to Second Amended Complaint (991) |
| Aug 6, 2019 | 208 | Exhibits M-V to Second Amended Complaint (918) |
| Aug 6, 2019 | 208 | Exhibits W-X to Second Amended Complaint (139) |
| Aug 6, 2019 | 208 | Exhibit 2 - Redline (91) |
| Aug 6, 2019 | 204 | Amended Complaint* (1) |
| Aug 5, 2019 | 201 | Redacted Document (7) Docket Text: REDACTED VERSION of [200] Stipulation Staying the Case as to Cipla by Cipla Limited, Cipla USA Inc.. (Phillips, John) |
| Aug 5, 2019 | 202 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Tara L. Kurtis as co-counsel.. (Farnan, Brian) |
| Aug 1, 2019 | 198 | Motion for Leave to File (5) Docket Text: MOTION for Leave to File Second Amended Complaint Against SunPharma Global FZE and Sun Pharmaceutical Industries Ltd - filed by Janssen Biotech Inc., Pharmacyclics LLC. (Attachments: # (1) Second Amended Complaint, # (2) Exhibits A-H to Second Amended Complaint, # (3) Exhibit 2)(Blumenfeld, Jack) |
| Aug 1, 2019 | 198 | Second Amended Complaint (24) |
| Aug 1, 2019 | 198 | Exhibits A-H to Second Amended Complaint (723) |
| Aug 1, 2019 | 198 | Exhibit 2 (41) |
| Aug 1, 2019 | 199 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,294,232 . (Blumenfeld, Jack) |
| Jul 30, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [196] STIPULATION TO EXTEND TIME deadline for substantial completion of the production of document between Plaintiff and Cipla to August 5, 2019 filed by Cipla Limited, Cipla USA Inc. Signed by Judge Colm F. Connolly on 7/30/2019. (nmf) |
| Jul 30, 2019 | 197 | Redacted Document (3) Docket Text: REDACTED VERSION of [194] Proposed Order by Janssen Biotech Inc., Pharmacyclics LLC. (Attachments: # (1) Letter to Judge Connolly)(Tigan, Jeremy) |
| Jul 30, 2019 | 197 | Letter to Judge Connolly (1) |
| Jul 29, 2019 | 196 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME deadline for substantial completion of the production of document between Plaintiff and Cipla to August 5, 2019 - filed by Cipla Limited, Cipla USA Inc.. (Phillips, John) |
| Jul 23, 2019 | 191 | Redacted Document (9) Docket Text: REDACTED VERSION of [181] MOTION to Compel Discovery from Zydus by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| Jul 23, 2019 | 192 | Redacted Document (30) Docket Text: REDACTED VERSION of [182] Letter to The Honorable Colm F. Connolly from Jack B. Blumenfeld regarding motion to compel discovery by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| Jul 23, 2019 | 193 | Redacted Document (5) Docket Text: REDACTED VERSION of [184] Letter to Judge Connolly from David Moore regarding discovery dispute response by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Attachments: # (1) Exhibit 1-11)(Moore, David) |
| Jul 23, 2019 | 193 | Exhibit 1-11 (93) |
| Jul 19, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [188] STIPULATION TO EXTEND TIME the Deadline for the Production of Documents set forth at paragraph 3(b) in the Scheduling Order ( DI 85 as amended by DI 176) to July 29, 2019 filed by Lek Pharmaceuticals d.d., Sandoz Inc. Signed by Judge Colm F. Connolly on 7/19/2019. (fms) |
| Jul 19, 2019 | 185 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Cipla's [CONFIDENTIAL] Objections and Responses to Plaintiffs' First Set of Common Requests (No. 1) to Defendants for the Production of Documents and Things filed by Cipla Limited, Cipla USA Inc..(Bilson, David) |
| Jul 19, 2019 | 186 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC's and Cadila Healthcare Limited's Responses and Objections to Plaintiffs' First Set of Common Requests (No. 1) to Defendants for the Production of Documents and Things filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Moore, David) |
| Jul 19, 2019 | 187 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Sandoz Inc. and Lek Pharmaceuticals d.d.'s Objections and Responses to Plaintiffs' First Set of Common Requests (No.1) for the Production of Documents and Things filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Jul 19, 2019 | 188 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME the Deadline for the Production of Documents set forth at paragraph 3(b) in the Scheduling Order ( DI 85 as amended by DI 176) to July 29, 2019 - filed by Lek Pharmaceuticals d.d., Sandoz Inc.. (Gattuso, Dominick) |
| Jul 19, 2019 | 189 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Limited's Objections and Responses to Plaintiffs' First Set of Common Requests (No. 1) to Defendants for the Production of Documents and Things filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Jul 19, 2019 | 190 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sun Pharma Global FZEs and Sun Pharmaceutical Industries, Ltd.s Responses and Objections to Plaintiffs First Set of Common Requests for the Production of Documents and Things filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| Jul 18, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Hannah Lee for Janssen Biotech Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jul 18, 2019 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Discovery Conference held on 7/18/2019. (Court Reporter V. Gunning.) (nmf) |
| Jul 17, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (183 in 1:18-cv-00192-CFC, 28 in 1:19-cv-00434-CFC) MOTION for Pro Hac Vice Appearance of Attorney Hannah Lee filed by Janssen Biotech, Inc. Signed by Judge Colm F. Connolly on 7/17/2019. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00434-CFC(fms) |
| Jul 17, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Irena Royzman for Janssen Biotech Inc., Pharmacyclics LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Jul 16, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Shelley Ivan for Cadila Healthcare Limited, for Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jul 16, 2019 | 183 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Hannah Lee - filed by Janssen Biotech, Inc.. (Tigan, Jeremy) |
| Jul 3, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (178 in 1:18-cv-00192-CFC, 25 in 1:19-cv-00434-CFC) MOTION for Pro Hac Vice Appearance of Attorney Cristina L. Martinez and Marcus A. Colucci filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 7/3/2019. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00434-CFC(fms) |
| Jul 3, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [179] MOTION for Pro Hac Vice Appearance of Attorney Shelley Ivan of Kasowitz Benson Torres LLP filed by Zydus Worldwide DMCC, Cadila Healthcare Limited. Signed by Judge Colm F. Connolly on 7/3/2019. (fms) |
| Jul 3, 2019 | 179 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Shelley Ivan of Kasowitz Benson Torres LLP - filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Palapura, Bindu) |
| Jul 3, 2019 | 180 | Answer to Counterclaim (30) Docket Text: ANSWER to [174] Answer to Amended Complaint, Counterclaim -- Plaintiffs' Answer to Defendant Cipla Limited's Second Amended Counterclaims -- by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Jul 2, 2019 | 178 | Motion for Leave to Appear Pro Hac Vice (9) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Cristina L. Martinez and Marcus A. Colucci - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Tigan, Jeremy) |
| Jul 1, 2019 | N/A | Set/Reset Hearings (0) Docket Text: Set Hearings: A Discovery Conference is set per request of counsel for plaintiffs and defendant Zydus for 7/18/2019 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. (nmf) |
| Jun 27, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [176] Joint STIPULATION TO EXTEND TIME re: Deadline for Production of Documents to July 19, 2019 filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited. Signed by Judge Colm F. Connolly on 6/27/2019. (nmf) |
| Jun 27, 2019 | 176 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME re: Deadline for Production of Documents to July 19, 2019 - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited. (Farnan, Kelly) |
| Jun 27, 2019 | 177 | Notice Requesting Removal of Co-Counsel (4) Docket Text: NOTICE requesting Clerk to remove Gregory L. Diskant, Jordan M. Engelhardt, Lachlan Campbell-Verduyn, Nicole A. Conlon, and Isaac J. Weingram and the Law Firm of Patterson Belknap Webb & Tyler LLP as co-counsel.. (Tigan, Jeremy) |
| Jun 24, 2019 | 175 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Requests for Admission (Nos. 1-2) filed by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Jun 21, 2019 | 173 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Cipla's [CONFIDENTIAL] Objections and Responses to Plaintiffs' Interrogatory No. 9 to Cipla Limited and Cipla USA Inc. filed by Cipla Limited, Cipla USA Inc..(Bilson, David) |
| Jun 21, 2019 | 174 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [163] Amended Complaint Affirmative Defenses and, COUNTERCLAIM against Janssen Biotech Inc., Pharmacyclics LLC by Cipla Limited, Cipla USA Inc..(Bilson, David) |
| Jun 20, 2019 | 172 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Renee Marie Mosley on behalf of Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited (Mosley, Renee) |
| Jun 19, 2019 | 170 | Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Sara M. Metzler as Counsel forDefendants Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd. by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited (Metzler, Sara) |
| Jun 19, 2019 | 171 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Common Requests (No. 1) to Defendants for the Production of Documents and Things filed by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Jun 14, 2019 | 169 | Transcript (120) Docket Text: Official Transcript of Markman hearing held on May 20, 2019 before Judge Connolly. Court Reporter/Transcriber Valerie Gunning. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/5/2019. Redacted Transcript Deadline set for 7/15/2019. Release of Transcript Restriction set for 9/12/2019. (vjg) |
| Jun 12, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [168] STIPULATION TO EXTEND TIME for Cipla to answer, plead or otherwise respond to the Second Amended Complaint Against Cipla for Patent Infringement (D.I. 163) to June 21, 2019 filed by Cipla Limited, Cipla USA Inc. Set/Reset Answer Deadlines: Cipla Limited answer due 6/21/2019; Cipla USA Inc. answer due 6/21/2019. Signed by Judge Colm F. Connolly on 6/12/2019. (fms) |
| Jun 12, 2019 | 168 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Cipla to answer, plead or otherwise respond to the Second Amended Complaint Against Cipla for Patent Infringement (D.I. 163) to June 21, 2019 - filed by Cipla Limited, Cipla USA Inc.. (Phillips, John) |
| Jun 11, 2019 | 167 | Notice (Other) (4) Docket Text: NOTICE of Change of Firm Affiliation for Irena Royzman by Janssen Biotech Inc. (Tigan, Jeremy) |
| Jun 10, 2019 | 166 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC's and Cadila Healthcare Limited's Amended Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Palapura, Bindu) |
| Jun 5, 2019 | 165 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd.'s Second Set of Requests for Production of Documents and Things (Nos. 16-25) filed by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Jun 3, 2019 | 164 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant Cipla's First Amended Set of Requests for Production of Documents and Things (Nos. 100-135) filed by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| May 29, 2019 | 162 | SO ORDERED (3) Docket Text: SO ORDERED, re [160] Stipulation and Order Regarding Second Amended Complaint Against Cipla re [91] Amended Complaint filed by Janssen Biotech Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 5/29/2019. (fms) |
| May 29, 2019 | 163 | Amended Complaint (28) Docket Text: SECOND AMENDED COMPLAINT against Cipla Limited, Cipla USA Inc.- filed by Pharmacyclics LLC, Janssen Biotech Inc. (Attachments: # (1) Exhibits A - I)(fms) |
| May 29, 2019 | 163 | Exhibits A - I (793) |
| May 29, 2019 | 163 | Amended Complaint* (1) |
| May 24, 2019 | 159 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Requests for Admission to Plaintiffs filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| May 24, 2019 | 160 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding Second Amended Complaint Against Cipla re [91] Amended Complaint by Janssen Biotech Inc., Pharmacyclics LLC. (Attachments: # (1) Exhibit 1 - Second Amended Complaint, # (2) Exhibits A-I to Second Amended Complaint)(Blumenfeld, Jack) |
| May 24, 2019 | 160 | Exhibit 1 - Second Amended Complaint (29) |
| May 24, 2019 | 160 | Exhibits A-I to Second Amended Complaint (793) |
| May 24, 2019 | 161 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,016,435 B2 . (Blumenfeld, Jack) |
| May 23, 2019 | 158 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Cipla's First Amended Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 100-135) filed by Cipla Limited, Cipla USA Inc..(Bilson, David) |
| May 20, 2019 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Markman Hearing held on 5/20/2019. (Court Reporter V. Gunning.) (nmf) |
| May 20, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER, for the reasons stated in the transcript of today's Markman hearing, IT IS ORDERED that D.I. [157] MOTION Defendants' request that the Court adopt their respective claim construction positions as set forth in the Joint Claim Construction Chart re [143] Claim Construction Chart is GRANTED IN PART AND DENIED IN PART and D.I. [156] MOTION Plaintiffs' request that the Court adopt their respective claim construction positions as set forth in the Joint Claim Construction Chart re [143] Claim Construction Chart is GRANTED IN PART AND DENIED IN PART. Ordered by Judge Colm F. Connolly on 5/20/2019. (nmf) |
| May 19, 2019 | 156 | Motion for Miscellaneous Relief (2) Docket Text: MOTION Plaintiffs request that the Court adopt their respective claim construction positions as set forth in the Joint Claim Construction Chart re [143] Claim Construction Chart - filed by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| May 19, 2019 | 157 | Motion for Miscellaneous Relief (4) Docket Text: MOTION Defendants request that the Court adopt their respective claim construction positions as set forth in the Joint Claim Construction Chart re [143] Claim Construction Chart re [143] Claim Construction Chart - filed by Lek Pharmaceuticals d.d., Sandoz Inc.. (Gattuso, Dominick) |
| May 17, 2019 | 155 | Motion for Miscellaneous Relief (4) Docket Text: MOTION Defendants Request Court to adopt their respective claim construction position[s] as set forth in the Joint Claim Construction Chart re [74] Claim Construction Chart - filed by Lek Pharmaceuticals d.d., Sandoz Inc.. (Gattuso, Dominick) |
| May 13, 2019 | 154 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Interrogatory No. 9 to Cipla Limited and Cipla USA Inc., filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| May 10, 2019 | 153 | Redacted Document (5) Docket Text: REDACTED VERSION of [118] Letter by Janssen Biotech Inc., Pharmacyclics LLC. (Attachments: # (1) Redacted Exhibits A-M, # (2) Redacted Averment)(Tigan, Jeremy) |
| May 10, 2019 | 153 | Redacted Exhibits A-M (52) |
| May 10, 2019 | 153 | Redacted Averment (2) |
| May 7, 2019 | 152 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sun Pharma Global FZEs and Sun Pharmaceutical Industries, Ltd.s Second Set of Requests for Production of Documents and Things To Plaintiffs (Nos. 16-25) filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| May 3, 2019 | 150 | SO ORDERED (3) Docket Text: SO ORDERED, re (149 in 1:18-cv-00192-CFC, 14 in 1:19-cv-00143-CFC) Joint STIPULATION for Consolidation. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 18-192-CFC ONLY. Signed by Judge Colm F. Connolly on 5/2/2019. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00143-CFC(nmf) |
| May 3, 2019 | 151 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sun Pharma Global FZE's and Sun Pharmaceutical Industries, Ltd.'s Second Amended Initial Disclosures Under Paragraph 3 of the Default Standard for Discovery filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| May 1, 2019 | 149 | Stipulation (3) Docket Text: Joint STIPULATION for Consolidation by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| Apr 26, 2019 | 148 | Redacted Document (345) Docket Text: REDACTED VERSION of [145] Appendix (Joint Claim Construction Appendix) by Janssen Biotech Inc., Pharmacyclics LLC. (Attachments: # (1) Part 2 (Exhibits 9O-12H))(Tigan, Jeremy) |
| Apr 26, 2019 | 148 | Part 2 (Exhibits 9O-12H) (307) |
| Apr 22, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The appendix at D.I. [145] has been placed under seal per request of filer. (nmf) |
| Apr 22, 2019 | 147 | Notice (Other) (2) Docket Text: NOTICE of Defendants' Supplemental Paragraph 3 Initial Disclosures by Lek Pharmaceuticals d.d., Sandoz Inc. (Gattuso, Dominick) |
| Apr 19, 2019 | 143 | Claim Construction Chart (29) Docket Text: CLAIM Construction Chart by Janssen Biotech Inc., Pharmacyclics LLC. (Attachments: # (1) Construction Chart Exhibits)(Tigan, Jeremy) |
| Apr 19, 2019 | 143 | Construction Chart Exhibits (576) |
| Apr 19, 2019 | 144 | Statement (30) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF re [143] Claim Construction Chart Joint Claim Construction Brief by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) Modified on 4/23/2019 (fms). |
| Apr 19, 2019 | 146 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Joint Claim Construction Case Compendium re [144] Statement filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Apr 10, 2019 | 142 | Notice (Other) (2) Docket Text: NOTICE of a document in Compliance with DI 122 by Lek Pharmaceuticals d.d., Sandoz Inc. re [122] Order (Gattuso, Dominick) |
| Apr 9, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [141] Stipulation To Extend Time to Comply to March 11, 2019 Order re [122] Order filed by Lek Pharmaceuticals d.d., Sandoz Inc. Signed by Judge Colm F. Connolly on 4/9/2019. (fms) |
| Apr 8, 2019 | 140 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief and the Reply Declaration of Craig Exckhardt, Ph.D filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Apr 8, 2019 | 141 | Stipulation (2) Docket Text: STIPULATION To Extend Time to Comply to March 11, 2019 Order re [122] Order by Lek Pharmaceuticals d.d., Sandoz Inc.. (Gattuso, Dominick) |
| Apr 1, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [138] STIPULATION TO EXTEND TIME to EXTEND the deadline for Fresenius Defendants to produce samples to 4/15/2019 filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC. Signed by Judge Colm F. Connolly on 4/1/2019. (fms) |
| Apr 1, 2019 | 139 | Redacted Document (2) Docket Text: REDACTED VERSION of [131] STIPULATION TO EXTEND TIME to Comply with the Court's March 11, 2019 Order to April 8, 2019, [122] Order by Lek Pharmaceuticals d.d., Sandoz Inc.. (Gattuso, Dominick) |
| Mar 29, 2019 | 137 | Answer to Counterclaim (22) Docket Text: ANSWER to Counterclaim (Plaintiffs' Answer to Sun's First Amended Counterclaims (D.I. 129)) by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Mar 29, 2019 | 138 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to EXTEND the deadline for Fresenius Defendants to produce samples to 4/15/2019 - filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC. (Farnan, Michael) |
| Mar 27, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [135] STIPULATION TO EXTEND TIME to EXTEND the deadline for Fresenius Defendants to produce samples to 3/29/2019 filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC. Signed by Judge Colm F. Connolly on 3/27/2019. (fms) |
| Mar 27, 2019 | 136 | Answer to Counterclaim (30) Docket Text: ANSWER to [126] Answer to Amended Complaint, Counterclaim (Answer to Zydus's First Amended Counterclaims) by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Mar 26, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [131] STIPULATION TO EXTEND TIME to Comply with the Court's March 11, 2019 Order to April 8, 2019 filed by Lek Pharmaceuticals d.d., Sandoz Inc. Signed by Judge Colm F. Connolly on 3/26/2019. (nmf) |
| Mar 26, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [133] STIPULATION and Order to Extend Time for Sun Defendants to produce documents. Signed by Judge Colm F. Connolly on 3/26/2019. (nmf) |
| Mar 26, 2019 | 135 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to EXTEND the deadline for Fresenius Defendants to produce samples to 3/29/2019 - filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC. (Farnan, Michael) |
| Mar 25, 2019 | 133 | Stipulation (2) Docket Text: STIPULATION and Order to Extend Time for Sun Defendants to produce documents by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited. (Farnan, Kelly) |
| Mar 25, 2019 | 134 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Cipla's First Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 1-108) filed by Cipla Limited, Cipla USA Inc..(Bilson, David) |
| Mar 22, 2019 | 132 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Reply Markman Brief filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Mar 15, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jayita Guhaniyogi for Cadila Healthcare Limited and Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Mar 15, 2019 | N/A | Counterclaim (0) Docket Text: COUNTERCLAIM against Janssen Biotech Inc., Pharmacyclics LLC- filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited (SEE D.I. [129]).(fms) |
| Mar 15, 2019 | 128 | Answer to Counterclaim (30) Docket Text: ANSWER to [113] Answer to Amended Complaint, Counterclaim -- Plaintiffs' Answer To Defendant Cipla Limited's First Amended Counterclaims -- by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Mar 15, 2019 | 129 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [103] Amended Complaint by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| Mar 15, 2019 | 130 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Responses to Defendants First Set of Joint Interrogatories (Nos. 1-4) filed by Janssen Biotech Inc..(Blumenfeld, Jack) |
| Mar 13, 2019 | 126 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [83] Amended Complaint, , COUNTERCLAIM against Janssen Biotech Inc., Pharmacyclics LLC by Zydus Worldwide DMCC, Cadila Healthcare Limited.(Moore, David) |
| Mar 13, 2019 | 127 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants Fresenius Kabi, Zydus, Sandoz, and Sun's Second Set of Requests for Production of Documents and Things (No. 100) filed by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Mar 12, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [123] STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Amended Complaint to March 13, 2019 filed by Zydus Worldwide DMCC, Cadila Healthcare Limited. Set/Reset Answer Deadlines: Cadila Healthcare Limited answer due 3/13/2019; Zydus Worldwide DMCC answer due 3/13/2019. Signed by Judge Colm F. Connolly on 3/12/2019. (fms) |
| Mar 12, 2019 | 125 | Order (2) Docket Text: ORDER re [121] Stipulation of Dismissal filed by Janssen Biotech Inc., Pharmacyclics LLC. Party Shilpa Medicare Limited terminated. Signed by Judge Colm F. Connolly on 3/12/2019. (fms) |
| Mar 11, 2019 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Discovery Conference held on 3/11/2019. (Court Reporter V. Gunning.) (nmf) |
| Mar 11, 2019 | 123 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Amended Complaint to March 13, 2019 - filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Palapura, Bindu) |
| Mar 11, 2019 | 124 | Answer to Counterclaim (28) Docket Text: ANSWER to [109] Answer to Amended Complaint, Counterclaim -- Answer to Counterclaims -- by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Mar 8, 2019 | 121 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal Between Plaintiffs and Shilpa Medicare Limited by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| Mar 7, 2019 | 120 | Letter (4) Docket Text: Letter to The Honorable Colm F. Connolly from Jack B. Blumenfeld regarding Response to Defendants' March 6, 2019 Letter Regarding Discovery Disputes. (Attachments: # (1) Exhibit A-B)(Blumenfeld, Jack) |
| Mar 7, 2019 | 120 | Exhibit A-B (14) |
| Mar 6, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [116] STIPULATION TO EXTEND TIME within which the Sun Defendants shall move, answer or otherwise respond to the First Amended Complaint (D.I. 103) to through and including March 15, 2019 filed by Sun Pharma Holdings, Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Ltd., Set/Reset Answer Deadlines: Sun Pharma Global FZE answer due 3/15/2019; Sun Pharmaceutical Industries Limited answer due 3/15/2019..Signed by Judge Colm F. Connolly on 3/6/2019. (fms) |
| Mar 6, 2019 | 117 | Letter (3) Docket Text: Letter to The Honorable Colm F. Connolly from Michael J. Farnan regarding Discovery Dispute. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Certification of Counsel, # (7) Text of Proposed Order)(Farnan, Michael) |
| Mar 6, 2019 | 117 | Exhibit A (28) |
| Mar 6, 2019 | 117 | Exhibit B (132) |
| Mar 6, 2019 | 117 | Exhibit C (51) |
| Mar 6, 2019 | 117 | Exhibit D (19) |
| Mar 6, 2019 | 117 | Exhibit E (15) |
| Mar 6, 2019 | 117 | Certification of Counsel (1) |
| Mar 6, 2019 | 117 | Text of Proposed Order (1) |
| Mar 5, 2019 | 116 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME within which the Sun Defendants shall move, answer or otherwise respond to the First Amended Complaint (D.I. 103) to through and including March 15, 2019 - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Ltd.. (Farnan, Kelly) |
| Mar 4, 2019 | 114 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Answering Claim Construction Brief and the Declaration of Craig Eckhardt, Ph.D. filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Mar 4, 2019 | 115 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendants Sandoz Inc. and Lek Pharmaceuticals d.d.'s Objections and Responses to Plaintiffs' Interrogatories Nos. 1-9 [CONFIDENTIAL]; and 2) Defendants Sandoz Inc. and Lek Pharmaceuticals d.d.'s Objections and Responses to Plaintiffs' Second Set of Requests (Nos. 12-92) for the Production of Documents and Things [CONFIDENTIAL] filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Mar 1, 2019 | 113 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [91] Amended Complaint Defenses, COUNTERCLAIM against All Plaintiffs by Cipla Limited, Cipla USA Inc..(Phillips, John) |
| Feb 26, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [110] STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Amended Complaint (D.I. 83) to March 11, 2019 filed by Zydus Worldwide DMCC, Cadila Healthcare Limited. Set/Reset Answer Deadlines: Cadila Healthcare Limited answer due 3/11/2019; Zydus Worldwide DMCC answer due 3/11/2019. Signed by Judge Colm F. Connolly on 2/26/2019. (fms) |
| Feb 26, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [112] MOTION for Pro Hac Vice Appearance of Attorney Jayita Guhaniyogi of Kasowitz Benson Torres LLP filed by Zydus Worldwide DMCC, Cadila Healthcare Limited. Signed by Judge Colm F. Connolly on 2/26/2019. (fms) |
| Feb 26, 2019 | 112 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jayita Guhaniyogi of Kasowitz Benson Torres LLP - filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Palapura, Bindu) |
| Feb 25, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [108] STIPULATION TO EXTEND TIME to Answer First Amended Complaint to April 1, 2019 filed by Shilpa Medicare Limited, Set/Reset Answer Deadlines: Shilpa Medicare Limited answer due 4/1/2019. Signed by Judge Colm F. Connolly on 2/25/2019. (fms) |
| Feb 25, 2019 | 109 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [83] Amended Complaint, with Jury Demand , COUNTERCLAIM against Janssen Biotech Inc., Pharmacyclics LLC by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Feb 25, 2019 | 110 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Amended Complaint (D.I. 83) to March 11, 2019 - filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Palapura, Bindu) |
| Feb 25, 2019 | 111 | Answer to Counterclaim (30) Docket Text: ANSWER to [95] Answer to Amended Complaint, Counterclaim by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Feb 22, 2019 | 108 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer First Amended Complaint to April 1, 2019 - filed by Shilpa Medicare Limited. (Ormerod, Eve) |
| Feb 19, 2019 | N/A | Set/Reset Hearings (0) Docket Text: Set Hearings: A Discovery Conference is set per request of counsel for 3/11/2019 at 11:30 AM in Courtroom 4B before Judge Colm F. Connolly. (nmf) |
| Feb 19, 2019 | 107 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Worldwide DMCC's Responses and Objections to Plaintiffs' First Set of Requests for Interrogatories (Nos. 1-8) (Highly Confidential); and Responses and Objections to Plaintiffs' Second Set of Requests (Nos. 12-82) for the Production of Documents and Things (Highly Confidential)) filed by Zydus Worldwide DMCC.(Moore, David) |
| Feb 18, 2019 | 106 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sun's (1) Responses and Objections to Plaintiffs' First Set of Interrogatories 1-7 and (2) Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| Feb 15, 2019 | 105 | Notice of Service (9) Docket Text: NOTICE OF SERVICE of Plaintiffs' Opening Markman Brief filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Feb 14, 2019 | 101 | SO ORDERED (6) Docket Text: SO ORDERED, re [98] Stipulation Regarding Claim Construction Schedule and Procedures for '548 and '140 patents filed by Janssen Biotech Inc., Pharmacyclics LLC. For purposes of addressing claim construction(s) of term(s)/phrase(s) from the '548 and ' 140 patents the word counts for the parties' remaining claim construction briefs shall be increased as follows: a. Defendants' answering claim construction brief: 9,000 words (from 8,250 words);b. Plaintiffs' reply claim construction brief: 6,000 words (from 5,550 words); and c. Defendants' sur-reply claim construction brief: 3,000 words (from 2,750 words). (See stipulation for further details and deadlines). Signed by Judge Colm F. Connolly on 2/13/2019. (fms) |
| Feb 14, 2019 | 102 | SO ORDERED (2) Docket Text: SO ORDERED, re [99] Stipulation filed by Janssen Biotech Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 2/13/2019. (fms) |
| Feb 14, 2019 | 103 | Amended Complaint (36) Docket Text: FIRST AMENDED COMPLAINT for Patent Infringement against Shilpa Medicare Limited, Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited- filed by Pharmacyclics LLC, Janssen Biotech Inc. (Attachments: # (1) Exhibits A - G)(fms) |
| Feb 14, 2019 | 103 | Exhibits A - G (654) |
| Feb 14, 2019 | 104 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,296,753 B2 ;9,725,455 B1 ;8,999,999 B2 ;9,801,881 B2 ;9,801,883 B2 ;10,125,140 B1 ;10,106,548 B2. (fms) |
| Feb 14, 2019 | 103 | Amended Complaint* (1) |
| Feb 13, 2019 | 100 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd.'s First Set of Requests for Production of Documents and Things (Nos. 1-15) filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Feb 12, 2019 | 98 | Stipulation (6) Docket Text: STIPULATION Regarding Claim Construction Schedule and Procedures for '548 and '140 patents by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| Feb 12, 2019 | 99 | Stipulation (2) Docket Text: STIPULATION and (Proposed) Order to File Amended Complaint Against Shilpa Medicare Limited, Sun Pharma Global FZE, and Sun Pharmaceutical Industries Ltd. by Janssen Biotech Inc., Pharmacyclics LLC. (Attachments: # (1) Exhibit 1 - Amended Complaint, # (2) Exhibit A-G to Amended Complaint, # (3) Patent/Trademark Report)(Tigan, Jeremy) |
| Feb 12, 2019 | 99 | Exhibit 1 - Amended Complaint (37) |
| Feb 12, 2019 | 99 | Exhibit A-G to Amended Complaint (654) |
| Feb 12, 2019 | 99 | Patent/Trademark Report (1) |
| Feb 11, 2019 | 95 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [80] Amended Complaint , COUNTERCLAIM against Janssen Biotech Inc., Pharmacyclics LLC by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Feb 11, 2019 | 96 | Notice of Service (9) Docket Text: NOTICE OF SERVICE of Plaintiffs' Supplemental Preliminary Claim Constructions and Intrinsic Evidence for U.S. Patent Nos. 10,125,140 and 10,106,548 filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Feb 11, 2019 | 97 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Fresenius Kabi's, Zydus's, Sandoz's, and Sun's Second Set of Requests for Production of Documents and Things to Plaintiffs (No. 100) filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Feb 8, 2019 | 94 | Notice of Service (9) Docket Text: NOTICE OF SERVICE of Plainitffs' Opening Markman Brief filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Feb 6, 2019 | 93 | SO ORDERED (2) Docket Text: SO ORDERED, re [87] STIPULATION of Dismissal Between Plaintiffs and Teva Pharmaceuticals USA, Inc., Party Teva Pharmaceuticals USA, Inc. terminated. Signed by Judge Colm F. Connolly on 2/5/2019. (nmf) |
| Feb 5, 2019 | 89 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Shilpa Medicare Limited's Responses and Objections to Plaintiffs'Interrogatories (Nos. 1-7) and Shilpa Medicare Limited's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 12-62) filed by Shilpa Medicare Limited.(Ormerod, Eve) |
| Feb 5, 2019 | 90 | Order (2) Docket Text: ORDER approving [86] STIPULATION and (Proposed) Order to File Amended Complaint Against Cipla Limited and Cipla USA Inc. Signed by Judge Colm F. Connolly on 2/5/2019. (nmf) |
| Feb 5, 2019 | 91 | Amended Complaint (27) Docket Text: AMENDED COMPLAINT against Cipla Limited, Cipla USA Inc.- filed by Pharmacyclics LLC, Janssen Biotech Inc. (Attachments: # (1) Exhibits A-H to the Amended Complaint)(nmf) |
| Feb 5, 2019 | 91 | Exhibits A-H to the Amended Complaint (658) |
| Feb 5, 2019 | 92 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,296,753 B2 ;9,725,455 B1 ;9,540,382 B2 ;9,713,617 B2 ;8,754,090 B2 ;9,125,889 B2 ;10,125,140 B1; 10,106,548 B2. (nmf) |
| Feb 5, 2019 | 91 | Amended Complaint* (1) |
| Feb 4, 2019 | 87 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal Between Plaintiffs and Teva Pharmaceuticals USA, Inc. by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| Feb 4, 2019 | 88 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Defendants Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Limited's Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-9) and (ii) Defendants Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Limited's Objections and Responses to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 12-81) filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Feb 1, 2019 | 86 | Stipulation (2) Docket Text: STIPULATION and (Proposed) Order to File Amended Complaint Against Cipla Limited and Cipla USA Inc. by Janssen Biotech Inc., Pharmacyclics LLC. (Attachments: # (1) Exhibit 1 - Amended Complaint, # (2) Exhibit A-H to Amended Complaint, # (3) Patent/Trademark Report)(Tigan, Jeremy) |
| Feb 1, 2019 | 86 | Exhibit 1 - Amended Complaint (28) |
| Feb 1, 2019 | 86 | Exhibit A-H to Amended Complaint (658) |
| Feb 1, 2019 | 86 | Patent/Trademark Report (1) |
| Jan 31, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of Exhibits A-V to the Amended Complaint at D.I. [83] and the Stipulation to Amend at D.I. [73] have been replaced with a corrected version per request of filer. (nmf) |
| Jan 28, 2019 | 79 | Order (2) Docket Text: ORDER approving [72] STIPULATION and [Proposed] Order to file an Amended Complaint (as to Defendants Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Limited). Signed by Judge Colm F. Connolly on 1/25/2019. (nmf) |
| Jan 28, 2019 | 80 | Amended Complaint (41) Docket Text: AMENDED COMPLAINT against Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC- filed by Pharmacyclics LLC, Janssen Biotech Inc. (Attachments: # (1) Exhibits A-Q to the Amended Complaint)(nmf) |
| Jan 28, 2019 | 80 | Exhibits A-Q to Amended Complaint (1266) |
| Jan 28, 2019 | 81 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) (SEE DOCUMENT FOR LIST OF PATENTS re: Defendants Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Limited. (nmf) |
| Jan 28, 2019 | 82 | Order (2) Docket Text: ORDER approving [73] STIPULATION and [Proposed] Order to file an Amended Complaint (as to Defendants Zydus Worldwide DMCC, Cadila Healthcare Limited, Teva Pharmaceuticals USA, Inc., Sandoz Inc., and Lek Pharmaceuticals d.d.) by Janssen Biotech Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 1/25/2019. (nmf) |
| Jan 28, 2019 | 83 | Amended Complaint (83) Docket Text: AMENDED COMPLAINT against Cadila Healthcare Limited, Lek Pharmaceuticals d.d., Sandoz Inc., Teva Pharmaceuticals USA, Inc., Zydus Worldwide DMCC- filed by Pharmacyclics LLC, Janssen Biotech Inc. (Attachments: # (1) Exhibits A-V to the Amended Complaint)(nmf) (Attachment 1 replaced on 1/31/2019) (nmf, ). |
| Jan 28, 2019 | 83 | Exhibits A-V to the Amended Complaint (1910) |
| Jan 28, 2019 | 84 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) (SEE ATTACHED DOCUMENT FOR LIST OF PATENTS re: Defendants Zydus Worldwide DMCC; Cadila Healthcare Limited; Teva Pharmaceuticals USA, Inc.; Sandoz Inc. and Lek Pharmaceuticals d.d. (nmf) |
| Jan 28, 2019 | 85 | Scheduling Order (11) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 8/16/2019. Amended Pleadings due by 8/16/2019. Fact Discovery completed by 11/15/2019. Expert Discovery due by 7/1/2020. A Telephonic Status Conference to discuss trial length and consolidation for trial is set for 3/9/2020 at 09:00 AM before Judge Colm F. Connolly Joint Claim Construction Brief due by 4/19/2019. A Markman Hearing is set for 5/20/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 9/23/2020 at 04:30 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 10/13/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 1/25/2019. (nmf) |
| Jan 28, 2019 | 83 | Amended Complaint* (1) |
| Jan 22, 2019 | 78 | Proposed Order (11) Docket Text: PROPOSED ORDER -- [Proposed] Scheduling Order -- by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| Jan 18, 2019 | 72 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to file an Amended Complaint (as to Defendants Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Limited) by Janssen Biotech Inc., Pharmacyclics LLC. (Attachments: # (1) Exhibit 1 (Amended Complaint), # (2) Exhibits A-Q to Amended Complaint, # (3) Patent/Trademark Report)(Tigan, Jeremy) |
| Jan 18, 2019 | 72 | Exhibit 1 (Amended Complaint) (41) |
| Jan 18, 2019 | 72 | Exhibits A-Q to Amended Complaint (1266) |
| Jan 18, 2019 | 72 | Patent/Trademark Report (2) |
| Jan 18, 2019 | 73 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to file an Amended Complaint (as to Defendants Zydus Worldwide DMCC, Cadila Healthcare Limited, Teva Pharmaceuticals USA, Inc., Sandoz Inc., and Lek Pharmaceuticals d.d.) by Janssen Biotech Inc., Pharmacyclics LLC. (Attachments: # (1) Exhibit 1 (Amended Complaint), # (2) Exhibits A-V to Amended Complaint, # (3) Patent/Trademark Report)(Tigan, Jeremy) (Attachment 2 replaced on 1/31/2019) (nmf, ). |
| Jan 18, 2019 | 73 | Exhibit 1 (Amended Complaint) (83) |
| Jan 18, 2019 | 73 | Exhibits A-V to Amended Complaint (1910) |
| Jan 18, 2019 | 73 | Patent/Trademark Report (2) |
| Jan 18, 2019 | 74 | Claim Construction Chart (27) Docket Text: CLAIM Construction Chart by Janssen Biotech Inc., Pharmacyclics LLC. (Attachments: # (1) Joint CC Appendix Volume 1 (Exhibits A-I))(Tigan, Jeremy) |
| Jan 18, 2019 | 74 | Joint CC Appendix Volume 1 (Exhibits A-I) (704) |
| Jan 18, 2019 | 75 | Appendix (30) Docket Text: APPENDIX re [74] Claim Construction Chart -- Joint CC Appendix Volume 2 (Exhibits J-L) by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| Jan 18, 2019 | 76 | Appendix (30) Docket Text: APPENDIX re [74] Claim Construction Chart -- Joint CC Appendix Volume 3 (Exhibits M-T) by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| Jan 18, 2019 | 77 | Appendix (30) Docket Text: APPENDIX re [74] Claim Construction Chart -- Joint CC Appendix Volume 4 (Exhibits U-BB) -- by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| Jan 16, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 1/16/2019. (Court Reporter V. Gunning.) (nmf) |
| Jan 16, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER, Counsel for Plaintiffs shall submit a revised proposed scheduling order no later than close of business on January 23, 2019 that reflects the Court's rulings during the 1/16/2019 scheduling conference. Ordered by Judge Colm F. Connolly on 1/16/2019. (nmf) |
| Jan 16, 2019 | 71 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Plaintiffs' Objections and Responses to Defendants Sandoz Inc and Lek Pharmaceuticals d.d.'s First Set of Requests for Production of Documents and Things (Nos. 1-10), 2) Plaintiffs' Objections and Responses to Defendants Sandoz Inc and Lek Pharmaceuticals d.d.'s First Set of Requests for Admission (Nos. 1-5) and 3) Plaintiffs' Objections and Responses to Defendants Sandoz Inc and Lek Pharmaaceuticals d.d.'s First Set of Interrogatories (No. 1) filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Jan 15, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [69] MOTION for Pro Hac Vice Appearance of Attorney Isaac J. Weingram filed by Janssen Biotech Inc. Signed by Judge Colm F. Connolly on 1/15/2019. (fms) |
| Jan 15, 2019 | 69 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Isaac J. Weingram - filed by Janssen Biotech Inc.. (Tigan, Jeremy) |
| Jan 15, 2019 | 70 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sun Pharma Global FZE's and Sun Pharmaceutical Industries, Ltd.'s Requests for Production of Documents and Things to Plaintiff (Nos. 1-16) filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited.(Farnan, Kelly) |
| Jan 4, 2019 | 60 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Revised Proposed Preliminary Claim Constructions and Intrinsic Evidence filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Jan 4, 2019 | 61 | Notice of Service (10) Docket Text: NOTICE OF SERVICE of Plaintiffs' Identification of Intrinsic Evidence in Opposition to Defendants' Proposed Constructions filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Jan 4, 2019 | 62 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Interrogatories Nos. 1-8 to Cipla Limited and Cipla USA Inc.; and (2) Plaintiffs' Second Set of Requests (Nos. 12-80) to Cipla Limited and Cipla USA Inc. for the Production of Documents and Things filed by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Jan 4, 2019 | 63 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Interrogatories Nos. 1-9 to Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Limited; and (2) Plaintiffs' Second Set of Requests (Nos. 12-81) to Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Limited for the Production of Documents and Things filed by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Jan 4, 2019 | 64 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Interrogatories Nos. 1-9 to Sandoz, Inc. and Lek Pharmaceuticals D.D.; and (2) Plaintiffs' Second Set of Requests (Nos. 12-92) to Sandoz, Inc. and Lek Pharmaceuticals D.D. for the Production of Documents and Things filed by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Jan 4, 2019 | 65 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Interrogatories Nos. 1-7 to Shilpa Medicare Limited; and (2) Plaintiffs' Second Set of Requests (Nos. 12-62) to Shilpa Medicare Limited for the Production of Documents and Things filed by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Jan 4, 2019 | 66 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Interrogatories Nos. 1-7 to Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd.; and (2) Plaintiffs' Second Set of Requests (Nos. 12-69) to Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd. for the Production of Documents and Things filed by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Jan 4, 2019 | 67 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Interrogatories Nos. 1-7 to Teva Pharmaceutical USA, Inc.; and (2) Plaintiffs' Second Set of Requests (Nos. 12-68) to Teva Pharmaceutical USA, Inc. for the Production of Documents and Things filed by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Jan 4, 2019 | 68 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Interrogatories Nos. 1-8 to Zydus Worldwide DMCC and Cadila Healthcare Limited; and (2) Plaintiffs' Second Set of Requests (Nos. 12-82) to Zydus Worldwide DMCC and Cadila Healthcare Limited for the Production of Documents and Things filed by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Dec 21, 2018 | 58 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Proposed Preliminary Claim Constructions and Intrinsic Evidence filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Dec 21, 2018 | 59 | Notice of Service (9) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Claim Constructions and Intrinsic Evidence Pursuant to the Scheduling Order filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Dec 17, 2018 | 57 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Service of (i) Defendants Sandoz Inc. and Lek Pharmaceuticals d.d.'s First Set of Requests for Admission to Plaintiffs (Nos. 1-5); (ii) Defendants Sandoz Inc. and Lek Pharmaceuticals d.d.'s First SEt of Interrogatories to Plaintiffs (No.1); and (iii) Defendants Sandoz Inc. and Lek Pharmaceuticals d.d.'s First Set of Request for Production of Documents and Things to Plaintiffs (Nos. 1-10) filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Dec 13, 2018 | 56 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 1/16/2019 at 12:00 PM before Judge Colm F. Connolly. Counsel for plaintiffs shall coordinate and initiate this call. Signed by Judge Colm F. Connolly on 12/13/2018. (nmf) |
| Dec 7, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [55] MOTION for Pro Hac Vice Appearance of Attorney Chanson Chang filed by Janssen Biotech Inc., Pharmacyclics LLC. Signed by Judge Colm F. Connolly on 12/7/2018. (fms) |
| Dec 6, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER per footnote two on page three of the proposed scheduling order (D.I. [53]) stating that plaintiffs and defendants in Case No. 18-1543-CFC believe that this case should be consolidated with Case No. 18-192-CFC, It is ORDERED that for all purposes other than trial, these cases are to be treated as consolidated and all filings are to be made in Lead Case No. 18-192-CFC. Ordered by Judge Colm F. Connolly on 12/6/2018. (nmf) |
| Dec 6, 2018 | 55 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Chanson Chang - filed by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| Nov 30, 2018 | 54 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs Identification of Terms for Construction filed by Janssen Biotech Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Nov 29, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER approving Counsel's request re: [52] Letter. In the scheduling order to be filed with the Court, the trial shall begin on October 13, 2020 and the pretrial conference shall be held on Wednesday, September 23, 2020 at 4:30 p.m. Ordered by Judge Colm F. Connolly on 11/29/2018. (nmf) |
| Nov 29, 2018 | 53 | Proposed Order (15) Docket Text: PROPOSED ORDER Scheduling Order by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy) |
| Nov 28, 2018 | 52 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Jack B. Blumenfeld regarding scheduling order. (Blumenfeld, Jack) |
| Nov 26, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Whereas the Court directed the parties during the October 17, 2018 hearing to file a proposed scheduling order using the Court's form order and whereas the parties have not done so, it is hereby ORDERED that the parties shall file by no later than November 29, 2018 a proposed scheduling order using the Court's form order (revised as of November 14, 2018) that incorporates the dates and discovery limitations currently in effect. It is further ORDERED that for all purposes other than trial, these cases are to be treated as consolidated and all filings are to be made in Lead Case No. 18-192-CFC. Signed by Judge Colm F. Connolly on 11/26/2018. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(nmf) |
| Nov 2, 2018 | 51 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Oct 30, 2018 | 50 | Protective Order (30) Docket Text: PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 10/29/2018. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(fms) |
| Oct 29, 2018 | 49 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants Fresenius Kabi USA LLC, Fresenius Kabi Oncology Limited, Zydus Worldwide DMCC, Cadila Healthcare Limited, Teva Pharmaceuticals USA, Inc., Sandoz Inc., and Lek Pharmaceuticals d.d.'s First Set of Requests for Production of Documents and Things (Nos. 1-99) filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Tigan, Jeremy) |
| Oct 26, 2018 | 48 | Proposed Order (30) Docket Text: PROPOSED ORDER // Protective Order by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Tigan, Jeremy) |
| Oct 22, 2018 | 47 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses to Defendants' First Set of Joint Interrogatories (Nos. 1-4) filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Tigan, Jeremy) |
| Oct 18, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER, Having reviewed the parties' submissions and heard oral argument relating to two disputes over the otherwise agreed-upon protective order (PO) in Civil Actions 18-192-CFC, 18-237-CFC, 18-247-CFC, and 18-275-CFC, IT IS HEREBY ORDERED that Defendants proposal with respect to paragraphs 19 and 20 of the contemplated PO, which would prohibit Plaintiffs from disclosing confidential information (CI) produced to Plaintiffs in discovery by any one Defendant to the outside counsel and experts of any other Defendant without first obtaining the producing Defendants consent, is REJECTED for the reasons stated by the Court and made clear by the Courts questioning of the parties at oral argument on October 17, 2018. The Court further notes that its decision was informed by the following: (1) this action is one of four actions that have been effectively consolidated for pre-trial purposes with a single schedule (including a consolidated Markman hearing) and common discovery; (2) Plaintiffs have proposed a reasonable alternative to Defendants' proposal that would limit the cross-disclosure of CI to Defendants' outside counsel and experts; (3) Defendants agree that their outside counsel are not competitive decision makers and are subject to an agreed-upon prosecution bar in the contemplated PO; (4) the deadline for the parties to identify their respective experts affords each Defendant sufficient time to seek Court intervention in the event a Defendant believes (i) an identified expert is a competitive decision maker or should be subject to the PO's prosecution bar, and/or (ii) good cause exists to prohibit the expert in question from having access to a Defendants CI; (5) Defendants' proposal would place an undue, unfair, and unnecessary burden on Plaintiffs; (6) Defendants' proposal would lead to significant disruptions in discovery, depositions, and court proceedings and would impose an undue burden on the Court; and (7) Defendants have not demonstrated that restrictions beyond Plaintiffs' proposed alternative are necessary to avoid the risk that a co-Defendant would use a producing Defendants' CI's to the competitive disadvantage of the producing Defendant. Ordered by Judge Colm F. Connolly on 10/18/2018. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(nmf) |
| Oct 17, 2018 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Discovery Conference held on 10/17/2018. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(nmf) |
| Oct 16, 2018 | 46 | Letter (4) Docket Text: Letter to The Honorable Colm F. Connolly from Jeremy A. Tigan regarding the proposed Protective Order - re (45 in 1:18-cv-00192-CFC, 39 in 1:18-cv-00247-CFC, 57 in 1:18-cv-00237-CFC, 73 in 1:18-cv-00275-CFC) Letter. (Attachments: # (1) Exhibits A-D)(Tigan, Jeremy) |
| Oct 16, 2018 | 46 | Exhibits A-D (85) |
| Oct 15, 2018 | 45 | Letter (7) Docket Text: Letter to The Honorable Colm F. Connolly from Dominick T. Gattuso regarding Opening Discovery Dispute Letter. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Gattuso, Dominick) |
| Oct 15, 2018 | 45 | Exhibit A (37) |
| Oct 15, 2018 | 45 | Exhibit B (4) |
| Oct 9, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (71 in 1:18-cv-00275-CFC, 44 in 1:18-cv-00192-CFC, 55 in 1:18-cv-00237-CFC) STIPULATION TO EXTEND TIME to EXTEND the deadline for Defendants' Initial Invalidity Contentions to 11/2/2018 filed by Fresenius Kabi USA, LLC, (38 in 1:18-cv-00247-CFC) STIPULATION TO EXTEND TIME to Extend Deadline for Initial Invalidity Contentions to November 2, 2018 filed by Cipla Limited, Cipla USA Inc.. Signed by Judge Colm F. Connolly on 10/9/2018. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(fms) |
| Oct 5, 2018 | 44 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME to EXTEND the deadline for Defendants' Initial Invalidity Contentions to 11/2/2018 - filed by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Oct 3, 2018 | N/A | Set/Reset Hearings (0) Docket Text: Set Hearings: A Discovery Conference is set for 10/17/2018 at 11:00 AM per request of counsel in Courtroom 4B before Judge Colm F. Connolly. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(nmf) |
| Oct 3, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney John K. Hsu for Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Oct 1, 2018 | 43 | Order (4) Docket Text: ORDER: IT IS ORDERED that on or before October 22, 2018, each party or each party group shall email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, information requested regarding ADR. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 10/1/18. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(cak) |
| Sep 25, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kevin M. Nelson and Thomas A. Rammer, II for Fresenius Kabi USA, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Sep 25, 2018 | 42 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Jessica K. Walters as co-counsel.. (Farnan, Brian) |
| Sep 20, 2018 | N/A | Case Reassigned to CFC (0) Docket Text: Case reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC (rjb) |
| Sep 7, 2018 | 40 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Fresenius Kabi's, Zydus's, Sun's, Cipla's and Teva's First Set of Joint Interrogatories to Plaintiffs (Nos. 1-4) filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 7, 2018 | 41 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Fresenius Kabi's, Zydus's, and Teva's First Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 1-99) filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 5, 2018 | 38 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Limited's Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-11) filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 5, 2018 | 39 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions filed by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Aug 29, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (33 in 1:18-cv-00247-GMS, 59 in 1:18-cv-00275-GMS, 37 in 1:18-cv-00192-GMS, 48 in 1:18-cv-00237-GMS) STIPULATION TO EXTEND TIME for the parties to submit their Protective Order to September 7, 2018 filed by Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 8/29/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Aug 27, 2018 | 37 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit their Protective Order to September 7, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC. (Blumenfeld, Jack) |
| Aug 22, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (31 in 1:18-cv-00247-GMS, 57 in 1:18-cv-00275-GMS, 46 in 1:18-cv-00237-GMS, 35 in 1:18-cv-00192-GMS) STIPULATION TO EXTEND TIME for the parties to submit their protective order to August 20, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC, (58 in 1:18-cv-00275-GMS, 32 in 1:18-cv-00247-GMS, 36 in 1:18-cv-00192-GMS, 47 in 1:18-cv-00237-GMS) STIPULATION TO EXTEND TIME for the parties to submit their Protective Order to August 27, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 8/22/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Aug 20, 2018 | 36 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit their Protective Order to August 27, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Blumenfeld, Jack) |
| Aug 13, 2018 | 35 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit their protective order to August 20, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Blumenfeld, Jack) |
| Aug 6, 2018 | 34 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests (Nos. 1-11) to Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Limited for the Production of Documents and Things filed by Janssen Biotech Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Jul 31, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (55 in 1:18-cv-00275-GMS, 44 in 1:18-cv-00237-GMS, 29 in 1:18-cv-00247-GMS, 33 in 1:18-cv-00192-GMS) STIPULATION TO EXTEND TIME for the parties to submit the Protective Order to August 13, 2018 filed by Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 7/31/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Jul 27, 2018 | 33 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit the Protective Order to August 13, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC. (Noreika, Maryellen) |
| Jul 20, 2018 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(fms) |
| Jun 29, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (40 in 1:18-cv-00237-GMS, 28 in 1:18-cv-00247-GMS, 48 in 1:18-cv-00275-GMS, 32 in 1:18-cv-00192-GMS) Proposed Scheduling Order: Cases referred to the Magistrate Judge for the purpose of exploring ADR. (Motions for Joinder of Parties and to Amended Pleadings due by 8/16/2019., Claim Construction Opening Briefs due by 3/15/2019., Claim Construction Answering Briefs due by 4/19/2019., A Markman Hearing (full day) is set for 5/20/2019 at 09:30 AM in Courtroom 4A., Fact Discovery completed by 11/15/2019., Opening Expert Reports due by 2/7/2020., Rebuttal Expert Reports due by 3/27/2020., Expert Discovery due by 5/22/2020., A Status Telephone Conference is set for 3/9/2020 at 10:00 AM to discuss the length of trial and consolidation., Proposed Final Pretrial Order due by 7/31/2020., A Final Pretrial Conference is set for 8/10/2020 at 10:00 AM in Courtroom 4A., A Bench Trial (Length TBD) is set for 9/14/2020 at 09:00 AM in Courtroom 4A. See Proposed Scheduling Order for more details). Ordered by Judge Gregory M. Sleet on 6/29/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Jun 28, 2018 | 32 | Proposed Order (8) Docket Text: PROPOSED ORDER -- Scheduling Order -- by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Attachments: # (1) Letter to The Honorable Gregory M. Sleet)(Blumenfeld, Jack) |
| Jun 28, 2018 | 32 | Letter to The Honorable Gregory M. Sleet (1) |
| Jun 18, 2018 | 30 | Notice of Service (11) Docket Text: NOTICE OF SERVICE of Plaintiffs' Paragraph 3 Initial Disclosures filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Blumenfeld, Jack) |
| Jun 18, 2018 | 31 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Limited's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Jun 15, 2018 | 29 | Transcript (19) Docket Text: Official Transcript of Telephone Conference held on 06 14 18 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/6/2018. Redacted Transcript Deadline set for 7/16/2018. Release of Transcript Restriction set for 9/13/2018. (kjm) |
| Jun 14, 2018 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Scheduling Conference held on 6/14/2018. The court assigned the following deadlines: The Markman Hearing (full day) is set for 5/20/2019 at 9:30 AM in Courtroom 4A; a Telephone Conference, to discuss the length of trial and consolidation, is set for 3/9/2020 at 10:00 AM; the Final Proposed Pretrial Order is due by the close of business on 7/31/2020; the Final Pretrial Conference is set for 8/10/2020 at 10:00 AM in Courtroom 4A; and the Bench Trial (length TBD) is set for 9/14/2020 at 9:00 AM in Courtroom 4A. The cases are referred to the Magistrate Judge for exploring ADR. An amended proposed scheduling order is due by 6/28/2018. The parties shall work out the rest of the schedule, given the dates and orders provided. (Court Reporter Kevin Maurer.) Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) Modified on 6/14/2018 (mdb). |
| Jun 14, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Minute Entry dated today has been corrected to reflect that the Final Pretrial Conference is set for 8/10/2020 at 10:00 AM in Courtroom 4A. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Jun 6, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER re (31 in 1:18-cv-00237-GMS, 37 in 1:18-cv-00275-GMS, 26 in 1:18-cv-00192-GMS, 22 in 1:18-cv-00247-GMS) Joint Status Report - A Scheduling Telephone Conference is set for 6/14/2018 at 02:00 PM before Judge Gregory M. Sleet. The plaintiffs shall arrange the call and contact Chambers at (32) 573-4559 once all parties are on the line. Ordered by Judge Gregory M. Sleet on 6/6/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Jun 5, 2018 | 27 | Notice of Service (12) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Pharmacyclics LLC and Janssen Biotech, Inc.'s Initial Disclosures Pursuant to Rule 26(a)(1) and (2) Plaintiffs Pharmacyclics LLC and Janssen Biotech, Inc.'s Identification of Accused Products and Asserted Patents filed by Pharmacyclics LLC, Janssen Biotech Inc..(Blumenfeld, Jack) |
| Jun 5, 2018 | 28 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Limited's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| May 25, 2018 | 26 | Status Report (19) Docket Text: Joint STATUS REPORT by Janssen Biotech, Inc., Pharmacyclics LLC. (Attachments: # (1) Proposed Schedulng Order)(Blumenfeld, Jack) |
| May 25, 2018 | 26 | Proposed Schedulng Order (10) |
| May 24, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (35 in 1:18-cv-00275-GMS, 25 in 1:18-cv-00192-GMS, 29 in 1:18-cv-00237-GMS, 21 in 1:18-cv-00247-GMS) STIPULATION TO EXTEND TIME for the parties to submit the joint status report and proposed scheduling order to May 25, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 5/24/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| May 22, 2018 | 25 | Stipulation to EXTEND Time (7) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit the joint status report and proposed scheduling order to May 25, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Noreika, Maryellen) |
| May 18, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (28 in 1:18-cv-00237-GMS, 24 in 1:18-cv-00192-GMS, 33 in 1:18-cv-00275-GMS, 20 in 1:18-cv-00247-GMS) MOTION for Pro Hac Vice Appearance of Attorney Nicole A. Conlon filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 5/18/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| May 17, 2018 | 24 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicole A. Conlon - filed by Janssen Biotech, Inc. (Noreika, Maryellen) Modified on 5/17/2018 (ceg). |
| May 15, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (26 in 1:18-cv-00237-GMS, 18 in 1:18-cv-00247-GMS, 30 in 1:18-cv-00275-GMS, 23 in 1:18-cv-00192-GMS) STIPULATION TO EXTEND TIME for the parties to submit the Joint Status Report and proposed scheduling order to May 22, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 5/15/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| May 14, 2018 | 23 | Stipulation to EXTEND Time (6) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit the Joint Status Report and proposed scheduling order to May 22, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Blumenfeld, Jack) |
| Apr 13, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (22 in 1:18-cv-00192-GMS, 25 in 1:18-cv-00275-GMS, 20 in 1:18-cv-00237-GMS, 13 in 1:18-cv-00247-GMS) STIPULATION TO EXTEND TIME to Submit Joint Status Report and Proposed Scheduling Order to May 15, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 4/13/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Apr 12, 2018 | 22 | Stipulation to EXTEND Time (9) Docket Text: STIPULATION TO EXTEND TIME to Submit Joint Status Report and Proposed Scheduling Order to May 15, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Blumenfeld, Jack) |
| Apr 11, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (21 in 1:18-cv-00192-GMS, 24 in 1:18-cv-00275-GMS, 12 in 1:18-cv-00247-GMS) MOTION for Pro Hac Vice Appearance of Attorney Gregory L. Diskant, Irena Royzman, Jordan M. Engelhardt, and Lachlan Campbell-Verduyn filed by Janssen Biotech, Inc.. Ordered by Judge Gregory M. Sleet on 4/11/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Apr 11, 2018 | 21 | Motion for Leave to Appear Pro Hac Vice (10) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gregory L. Diskant, Irena Royzman, Jordan M. Engelhardt, and Lachlan Campbell-Verduyn - filed by Janssen Biotech, Inc.. (Blumenfeld, Jack) |
| Apr 6, 2018 | 20 | SO ORDERED (3) Docket Text: SO ORDERED - re [18] Stipulation and Order Dismissing Fresenius Kabi's Seventh Affirmative Defense without Prejudice filed by Janssen Biotech Inc., Pharmacyclics LLC. Signed by Judge Gregory M. Sleet on 4/6/2018. (mdb) |
| Apr 5, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (19 in 1:18-cv-00192-GMS, 11 in 1:18-cv-00247-GMS, 13 in 1:18-cv-00237-GMS, 20 in 1:18-cv-00275-GMS) MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Erica N. Andersen, Brianne Bharkhda, and Nicholas L. Evoy filed by Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 4/5/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Apr 3, 2018 | 19 | Motion for Leave to Appear Pro Hac Vice (11) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Erica N. Andersen, Brianne Bharkhda, and Nicholas L. Evoy - filed by Pharmacyclics LLC. (Blumenfeld, Jack) |
| Apr 2, 2018 | 17 | Answer to Counterclaim (30) Docket Text: ANSWER to [12] Answer to Complaint, Counterclaims by Janssen Biotech Inc., Pharmacyclics LLC.(Noreika, Maryellen) Modified on 4/3/2018 (mdb). |
| Apr 2, 2018 | 18 | Stipulation (3) Docket Text: STIPULATION and Order Dismissing Fresenius Kabi's Seventh Affirmative Defense without Prejudice by Janssen Biotech Inc., Pharmacyclics LLC. (Noreika, Maryellen) |
| Mar 19, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Tara L. Kurtis,Imron T. Aly for Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Mar 15, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [15] MOTION for Pro Hac Vice Appearance of Attorney Imron T. Aly, Kevin M. Nelson, John K. Hsu, Thomas A. Rammer II, Ahmed M.T. Riaz, Tara L. Kurtis, and Jessica K. Walter filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC. Ordered by Judge Gregory M. Sleet on 3/15/2018. (mdb) |
| Mar 15, 2018 | 16 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Fresenius Kabi Pharmaceuticals Holding, Inc., Other Affiliate Fresenius Kabi AG, Other Affiliate Fresenius SE & Co. KGaA for Fresenius Kabi USA, LLC; Corporate Parent Fresenius Kabi (Singapore) Pte. Ltd., Other Affiliate Fresenius Kabi AG, Other Affiliate Fresenius SE & Co. KGaA, Other Affiliate Fresenius Kabi Deutschland GmbH, Other Affiliate Fresenius Kabi Austria GmbH, Other Affiliate Fresenius Kabi Asiaco GmbH for Fresenius Kabi Oncology Limited filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Mar 14, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [13] Stipulation of Dismissal of Fresenius Kabi USA, Inc. filed by Fresenius Kabi USA, Inc., Party Fresenius Kabi USA, Inc. terminated.. Ordered by Judge Gregory M. Sleet on 3/14/2018. (mdb) |
| Mar 13, 2018 | 14 | Order (2) Docket Text: ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 3/14/2018. (asw) |
| Mar 13, 2018 | 15 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Imron T. Aly, Kevin M. Nelson, John K. Hsu, Thomas A. Rammer II, Ahmed M.T. Riaz, Tara L. Kurtis, and Jessica K. Walter - filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Mar 12, 2018 | 12 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against All Plaintiffs by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Mar 12, 2018 | 13 | Stipulation of Dismissal (3) Docket Text: STIPULATION of Dismissal of Fresenius Kabi USA, Inc. by Fresenius Kabi USA, Inc.. (Farnan, Brian) Modified on 3/13/2018 (mdb). |
| Feb 26, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [11] STIPULATION TO EXTEND TIME for Defendants to Answer or Otherwise Respond to the Complaint to 3/12/2018 filed by Fresenius Kabi USA, Inc., Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC, Set/Reset Answer Deadlines: Fresenius Kabi Oncology Limited answer due 3/12/2018; Fresenius Kabi USA, Inc. answer due 3/12/2018; Fresenius Kabi USA, LLC answer due 3/12/2018.. Ordered by Judge Gregory M. Sleet on 2/26/2018. (mdb) |
| Feb 22, 2018 | 10 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Brian E. Farnan on behalf of Fresenius Kabi Oncology Limited, Fresenius Kabi USA, Inc., Fresenius Kabi USA, LLC (Farnan, Brian) |
| Feb 22, 2018 | 11 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Defendants to Answer or Otherwise Respond to the Complaint to 3/12/2018 - filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, Inc., Fresenius Kabi USA, LLC. (Farnan, Michael) |
| Feb 7, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (nms) |
| Feb 6, 2018 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Janssen Biotech Inc., Pharmacyclics LLC. Fresenius Kabi Oncology Limited served on 2/5/2018, answer due 2/26/2018. (Blumenfeld, Jack) |
| Feb 6, 2018 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Janssen Biotech Inc., Pharmacyclics LLC. Fresenius Kabi USA, LLC served on 2/5/2018, answer due 2/26/2018. (Blumenfeld, Jack) |
| Feb 6, 2018 | 9 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Janssen Biotech Inc., Pharmacyclics LLC. Fresenius Kabi USA, Inc. served on 2/5/2018, answer due 2/26/2018. (Blumenfeld, Jack) |
| Feb 2, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Fresenius Kabi Oncology Limited on 2/2/2018; Fresenius Kabi USA, Inc. on 2/2/2018; Fresenius Kabi USA, LLC on 2/2/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (fms) |
| Feb 1, 2018 | 1 | Exhibits A-O (1129) |
| Feb 1, 2018 | 1 | Civil Cover Sheet (1) |
| Feb 1, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (fms) |
| Feb 1, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Not earlier than 12/21/2017. Date of Expiration of Patent: See form.Thirty Month Stay Deadline: 5/13/2021. (fms) |
| Feb 1, 2018 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): See patent report for patent numbers. (fms) |
| Feb 1, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Pharmacyclics LLC filed by Pharmacyclics LLC. (fms) |
| Feb 1, 2018 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Biotech Inc. filed by Janssen Biotech Inc. (fms) |
| Feb 1, 2018 | 1 | Complaint* (1) |
